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Vimentin is a type III intermediate filament protein commonly found in 
fibroblasts, leukocytes, other cells of mesenchymal origin and in the eye lens. 
Over the years, vimentin has been described to play diverse roles across a 
great variety of cell and tissue functions and to be involved in the pathogenic 
mechanisms of several diseases [1].  
In cells, vimentin builds an extended and actively dynamic network of 
filaments that spans the cytoplasm, and undergoes constant and relatively rapid 
alterations of shape and localization in response to post-translational 
modifications and to biochemical and/or mechanical stress [2].  
Vimentin is a key sensor for oxidative or nitrosative stress, and it is the 
target for lipoxidation by several electrophilic lipids, which induce a marked 
remodeling of its filamentous network, as observed in work derived from this 
Thesis [3] and in previous works [4]. Furthermore, vimentin organization and 
function can be modulated by the ionic strength and by the presence of divalent 
cations, such as zinc [5, 6]. Indeed, previous work unveiled that vimentin 
strongly binds zinc, in vitro, and its function is importantly modulated by zinc 
availability, in cells [4, 7]. 
Remarkably, the highly conserved cysteine residue, C328, is important 
for the effect of oxidants on the assembly and on the morphology of vimentin 
filaments in vitro [8], and for vimentin remodeling in response to electrophilic 
attack in cells. Moreover, mutation of this cysteine residue alters filament 
assembly and/or properties in cellular models [4]. 
Nevertheless, the mechanisms underlying the effect of lipoxidation on 
vimentin organization as well as the structural and functional consequences of 
the vimentin-zinc interplay and its impact on the vimentin response against 
lipoxidative stress have not been totally elucidated. Therefore, an integrative 
approach was designed in order to characterize vimentin as a target for 
lipoxidation and to explore the interaction between vimentin and zinc, paying 
special attention to the cysteine residue as a hinge influencing vimentin 
responses to different stimuli.  
In vitro assays were the first approach used to study vimentin 
oligomerization and modification by different electrophilic agents. Since the 
objective of this work was the study of the effect of micromolar concentrations of 
divalent cations and reactive agents on vimentin structure and function, first, a 
Summary in English 
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procedure was set up to ensure the functional reconstitution of the protein, in 
the absence of metal chelators, in particular EDTA, which could interfere with 
the results. 
The efficiency of the removal of EDTA was monitored both by a 
colorimetric assay, using the zinc binding compound PAR, and by NMR, taking 
advantage of the ability of EDTA to complex zinc. Moreover, ultrafiltration is 
revealed to be a good choice for efficient removal of EDTA, suitable for small 
sample volumes, and that, when followed by dialysis, allows the functional 
refolding of vimentin.  
The in vitro modification by structurally diverse compounds was explored 
using this highly pure vimentin preparation. The structural and chemical 
properties of oxidants and electrophilic lipids, referred here as lipoxidants, 
markedly influence the functional outcome, which include morphological 
alterations such as aggregation, increased filament diameter, heterogeneity 
and/or bundling. Remarkably, the lipoxidant-induced alterations are attenuated 
in the C328S vimentin mutant, as well as in preformed filaments, highlighting 
the importance of the cysteine residue and the polymerization state of the 
protein in the vimentin response to lipoxidative modifications. 
In cells, the presence of the cysteine residue and the dynamic exchange 
between polymerized and non-polymerized vimentin are crucial for the network 
reorganization induced by oxidation or lipoxidaton, referred here as 
(lip)oxidation. Indeed, cysteine crosslinking and inhibition of mitochondrial 
oxidative phosphorylation, two strategies used to minimize vimentin dynamics, 
protect the vimentin network from disruption by diamide. Thus, (lip)oxidation of 
soluble vimentin appears to impair normal assembly.  
Interestingly, vimentin (lip)oxidation can also be modulated by context 
factors, including the levels of antioxidant defenses and certain divalent cations. 
Indeed, the results obtained indicate that zinc binds to the thiolate form of C328 
and is able to prevent modification of vimentin by several electrophiles and 
cysteine crosslinkers, in vitro. In addition, micromolar concentrations of zinc are 
able to promote vimentin oligomerization and induce morphological changes in 
vimentin organization, which depend on the support used and whether vimentin 
is in its soluble or previously assembled form.  




In cells, zinc availability seems to play a protective role against the 
disruption of the vimentin network induced by several electrophilic agents.  
Taken together, these results substantiate vimentin as target for several 
electrophilic compounds and highlight the single cysteine residue, C328, and 
filament dynamics as critical factors for electrophile-induced network disruption. 
Moreover, the interplay between vimentin and zinc has a strong impact on the 
organization and on the assembly properties of vimentin and modulates its 
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La vimentina es una proteína perteneciente a la familia de filamentos 
intermedios de tipo III que se encuentra comúnmente en fibroblastos, 
leucocitos, otras células de origen mesenquimatoso y en cristalino. A lo largo 
de los años, se ha descrito que la vimentina participa en una gran variedad de 
funciones celulares y tisulares y está involucrada en los mecanismos 
patogénicos de varias enfermedades [1]. 
En células, la vimentina forma una extensa y dinámica trama de 
filamentos que se extiende por todo el citoplasma, y sufre alteraciones 
constantes y relativamente rápidas de su organización y localización en 
respuesta a modificaciones postraduccionales y a estrés bioquímico y / o 
mecánico [2].  
La vimentina es un sensor clave para el estrés oxidativo o nitrosativo, y 
es diana de lipoxidación de varios lípidos electrófilos, que normalmente inducen 
una remodelación marcada de su red de filamentos [3, 4]. Además, la 
organización y función de la vimentina pueden ser moduladas por la fuerza 
iónica y por la presencia de cationes divalentes [5, 6] Estudios previos han 
revelado que la vimentina se une a zinc, in vitro y que su función está sujeta a 
una estrecha regulación por la disponibilidad de zinc en células [4, 7]. 
Es importante destacar que el único residuo de cisteína de la vimentina, 
la cisteína 328, que se encuentra altamente conservada, es crucial para el 
efecto de los oxidantes en el ensamblaje y en la morfología de los filamentos in 
vitro [8], y para la remodelación de la vimentina en respuesta a agentes 
electrófilos en células. Además, la mutación de la cisteína 328 altera el 
ensamblaje de los filamentos de vimentina y / o sus propiedades en modelos 
celulares [4]. 
Sin embargo, los mecanismos subyacentes al efecto de la lipoxidación 
de vimentina, así como las consecuencias estructurales y funcionales de la 
interacción vimentina-zinc y su impacto en la respuesta de vimentina frente al 
estrés lipoxidativo no han sido totalmente aclarados. Por lo tanto, en este 
trabajo se elaboró una estrategia para caracterizar la vimentina como diana de 
lipoxidación y para explorar la interacción entre la vimentina y el zinc, prestando 
especial atención a su único residuo de cisteína como un factor importante en 
la respuesta de la vimentina frente a diferentes estímulos. 
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En primer lugar empleamos ensayos in vitro para estudiar la 
oligomerización de vimentina y su alteración por diferentes agentes 
electrofílicos. Dado que nuestro objetivo implicaba el estudio del efecto de 
concentraciones micromolares de cationes divalentes y compuestos reactivos 
sobre la estructura y función de la vimentina, se diseñó un procedimiento para 
asegurar la reconstitución funcional de la proteína recombinante libre de 
quelantes de metales, que podían interferir con los resultados de nuestros 
ensayos. 
En particular, se emplearon métodos para eliminar el EDTA. La eficacia 
de la eliminación del quelante de metales se controló tanto mediante un ensayo 
colorimétrico, utilizando el compuesto capaz de unir zinc, PAR, como mediante 
RMN, aprovechando la capacidad del EDTA para formar complejos con zinc. 
Además, la ultrafiltración reveló ser una buena opción para la eliminación eficaz 
de EDTA, adecuada para pequeños volúmenes de muestra, y que en 
combinación con diálisis, permite el plegamiento funcional de la vimentina. 
Los ensayos in vitro han demostrado que la vimentina es susceptible de 
modificación covalente por compuestos estructuralmente diversos. Las 
propiedades estructurales y químicas de los oxidantes y lípidos electrofílicos, 
denominados lipoxidantes en este trabajo, influyen notablemente en el 
resultado funcional de la modificación, que incluye alteraciones morfológicas 
como agregación, aumento del diámetro del filamento, heterogeneidad y / o 
asociación lateral de los filamentos. 
Se ha observado que tanto el mutante vimentina C328S, como los 
filamentos previamente ensamblados presentan una respuesta atenuada a los 
compuestos electrófilos. Estas observaciones destacan la importancia del 
residuo de cisteína y del estado de polimerización de la proteína en la 
respuesta de la vimentina frente a la modificación lipoxidativa. 
En células, la presencia del residuo de cisteína y el intercambio dinámico 
de subunidades entre vimentina polimerizada y no polimerizada parecen ser 
cruciales para la reorganización de la red de filamentos inducida por oxidación 
o lipoxidación, procesos que se incluyen en el término (lip)oxidación. De hecho, 
el crosslinking de cisteína y la inhibición de la fosforilación oxidativa 
mitocondrial, dos estrategias que minimizan la dinámica de vimentina, protegen 
los filamentos de vimentina de la fragmentación provocada por diamida. Por lo 




tanto, la lipoxidación de la vimentina soluble parece afectar a ensamblaje 
normal. 
Curiosamente, la (lip)oxidación de la vimentina también puede ser 
modulada por otros factores, como por ejemplo los niveles de las defensas 
antioxidantes celulares y de ciertos cationes divalentes. De hecho, los 
resultados indican que el zinc se coordina con la forma tiolato de la C328, y 
puede prevenir la modificación in vitro de la vimentina por varios agentes 
electrófilos y crosslinkers de cisteínas. Además, concentraciones micromolares 
de zinc pueden promover la oligomerización de vimentina e inducir cambios 
morfológicos en la organización de la proteína, que son variables según el 
soporte utilizado y dependen de si la vimentina es soluble o se ha ensamblado 
previamente. 
En células, la disponibilidad de zinc parece tener un papel protector 
contra la alteración de la trama de filamentos de vimentina inducida por varios 
agentes electrófilos. 
En conjunto, los resultados identifican la vimentina como diana de varios 
compuestos electrófilos y resaltan la presencia de la C328 y la dinámica de los 
filamentos como factores críticos para la alteración de la trama de filamentos 
inducida por estos agentes. Además, la interacción entre vimentina y zinc tiene 
un fuerte impacto en la organización de esta proteína y modula su respuesta 














































1. Cytoskeletal proteins 
 
Cell integrity is supported by a complex and dynamic network of 
filaments known as the cytoskeleton. Cytoskeletal proteins not only contribute to 
maintain cell shape, but also participate in the correct positioning of organelles, 
provide tracks for the transport of vesicles and enable cells to carry out 
essential functions like division and movement [9, 10]. 
The eukaryotic cytoskeleton is constituted by three principal networks of 
filaments or fibers that differ in size and protein composition. Two of them are 
well-characterized: microtubules, which are composed of tubulin subunits, and 
actin microfilaments. Intermediate filaments (IFs) constitute the third 
cytoskeletal component, they are ubiquitously found in virtually all cells and are 
present both in the cytoplasm and in the nucleus. 
Microtubules are the thickest of the three types of cytoskeletal fibers, with 
a diameter of about 25 nm. The building block of a microtubule is a dimer of 
homologous α- and β-tubulin subunits, which associate end-to-end to form 
protofilaments that run along the length of cylindrical microtubules, under 
requirement of the nucleotide GTP. These long polymers form a network 
radiating from the juxtanuclear centrosome or microtubule-organizing center to 
the cell periphery, enabling the transport of cargo through the cell and acting as 
compression-bearing mechanical elements [11]. 
Actin microfilaments display a diameter of approximately 7 nm. Individual 
actin monomers are globular proteins, G-actin, which interact head-to-tail with 
two other actin monomers to form actin filaments, F-actin. Within cells, actin 
filaments localize at the periphery of the cell, in the cortex underlying the 
plasma membrane, and in bundles called stress fibers. The microfilament 
system is required for cell contraction and to form protrusions like lamellipodia, 
filopodia and pseudopodia [12]. 
Lastly, intermediate filaments comprehend a group of fibrillary structures 
of variable size, ranging from 3-4 nm to approximately 12 nm. Cytoplasmic IFs 
create an extensive network of filaments from the perinuclear region towards 
the cell surface, while nuclear lamins constitute a filamentous layer located 
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between the inner nuclear membrane and the peripheral heterochromatin [13], 
and both contribute considerably to cell mechanics. 
 
1.1 Intermediate filaments 
 
Intermediate filaments establish a sophisticated and dynamic network 
that can be found in nearly all differentiated cells. They work as an 
interconnected system, interacting closely with the other cytoskeletal 
components. IFs differ from actin and tubulin in their diverse primary structure, 
their relative insolubility, their particular nonpolar architecture and their 
apparently nucleotide-independent dynamics [13, 14]. 
 Within the human genome, IFs are encoded by over 70 functional genes 
and can be grouped into six distinct classes based on their sequence homology, 
encoding gene structure, charge, assembly mechanism and expression pattern 
[15], as summarized in table 1.  
 
Table 1: Classification of intermediate filaments (IFs) 
Class Proteins Size (kd) 
Typical 
Localization 
I Acidic keratins 40-64 Epithelial cells 
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Types I and II are the largest group, composed by acidic and neutral-
basic keratins typically found in epithelial cells. Vimentin, desmin, peripherin 
and glial fibrillary acidic protein (GFAP) integrate the type III IFs group. Vimentin 
is the most broadly distributed IF protein, characteristically expressed in cells of 
mesenchymal origin. Desmin is specifically expressed in muscle cells, whereas 
GFAP is expressed in glial cells, and peripherin is expressed in neurons of the 
peripheral nervous system. Type IV comprises neurofilaments (NF) NF-L, NF-M 
and NF-H, nestin, synemin and syncoilin, while the nuclear lamins (lamins A 
and C, B1 and B2) constitute the type V IF class. Filensin and phakinin are 
intermediate filament proteins expressed during differentiation of the lens 
epithelium, but they are not classified into any of the five types described, due 
to different features of its α-helical rod domain [16, 17]. 
 
1.1.1 Intermediate filament architecture and assembly 
 
IF proteins share an analogous tripartite structure consisting of a central 
α-helical rod domain, and poorly ordered N-terminal head and C-terminal tail 
domains, the size and sequence of which vary among the different classes of 
IFs [13]. The conserved rod domain is the “signature” feature of the IF family 
and point mutations at the beginning or end of the rod strongly alter IF 
organization and dynamics [18]. Secondary structure prediction based on IF’s 
sequence reveals that the rod domain contains three α-helical regions of largely 
conserved length, termed coils 1A, 1B and 2, interconnected by non-helical 




Figure 1. Structural organization of the IF monomer.  
Helical segments are nominated “coil” and represented as boxes; the corresponding number of 
amino acids is detailed below each segment. “CM” designates conserved amino acid sequence 
motifs that occur at the amino-terminal and carboxy-terminal ends of the rod. Intrinsically 
disordered linker segments connecting the different helices are shown as L1 and L12. 
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The rod domain plays an important role in the interaction between IF 
monomers, which assemble to form a parallel coiled-coil homo- or 
heterodimers, depending on the type of fibrillary protein. Parallel dimers gather 
to form non-polar tetramers, adopting an antiparallel and half-staggered 
configuration, which further laterally associate to give origin to unit length 
filaments (ULFs) of about 60 nm length. Longitudinal association of ULFs and 
subsequent radial compaction result in extended filaments, as explained below 
for vimentin (fig. 2) [13]. The IF assembly process does not require cofactors in 
vitro, and apparently, is nucleotide-independent. 
 
1.1.2 Pathophysiological relevance of intermediate filaments  
 
Cytoplasmic IF expression and composition varies according to the cell-
type. They participate in a wide scope of biological functions. Their intrinsic 
viscoelastic properties and their ability to build an extended network through the 
cell cytoplasm turn IFs into key regulators of cell shape and cell mechanics as 
well as controllers of the correct localization of organelles within the cell [2, 14]. 
In addition, IF dynamics actively influence the cell behavior in response to 
distinct environmental signals, which may include the regulation of key signaling 
pathways that control cell division, cell death or cell migration [16]. 
 Contribution of IFs to human diseases may occur at different levels. 
Mutations in genes encoding IF proteins may be involved in pathogenesis, and 
IF variants may either predispose to or protect from disease. As summarized in 
table 2, more than 30 diseases are related to mutations of IF genes and the 
majority of them are considered rare (disease affecting less than 1 in 2000 
citizens, in Europe, EURORDIS-Rare Diseases Europe, www.eurordis.org). 
Briefly, keratin mutations contribute to several diseases of skin and hair [19], 
myopathies and lens disorders are caused by genetic abnormalities of desmin, 
vimentin, filensin and phakinin [20], mutations of GFAP and neurofilaments are 
reported to be involved in neurodegenerative pathologies [21] and finally, lamin 
mutations induce several disorders, known as laminopathies, including 
premature aging syndromes, muscular dystrophy, lipodystrophy and neuropathy 
[22].  
 




Data obtained from The Human Intermediate Filament Database [23] 
  
 In many of these diseases, alterations of IF proteins may lead to the 
appearance of IF-containing inclusion bodies. This is the case for Mallory-Denk 
bodies constituted by keratins in alcoholic and non-alcoholic steatohepatitis 
[24], Rosenthal fibers formed by GFAP in Alexander disease [25] and formation 
of desmin bodies in myopathies [26].  
 Lastly, IF proteins may be clinically relevant as diagnostic markers for 
disease. Identification and analysis of IF proteins in tissues, in blood or in 
cerebrospinal fluids may help to diagnose poorly differentiated tumors and to 
evaluate tissue injury [27]. 
 In summary, IFs comprehend a large family of proteins, the expression 
and regulation of which are cell-type dependent. Their unique mechanical 
characteristics and their dynamics allow them to fulfil a wide array of biological 
 
Intermediate filament Disease 
Type I and II  
Acidic and neutral-basic keratins ▪ Epidermolysis bullosa simplex 
▪ Epidermolytic hyperkeratosis 
▪ Meesman corneal dystrophy 
▪ Keratodermas 
Type III  
Desmin ▪ Desmin-related myopathy 
▪ Dilated cardiomyopathy 1A 
▪ Distal myopathy 
GFAP ▪ Alexander disease 
Peripherin ▪ Amyotrophic lateral sclerosis 1 
Vimentin ▪ Dominant cataract 
Type IV  
Neurofilaments (NF-L, -M, -H) ▪ Parkinson disease 
▪ Amyotrophic lateral sclerosis 1 
▪ Neuronal IF inclusion disease 
Type V  
A-type lamins ▪ Hutchinson-Gilford progeria syndrome 
▪ Restrictive dermopathy 
▪ Charcot-Marie-Tooth disorder type 2B1 
▪ Familial partial lipodystrophy 
▪ Limb-girdle muscular dystrophy 
B-type lamins ▪ Acquired partial lipodystrophy 
 ▪ Adult-onset leukodystrophy 
Type VI  
Bfsp1 (filensin) Bfsp2 (phakinin)  ▪ Autosomal-dominant cataract 
Table 2: Examples of diseases related to mutations in genes encoding IFs.  
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functions, ranging from supporting cell architecture to participating in cell 
survival, migration and division. This significant contribution of IFs to maintain 
cell and tissue homeostasis is reflected in their involvement in several 
pathologies, either by representing putative therapeutic targets or by acting as 




Vimentin is a type III intermediate filament protein and it is the most 
widely distributed of the all IF proteins [1]. The sequence of vimentin is highly 
conserved across species, ranging from zebrafish to humans, which unveils an 
evolutionary role of vimentin in the physiological context [28, 29]. Over the 
years, vimentin has been described to play diverse roles in a great variety of 
cell and tissue functions and to be involved in the pathogenesis of diseases, 
such as cataracts, cancer, Chron’s disease and HIV infection [30-33]. Moreover, 
our group previously identified vimentin as a target for reactive inflammatory 




The complete sequence of human vimentin, first described in 1988, 
codes for a protein of 466 amino acids, with a molecular weight (Mw) of 53 x 10
3 
g/mol (UniProtKB; P08670 VIME) [35].  
As reported for IFs, the vimentin monomer entails a tripartite structure 
comprising an α-helical rod of 310 amino acids, a poorly ordered “head” 
constituted by 95 amino acids at the N-terminal end and a likely disordered “tail” 
with a 61 amino acid-long sequence at the C-terminal end [36]. The rod domain 
is mostly arranged as a left-handed coiled-coil, consistent with its sequence 
organization into repeats of seven amino acids (heptads), where a hydrophobic 
residue is found at the first and fourth positions of the repeats [37]. The rod 
domain is segmented into three regions, as the result of the interruption of the 
heptad repetition in two conserved places that are described as flexible linkers, 
the 8-amino acid long linker L1 within coil 1 and the 16-amino acid long non-α-
helical linker L12 between coil 1 and 2, similar to that illustrated in figure 1. At 
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the beginning of coil 2, the amino acid sequence presents a different 
hydrophobic pattern of 11-residue-long repeats (hendecads). Likewise, at 
position 350 of coil 2 there is a brief disruption in the heptad pattern by a single 
hendecad repeat that is referred to as “stutter”, and divides coil 2 into two 
segments as coil 2A and coil 2B  [36]. 
Establishment of the molecular organization of full-length vimentin has 
been revealed to be very challenging due to its intrinsic capacity to self-
assemble into flexible filaments which may prevent protein crystallization [38]. 
Therefore, a “divide-and-conquer” approach based on preparing multiple 
recombinant fragments of vimentin, preferably comprising 60 to 100 residues, 
has been proposed to study vimentin at the atomic level [39].  
So far, several crystal structures of vimentin fragments have been 
achieved, corresponding to coil 1A as a monomer and as a dimer [40, 41], to 
coil 1B, from monomer up to its tetramer configuration [42] and to coil 2, at 
different low order assembly states [43, 44]. Recently, the first crystal structure 
of a high-order filamentous state of vimentin coil 1B was successfully achieved 
[45]. Superimposition of crystal structures of several overlapping segments of 
vimentin in combination with molecular dynamics simulations yielded a model of 
the complete rod domain [46]. Meanwhile, the N-terminal head and C-terminal 
tail domains have not been resolved yet, due to lack of a defined structure. 
 
1.2.2 Assembly in vitro 
 
Vimentin is highly insoluble in physiological buffers but under conditions 
of very low ionic strength or in the presence of chaotropic substances, such as 
urea or guanidinium hydrochloride, it is possible to find vimentin as a soluble 
form. In the presence of concentrations of urea above 8 M, vimentin exists 
mainly in the monomeric form. Decreasing urea concentration down to 6 M 
triggers the multi-step mechanism of vimentin assembly (fig. 2). The first event 
corresponds to the formation of a 46-nm-long dimer by the parallel alignment of 
the rod domains of two different vimentin polypeptides [41, 47]. Further dialysis 
into 5 M urea promotes the lateral association of two of these dimers to give 
origin to an antiparallel and, approximately, half-staggered tetramer, which 
constitutes the smallest soluble oligomeric form that occurs in low-salt buffer, 
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e.g. 5 mM Pipes-Na, pH 7.0 [48]. Under the electron microscope, these 
tetramers typically appear as rod-like structures, with a diameter of 
approximately 2-3 nm and 65 nm in length [49].  
 
Earlier in vitro studies using lysine-specific crosslinkers suggested three 
different alignments of the dimers within the tetramer: A11 and A22, in which 
the dimers are staggered in a way to bring either their 1B or 2B rod domain 
segments, respectively, into register; and A12 in which the two dimers are 
nearly overlapped [8, 50, 51].  
Additionally, exploring the architecture of the dimer-dimer interaction has 
shown that glutamic acid residues at position 191 and position 348 correspond 











Molecular alignments of tetramer






















1A 1B 2A 2B
Figure 2: Schematic representation of the assembly of vimentin.  
Vimentin comprises a central alfa-helical rod domain, an amino-terminal head and carboxy-
terminal tail domains. The assembly process starts with the formation of a ~46nm-long parallel 
dimer, which further assembles into an anti-parallel tetramer of approximately 65 nm in length. 
These anti-parallel tetramers laterally assemble into unit-length filaments (ULFs), with ~65 nm in 
length, that longitudinally anneal and radially compact to give origin to long filaments (> 240 nm). 
Vimentin dimers can adopt different molecular alignments within tetramers (right panel): A11, 
A22, and A12, organized as illustrated. 
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alignments, respectively [47, 52]. At the same time, the formation of a correctly 
aligned tetramer that is competent to further assembly into filaments is 
mediated by the disordered head domain, involving basic residues responsible 
to attract the acidic residues existing in the rod domain of the second dimer [51, 
53, 54]. Moreover, there is a complementarity in the charge distribution on 
adjacent surfaces, within the tetramer, important for the assembly of vimentin 
[41]. 
Once the ionic strength is raised, the highly charged rod-like tetrameric 
complexes assemble into 32-meric complexes known as unit-length filaments 
(ULFs) of roughly 60 nm in length and up to 20 nm in width [54]. The increase of 
the ionic strength relieves the basic head domain from intra-tetrameric 
interactions to form new contacts that engage two tetramers together. Such 
inter-tetrameric association is reinforced by the close interaction between the 
adjacent coiled-coils of the segments 1A and 2A. Successive cross-coiling of 
the coil 1A and coil 2A segments originating from different tetramers induces 
lateral association, enabling the oligomer to grow, in a roughly circular fashion, 
into octamers, 16-mers, and finally into ULFs [53, 55]. Interestingly, crosslinking 
studies using a temperature-sensitive mutant, vimentin K139C, unveiled that 
ULFs are predominantly assembled from A11 type tetramers and A22 and A12 
configurations typically occur in the compacted filaments [51]. 
The ULF formation is termed as “phase 1” of IF assembly, and it is so 
fast that A11 tetramers are all consumed within milliseconds, as determined by 
an “stopped-flow” approach in combination with static light-scattering 
measurements [56]. 
The elongation process corresponds to the second step of vimentin 
assembly and it occurs within the first minutes after addition of assembly buffer, 
as followed by time-resolved static and dynamic light scattering [57] and by 
observation under electron microscopy of different time point preparations [38, 
49, 58, 59]. In this assembly step, ULFs longitudinally anneal end-to-end into 
immature filaments. Consecutive ULF addition increases vimentin IF length till 
several microns [59]. Elongation stabilizes after 1 h, though it slowly continues 
through longitudinal annealing of long filaments, as verified by total internal 
reflection fluorescence microscopy of fluorescently labeled vimentin [60]. 
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The third and last step of the assembly process consists in the radial 
compaction of protofibrils into mature filaments. Vimentin IFs radially compact 
from around 18 nm of diameter, at  ten seconds, to approximately  13 nm  after 
1 h, as determined by EM [54]. Results from several studies indicate that the 
vimentin C-terminal tail domain plays an important role in width control during IF 
assembly [48].  
Mass measurements with scanning transmission electron microscopy 
(STEM) are consistent with a typical average of 32 vimentin molecules (8 
tetramers) per filament cross section [13]. Nevertheless, vimentin IFs display a 
high level of polymorphism, reflected in a heterogeneous mass per length 
(MPL) distribution along the different assembly stages. Correspondingly, 
vimentin ULFs may vary between 32 till 45 monomers per cross section, after 
two seconds of being challenged by a high-salt buffer, and vimentin mature IFs 
may contain from 30 to 44 monomers per filament cross section, after 1 h of 
polymerization [54].  
Moreover, vimentin IF polymorphism strongly depends on the assembly 
conditions. As such, vimentin filaments formed by slow dialysis present a more 
regular and homogenous morphology, compared to those formed by dilution of 
vimentin into assembly buffer, which induces an abrupt increase of the ionic 
strength, causing a more heterogeneous rearrangement of tetramers [13, 54]. 
Similarly, salt concentration, temperature and the presence of divalent cations 
influence filament morphology, IF formation kinetics and mass per length 
composition along vimentin IFs, as reflected, for instance, by the increase in the 
number of subunits up to 56 or 84 upon assembly in the presence of 2.5 mM 
MgCl2 [6, 54, 61, 62]. 
Summing up, vimentin filaments result from coiled-coil multi-domain 
amino acid sequences that are stabilized and linked by hydrophobic and ionic 
interactions, to form the fibrous protein structure. Morphology of the different 
assembly intermediates as well as IF formation kinetics can be followed by 
different techniques, which unveiled important context factors that may 
influence the assembly behavior of vimentin. 
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1.2.3 Assembly in cells 
 
In cells, vimentin builds an extended and dynamic filamentous network 
which undergoes through constant and relatively rapid alterations of shape and 
localization. Cryo-electron tomography of ultrathin cryo-sections of cell 
cytoplasm showed vimentin filaments with an average diameter of roughly 12.5-
13.5 nm [58].  
Within the cell environment, vimentin exists both as soluble tetrameric 
complexes and polymerized forms, which are continuously exchanging 
subunits. Successful works using cell fusion, photobleaching and 
photoactivation strategies revealed that  vimentin filament turnover, essential to 
maintain its structural integrity, occurs either by constant severing and 
reannealing at filament ends or by swapping units along the filament length [63].  
In addition, vimentin assembly dynamics is regulated by post-
translational modifications, such as phosphorylation, and requires ATP [3, 64, 
65]. Accordingly, phosphorylation of several residues in the N-terminal head 
domain is important for the integrity and dynamics of the filamentous network. 
Particularly, phosphorylation of S55 promotes vimentin disassembly necessary 
for cells to undergo mitosis [66]. Recently, our group has demonstrated that C-
terminal domain is fundamental for an extended vimentin IF network and for the 




 In 1990s, studies with vimentin knockout mice originally pointed to a very 
mild phenotype, with mice being able to develop and reproduce without 
apparent defects [68, 69]. However, further detailed analyses of vimentin -/- 
mice have unveiled that loss of vimentin elicits marked cellular alterations with 
important pathophysiological implications. Indeed, vimentin deficiency is 
associated with cell morphological changes, impaired wound healing and 
reduction in cell adhesion, migration and stiffness [70-73]. Consequently, these 
reported phenotypes have unveiled various functional roles for vimentin within 
physiological systems, ranging from cell architecture to signaling, which may be 
translated either in the maintenance of cell and tissue homeostasis or be related 
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to the occurrence of pathologies. The main functions of vimentin are briefly 










Vimentin builds an extended and dynamic network 
important for cell shape and organelle position, by: 
 regulating the location and motility of 
mitochondria, Golgi complex and lysosomes;  
 surrounding lipid droplets or misfolded proteins, 
forming cage-like structures  and routing them to 
their fate;  
 accumulating at the nuclear periphery, stabilizing 







Vimentin IFs create particular viscoelastic properties 
important to: 
 maintain cell integrity in response to compressive 
stress;  
 provide mechanical flexibility required for cell 
contraction, migration and proliferation.  
 [81] 
Cell motility 
Vimentin stimulates cell migration by:  
 restricting actin flow and aligning traction forces; 
 interacting with tubulin and actin to maintain cell 
polarity;  
 supporting the development of membrane 






Vimentin is both a marker and effector for EMT by 
regulating cell motility required for the mesenchymal 
phenotype. 
 EMT is a biological process essential to 
embryonic development, wound healing and to 
cancer metastases formation, characterized by 
induction of cell motility, changes in gene 




Vimentin is important for the cell-cell and cell-
extracellular matrix contacts by: 
 promoting the stability and shape of focal 
adhesions, through interaction with integrins;  
 interacting with focal-adhesion intermediates, like 
plectin and with actin-crosslinking proteins, as 
filamin A  and fimbrin; 
 protecting cell-matrix adhesions from shear stress 






Table 3: Biological functions of vimentin 
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Continuation of table 3: Biological functions of vimentin 
 
 
1.2.5 Vimentin related to disease 
 
Vimentin biological functions are important for tissue and cell 
homeostasis. Nevertheless, such roles may contribute to the appearance of 
certain diseases, which turn vimentin as a putative drug target and an important 
diagnostic biomarker [1].  
In the eye lens epithelium, the missense mutation E151K in coil 1B of 
vimentin provokes its misfolding and aggregation. Such incidence leads to 
opacification of the eye lens characteristically occurring in cataracts [94].  
Due to its involvement in EMT, vimentin has been extensively reported 
as a key component of cancer progression and frequently described as a 
prognostic factor for poor survival in lung, breast, prostate, gastrointestinal 
cancers and malignant melanoma [95-100].  
In addition to cancer, EMT is also involved in other pathological 
processes. EMT is related to the invasive properties of cells and to the 
development of intestinal fibrosis in Crohn’s disease [101]. In rheumatoid 
arthritis, EMT induces hyperplasia of the tissues surrounding the synovial 
membrane and promotes cell invasion [102]. A similar phenomenon called 
Function Description Reference 
Cell 
signaling 
Vimentin IF network is enrolled in several intracellular 
signaling processes. Such as: 
 Signaling pathways requiring the 14-3-3 proteins, 
in a phosphorylation-dependent manner; 
 TGF-β-Slug signaling process, orchestrating 
fibroblast proliferation and keratinocyte activation, 
in wound healing;  
 AKT dependent signaling pathway, inhibiting 





Vimentin network undergoes a drastic remodeling 
during cell division:  
 vimentin filaments can be either solubilized or 
redistributed towards the cell cortex, depending 
on the cell type.  





   
28 
 
endothelial-to-mesenchymal transition is observed in atherosclerotic lesions 
[103]. Finally, vimentin overexpression is also considered a pathogenic factor in 
lung fibrosis [104]. 
During infection, vimentin mediates pathogen-host cell interaction and it 
has been reported to control the replication of HIV in the human T cell line MT4 
[33, 105]. 
Vimentin may also behave as antigen in autoimmune diseases. Post-
translational modification of vimentin creates antigenic epitopes, and 
consequently leads to the synthesis of antibodies. For instance, citrullinated, 
carbamylated and acetylated forms of vimentin function as antigens in 
rheumatoid arthritis and antibodies against them serve as diagnostic markers of 
the disease [106, 107].  
Finally, vimentin is also related to aging and cell senescence. Proteomic 
studies have identified vimentin oxidatively modified by malondialdehyde (MDA) 
at the surface of senescent primary human fibroblasts. Moreover, secreted 
MDA-modified vimentin was detected in the plasma of aged senescence-
accelerated mice, which have deregulated redox metabolism and accelerated 
aging [108]. Additionally, glycation of vimentin was found in skin fibroblasts of 
elderly donors and lack of serine phosphorylation during mitosis is associated to 
impaired cytokinesis and therefore, increased senescence [30, 109]. 
As a general overview, the type III IF vimentin is an important component 
of the cytoskeleton. Vimentin structural plasticity is reflected in the variety of its 
biological functions. This functional diversity is not only involved in physiological 
conditions but it may also participate in the pathogenesis of several diseases, 
which make vimentin a putative drug target and a relevant clinical biomarker. 
 
1.2.6 Post-translational modifications (PTMs) of vimentin 
 
Vimentin PTM is a critical mechanism for the regulation of network 
organization and remodeling in a broad range of physiological and pathological 
contexts.  
 Phosphorylation has been the primary covalent PTM regulator of IF 
dynamics studied over the years. Vimentin phosphorylation is tightly regulated 
by a broad group of coordinated kinases and phosphatases [65, 110-112]. 
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Briefly, reversible phosphorylation and dephosphorylation of serine or threonine 
residues, particularly located in the head and tail domains, dynamically control 
vimentin assembly and disassembly, which are crucial for mitosis and 
maintenance of cell structural integrity [113-115]. In addition, vimentin 
phosphorylation mediates binding to other proteins, such as 14-3-3 proteins, 
regulating cell signaling and cell cycle control [92, 116]. Lastly, vimentin 
phosphorylation influences processes underlying cell motility of both normal and 
cancer cells, and mediates interaction with integrins important for cell adhesion 
[117-119].  
Sumoylation, ubiquitination and acetylation have also been reported to 
regulate vimentin properties, commonly associated to pathological situations, as 
cancer [119-121]. For instance, increased levels of acetylated-vimentin are 
reported to be involved in Sirtuin 5-mediated hepatocellular carcinoma 
migration, whereas decreased levels of ubiquitinated vimentin are associated to 
its up-regulation in gastric cancer cells, promoting its aggressiveness. 
Furthermore, vimentin is a target for advanced glycation end products, 
mainly through Maillard reaction, and it is also enzymatically modified by O-
linked β-N-acetylglusosamine (O-GlcNac), known as O-GlcNAcylation. 
Glycation induces vimentin network remodeling into aggresomes in human skin 
cells, whereas O-glycosylation is required for host IF cytoskeleton-intracellular 
pathogen interaction during infection [105, 109].  
 Vimentin can also be modified by a broad range of oxidants and 
electrophilic lipids, which generally induces an extensive IF network 
organization [4]. Such oxidative and lipoxidative modifications are going to be 
the main topic of this thesis, thus a detailed description of their impact on 
vimentin is given later in this work. 
The crosstalk between PTMs represents an additional level of cell 
regulation and signaling complexity. One of the best established examples of IF 
PTM cross-talk is the inverse correlation between phosphorylation and 
glycosylation. Typically, O-GlcNAcylation occurs on the same, or adjacent to 
phosphorylatable serine/threonine residues, which may compete with 
phosphorylation, stimulating or preventing it [122, 123].  
 Recently, we have demonstrated a putative interplay between vimentin 
phosphorylation and the impact of oxidative and lipoxidative modifications. 
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Vimentin hyperphosphorylation caused by phosphatase inhibitors, such as 
calyculin A, intensified the network fragmentation by diamide and potentiated 
vimentin IF juxtanuclear condensation and loss of peripheral filaments induced 
by 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2). On the other hand, a 
phosphorylation-deficient vimentin “SA mutant”, in which 11 phosphorylatable 
serine residues present in the N-terminal head have been replaced by alanines, 
showed an attenuated IF network remodeling in the presence of the above 
mentioned compounds [3]. 
As a general overview, there are a broad range of PTMs that may target 
vimentin, contributing and modulating its structural and functional properties in a 
cell-type dependent manner. Accordingly, vimentin PTMs are essential to 
preserve cellular and tissue homeostasis and their abnormal regulation may 
lead to the appearance of diseases [119, 124]. 
 
2. Redox imbalance and protein lipoxidation  
 
 Cells are constantly exposed to oxidant species, arising from 
endogenous cellular metabolism or by exposure to environmental oxidants. The 
cellular concentration of such oxidative species is controlled by an elaborate 
antioxidant defense system, comprising antioxidant enzymes as superoxide 
dismutase (SOD) and glutathione peroxidase (GPx), and low-molecular-weight 
scavengers, such as glutathione and ascorbic acid [125]. 
Imbalance between oxidants and antioxidants in favor of the former leads 
to oxidative stress. The level of oxidative stress determines its physiological 
implications or pathological consequences, meaning that while low-level oxidant 
generation is involved in redox signaling, a high production of oxidative species 
may cause cell damage [126]. 
The cellular response to oxidative stimuli is mediated through an 
integrated system of thiol sensors, which work as molecular redox switches 
within redox signaling pathways with the main objective of conserving redox 
homeostasis [127].  
The oxidant species are able to react with several biomolecules, 
unsaturated lipids present in membrane bilayers being a common target giving 
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rise to electrophilic species. Consecutively, some of these lipid oxidation 
products are able to react with proteins, a phenomenon that is known as 
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Lipid species involved in lipoxidation include a wide variety of oxidized, 
nitrated and chlorinated products of phospholipid oxidation and metabolism, 
which are able to react with nucleophilic moieties, such as lysine, arginine, 
histidine and cysteine residues of proteins [129-131].  
These lipoxidative PTMs may be implicated in the pathogenesis of 
cardiovascular diseases, cancer immunity and brain aging and 
neurodegeneration [132-135]. For many years, covalent addition of electrophilic 
lipids to proteins has been considered as an injurious consequence of oxidative 
stress, but now, protein lipoxidation is being recognized as well as a new 
mechanism of cell signaling relevant to redox homeostasis, adaptive response 
and inflammatory resolution [136, 137]. 
Notably, under oxidative stress, both oxidants and electrophiles coexist 
and therefore, proteins can suffer combinations of oxidative and lipoxidative 
modifications that can affect the same protein/residues in variable proportions. 
To refer to these potentially diverse modifications, consisting in oxidation or 
lipoxidation, we will use the term (lip)oxidation. 
 
2.1 Electrophilic lipids and their involvement in protein modification 
 
Polyunsaturated fatty acids (PUFAs), constituents of membrane 
phospholipids or lipoproteins, are susceptible to enzymatic and non-enzymatic 
lipid peroxidation which generates a remarkable structural diversity of reactive 
breakdown products [138].  
Non-enzymatic phospholipid peroxidation is a radical-initiated and 
autocatalytic mechanism. It consists of the abstraction of the bis-allylic 
methylene hydrogen by other radical species followed by capture of oxygen 
atoms, originating lipid hydroperoxides. Such lipid hydroperoxides undergo 
rearrangement and cleavage reactions which result in the generation of lipid 
oxidation end products. On the other hand, cytochrome P450 enzymes, 
lipoxygenases and cyclooxygenases are also able to enzymatically produce 
oxidized fatty acids and phospholipids [139, 140]. 
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These reactive lipid products possess electrophilic properties due to the 
presence of carbonyl groups (aldehydes or ketones) or α,β-unsaturated 
moieties and they can be classified in five principal categories: alkanals (and 
hydroxyalkanals), 2-alkenals, 4-hydroxy–2-alkenals, keto-alkenals, and 
alkanedials (dialdehydes). Malondialdehyde (MDA), acrolein (ACR), 4-
hydroxyhexenal (HHE) and 4-hydroxynonenal (HNE) are the most abundant, 
active and studied electrophilic lipids [138]. Moreover, enzymatic and non-
enzymatic transformations of arachidonic acid give origin to electrophilic 




Figure 3. Main types of adducts formed between electrophilic lipids and proteins.  
Schiff adducts are exemplified for alkanals and lysine and arginine residues of peptides. Michael 
adducts are illustrated for alkenals and lysine, arginine, histidine and cysteine residues of 
peptides. This image was adapted from [128]. 
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The type of interaction between proteins and the reactive lipid oxidation 
products depends on the chemical reactivities of the electrophile and of the 
nucleophilic site in the protein, determined by its pKa, surface accessibility and 
the pH of the intracellular compartment. Electrophilic lipids can mainly form 
Schiff adducts and/or Michael adducts with nucleophilic groups in peptides and 
proteins, specifically with the free amine group of lysine, the imidazole of 
histidine, the guanidine of arginine and the sulfhydryl group of cysteine (fig. 3). 
Although both Michael and Schiff adducts are reversible, the Schiff adducts are 
generally more unstable whereas Michael addition is almost irreversible due to 
the low rate of the reverse reaction [142].  
 
2.2 Biological significance of lipoxidative PTMs 
 
Development and improvement of specific and more sensitive 
methodology expanded the evidence for the occurrence of lipoxidation in vivo, 
in both healthy and damaged tissues. Proteins targeted by reactive lipid 
oxidation products may suffer changes in its conformation and its assembly 
properties, and interact differently with small ligands, cofactors, other proteins 
and cellular compartments [143]. In many cases, lipoxidized proteins may have 
impaired function contributing to pathological consequences [132]. On the other 
hand, lipoxidation of proteins may also have important physiological roles, by 
being involved in signaling pathways and triggering adaptive responses to 
stress conditions (fig. 4) [136].  
The antioxidant response pathway via Keap1-Nrf2 and the heat shock 
response through HSF transcription factors, which have cytoprotective, 
proteostatic and anti-inflammatory functions, are examples of stress-activated 
pathways regulated by lipoxidation [136]. For instance, 4-hydroxynonenal (HNE) 
is reported to target the Keap1-Nrf2 pathway [144].  
Adducts formed between prostaglandins and peptides/proteins have also 
significant biological effects. Cyclopentenone prostaglandins (cyPG) are 
endogenous lipid mediators and they have shown protective effects in cellular 
and animal models of inflammation and tissue injury, revealing to be potential 
therapeutic agents, due to their anti-inflammatory, antiproliferative, antiviral and 
antitumoral activity [145]. Additionally, cyPG are able to form covalent adducts 
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with diverse proteins along the activation pathway of the proinflammatory 
transcription factor NF-κB, with the transcription factor PPARγ and with proteins 
involved in the control of cellular redox status, such as thioredoxin and 
thioredoxin reductase. These modifications are responsible for their anti-
inflammatory effects, their capacity to regulate lipid metabolism, adipocyte 
differentiation and to control the cellular redox status [146-148].  
Chronic inflammatory processes induce oxidative/nitrosative stress and 
consequently, they are associated with high levels of lipid peroxidation products 
and protein lipoxidation. In turn, the resulting electrophilic lipids can alter the 
functions of proteins involved in inflammation, such as the nuclear transcription 
factor NF-ĸB and enzymes as iNOS and COX-2 [149, 150], and modulate the 
immune system by originating lipoxidized proteins highly immunogenic and 
leading to the generation of antibodies against them [134, 151]. 
In cancer, lipoxidation may have divergent results, either by triggering 
mechanisms associated with cancer progression, increasing the grade of 
malignancy, or by having anti-carcinogenic effects through induction of cell 
cycle arrest and apoptosis in cancer cells [134]. HNE is a clear example of the 
dual effect of lipoxidation in cancer. While HNE contributes to cancer cell 
survival by forming potentially mutagenic DNA-adducts or by negatively 
regulating proteins involved in DNA repair, HNE is also able to induce adaptive 
responses, through activation of autophagy or by causing cell cycle arrest, in 
order to eliminate damaged molecules and prevent further aggravation and 
deleterious consequences [144]. Interestingly, electrophilic prostaglandins, 
namely 15d-PGJ2, covalently binds to glutathione S-transferase P1, an enzyme 
related to tumor chemoresistance, unveiling a potential application of 
electrophilic lipids to overcome the resistance of certain tumors to 
chemotherapy and radiation [152, 153]. 
The brain tissue is highly rich in PUFA-containing membrane 
compartments, which combined with the high abundance of redox transition 
metals and intense oxygen consumption turn it into an important source of 
reactive electrophilic species. In fact, lipoxidation processes are frequently 
associated with neurodegenerative disorders [154]. Proteomic studies have 
demonstrated increased lipid peroxidation in the brain of patients with Alzheimer 
disease (AD), by measuring the levels of free and protein-bound HNE, 
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malondialdehyde and acrolein, and they have identified lipoxidized proteins, 
which are consistent with the biochemical and cognitive dysfunction described 
in AD [154]. In addition, recent studies have reported that lipoxidative 
modifications of the cysteine residue at position 294 of the type III IF protein 
GFAP could contribute to its disruption and aggregation, and they could 








2.3 Biological relevance of lipoxidation adducts in cytoskeletal 
proteins 
 
The above mentioned lipoxidative modification of GFAP illustrates the 
importance of cytoskeletal proteins as common targets for lipoxidation, which 
may have physiological or pathological relevance in oxidative stress, cellular 
senescence and age-related diseases [135, 156]. In fact, a lipidomic study 
focused on the mechanisms underlying the preservation or deterioration of 
Figure 4. Protein lipoxidation in pathophysiology. 
The generation of electrophilic lipids, during stress conditions, triggers the formation of covalent 
adducts with proteins (lipoxidation). Functional consequences in physiology (left box) or 
pathophysiology (right box), dependent on the levels of protein lipoxidation, are outlined. ROS, 
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neurons and cerebral functions has identified several cytoskeletal proteins, such 
as actin, dynamin 1, GFAP, spectrin, tubulin and vimentin, as important targets 
for lipoxidative damage, putatively contributing to neuronal aging [135]. 
Moreover, previous studies have detected neurofilaments as targets for 
modification by HNE in the nervous system of mice. The levels of HNE-modified 
neurofilaments were surprisingly found constant through the life span of the 
mice, indicating a putative physiological role of HNE adduction related to the 
protection of neurons from carbonyl-mediated stress [157]. 
Additionally, proteins involved in cytoskeletal organization, including 
tubulin, actin, tropomyosin and vimentin are covalently modified by electrophilic 
lipids, including HNE and 15d-PGJ2, which in all cases leads to cytoskeletal 
derangement, the intensity of the effect observed probably depending on the 
proportion of protein modified [34, 158, 159]. Actin, in particular, has been the 
subject of extensive investigation and proposed to serve as a potential marker 
for carbonylation damage and to act as a carbonyl scavenger [160]. 
 
2.3.1 Lipoxidative post-translational modifications of vimentin 
 
A high number of reactive species, generated during stress conditions, 
can reversibly and irreversibly react with vimentin through nitrosative, 
lipoxidative or oxidative mechanisms [3, 161]. (Lip)oxidation refers here to both 
oxidative and lipoxidative modifications of vimentin. 
Multiple amino acid residues may be targeted by (lip)oxidative 
modifications. Previous works reported vimentin sole cysteine at position 328 as 
highly susceptible for oxidation and a common site for electrophilic addition [4]. 
Cysteine modifications are often involved in redox sensing via disulfide 
formation, sulfenylation, S-glutathionylation or S-nitrosylation [162]. In fact,  in 
vitro incubation of vimentin with H2O2 and CuCl2 induces oxidative crosslinking, 
through disulfide formation [8, 163] and cell treatment with strong thiol oxidants, 
as diamide, induces extensive fragmentation of the vimentin IF network [3, 4] 
Moreover, reactive species bearing unsaturated carbonyl moieties, 
including cyclopentenone prostaglandins (cyPG) and aldehydic compounds, as 
HNE, are able to react with recombinant vimentin, mainly through Michael 
addition or via Schiff base formation [3, 34, 164]. Within the cell environment, 
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such reactive compounds induce strong bundling and/or juxtanuclear 
condensation of vimentin filaments, which in some cases display characteristics 
of aggresomes [3, 4]. The biological relevance of this network remodeling is not 
completely understood. Vimentin may be both a mediator of cell damage or play 
a protective role as scavenger of electrophilic and oxidant compounds, 
preventing them from damaging other proteins and cellular components [165]. 
Moreover, aggresome formation by vimentin in response to electrophilic attack 
may play a cytoprotective role helping to isolate potentially toxic 
damaged/misfolded proteins and facilitating their clearance by autophagy [78]. 
On the other hand, cells containing (lip)oxidatively remodeled vimentin IF 
network may present mitotic abnormalities [67, 166]. Table 4 illustrates some 
examples of lipoxidant agents reported in the literature to target vimentin. 
 
 
In summary, lipoxidative modification of cytoskeletal proteins may have 
direct or indirect functional consequences which could contribute either to 
maintenance of cell homeostasis or to cell damage and consequent 
development of pathologies. Besides, from a functional point of view, oxidized 
lipids bind to many targets in the cell proteome and their effects arise from 
interplay of the diverse modifications, which complicates the interpretation of the 
structural and functional outcomes. Consequently, attribution of functional roles 
to lipoxidation of proteins should be addressed with prudence and the use of 
sensitive and complementary methods to assess protein lipoxidation are 
extremely necessary. 
Lipoxidant agent Residue Species Reference 
H2O2 C328 Human [163] 
H2O2 + CuCl2 C328 Human [8] 
Diamide C328 Human [4]; [3] 
HNE C328 Human [167]; [3] 
PGA1 C328 Syrian Hamster [164] 
15d-PGJ2 C328 Human [34]; [3] 
MDA C328 Human [108] 
MDA R122, R440, R450 Human [168] 
2-nonenal K235 Human [169] 
Oxopentanal H437, K439 Rat [170] 
Oxobutanal K292, R158, R155 Rat [170] 
Oxooctanoic acid R155 Rat [170] 
Table 4: Oxidants and electrophiles reported to modify vimentin 
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2.4 Methods for the detection of protein–lipid adducts 
 
Given the importance of lipoxidation in pathophysiology, important efforts 
have been concentrated in the development of highly sensitive methods to 
unequivocally determine and characterize this modification, both in healthy and 
damaged tissues [171]. 
Mass spectrometry (MS) provides state of the art approaches for the 
identification and characterization of lipoxidized proteins/residues as well as the 
modifying agents. MS-based analytical strategies permit the highly sensitive 
detection of compounds, fast scan rates suitable for high throughput sample 
screening and structural information at a molecular level, providing structural 
characterization of protein-lipid adducts in vitro and ex vivo settings. In the mass 
spectrum, peptide-lipid adducts are commonly determined on the basis of the 
mass shift against the unmodified peptide, which gives a clue on the reactive 
moiety attached to the peptide [171, 172]. 
The low abundance of lipoxidation adducts, together with the high 
complexity of biological samples, represent a great challenge for their detection. 
Therefore, identification of protein lipoxidation adducts typically involves 
enrichment methods, chemical labelling approaches and bottom-up strategies 
combining enzymatic digestion, chromatography methods and analysis by MS. 
These methods are commonly used to enhance sensitivity and selectivity, 
improving the structural interpretation [173]. The most popular chemical labels 
used for derivatization of the free carbonyl groups present in Michael adducts 
are biotin based hydrazide-functionalized reagents, Girard P reagents and 
aldehyde reactive probes. Lipid–protein Schiff adducts cannot be derivatized by 
this approach, unless the electrophilic lipid is a di-aldehyde [171]. 
MS-based approaches combined with enrichment procedures using 
biotin are increasingly being used to identify site-specific modifications of 
proteins in complex proteomes [142]. For instance, in the case of vimentin, 
introduction of an avidin chromatography step after tryptic digestion allowed 
enrichment of the vimentin peptide modified by PGA1-B, thus making possible 
the identification of C328 as the site of modification by MALDI-TOF MS/MS 
analysis [164]. Another example is the identification of Rac1 as a target for 
modification by the biotinylated analog of 15d-PGJ2, in vitro, by LC-MS/MS, and 
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in endothelial cells, by biotin affinity precipitation followed by western blot 
analysis with streptavidin [174]. The latter example demonstrates that other 
non-MS methods can be used to detect protein-lipid adducts, such as the 
combination of labelling techniques or enrichment procedures with SDS-PAGE 
followed by immunoblotting [155].  
Alternatively, there are several antibodies available that directly 
recognize protein adducts of lipid peroxidation products, which can be applied 
to western blot, immunocytochemistry and immunohistochemistry [128 170]. 
These comprise antibodies against various types of HNE-, acrolein- and MDA-
lysine adducts [175-177]. In general, immunostaining methods have good 
sensitivity, though additional methods are required to identify the proteins 
modified and the sites of modification. 
Unquestionably, the identification and structural characterization of 
adducts formed between the oxidized lipids and proteins by the above 
mentioned methodology is critical to elucidate the impact of lipoxidation in cell 
biology [142]. Nevertheless, interpretation of functional consequences of protein 
lipoxidation is more complex to address. Therefore, insights into the functional 
consequences of protein lipoxidation requires interdisciplinary and integrative 
approaches involving additional biochemical and biophysical techniques 
associated with cell culture, purified systems, cytomimetic platforms and in vivo 
models.  
For instance, lipoxidation can promote protein polymerization or 
aggregation and associations into hetero-complexes that can be analyzed by 
light scattering, fluorescence anisotropy and ultracentrifugation techniques 
[178]. Besides, with the increasing size of the protein associations, electron 
microscopy becomes suitable for the observation of lipoxidation-induced protein 
assemblies. EM allows measurements of changes in the dimensions of proteins 
at nanometer scale and in combination with tagged electrophilic lipids permits 
the detection of adducted moieties by recognition with gold-labeled tools, for 
example [179, 180]. 
Lastly, immunofluorescence of the proteins of interest or the use of 
different tags on lipoxidized macromolecules or their precursors can be used to 
analyze lipoxidation-induced morphological changes by means of fluorescence 
microscopy or to explore the protein-protein interactions by assessment of 
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colocalization rates using confocal or superresolution microscopy [4, 67, 181]. 
For instance, incubation of biological samples with lipid peroxidation substrate 
arachidonic acid or 15d-PGJ2, tagged with either biotin or the fluorophore 
BODIPY, was used to assess their incorporation into cellular structures and 
their subcellular localization [182].  
In sum, the structural and functional study of protein lipoxidation 
represents a complex task due to the high reactivity of the electrophilic species, 
the possible occurrence of simultaneous modifications, like various types of 
oxidations, and the crosstalk between these PTMs. Thus, combined tools are 
required to overcome limitations inherent to each individual technique. 
Therefore, interdisciplinary approaches will be applied here to study the effect of 
lipoxidation on the structure and function of vimentin, the putative mechanisms 
of electrophilic modification involved and its modulation by context factors, for 




Zinc is the second most abundant trace element, only behind iron, and 
participates in diverse protein functions that are essential for life. Bioinformatic 
scanning of the human genome sequence estimated the remarkable number of 
over three thousand proteins with potential zinc-binding sites, which represents 
10% of the human proteome [183]. Functional annotation of the human 
proteome suggests that the majority of zinc-binding proteins are implicated in 
the regulation of gene expression, including DNA-binding transcription factors 
and members of the general transcription machinery [184]. The remaining zinc-
binding proteome is mostly composed by enzymes, such as oxidoreductases, 
transferases, hydrolases, and proteins involved in ion transport [185]. 
The adult human body contains approximately 2-3 g of zinc, which is 
distributed through all organs, tissues and secretions of the organism. 
Measurements of metal composition estimated that 60% of zinc is stored in 
skeletal muscle, 30% in bone, 5% in the liver and skin, and the remaining 2-3% 
in other tissues (fig. 5) [186]. The concentration in plasma is relatively low, 
accounting for 0.1% of the total zinc present in the human body, 80% of which 
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is loosely bound to albumin and 20% is strongly bound to α2-macroglobulin 
[187]. 
In cells, the total zinc concentration can vary between tens and hundreds 
of micromolar, where 50% of zinc is distributed in the cytoplasm, 30-40% in the 
nucleus and 10% in the cell membrane [187]. Nevertheless, zinc can be bound 
to several proteins and stored into organelles and vesicles, meaning that the 
“free” cytosolic concentration is very low, ranging between picomolar and low 
nanomolar, while inside the zinc-containing vesicles, such as the synaptic 
vesicles in the hippocampus, it can reach concentrations in the hundreds of 
micromolar [188, 189].  
Importantly, the biological activity of zinc depends on whether it is bound 
to a specific protein or present as free divalent ion. Therefore, regulation of 
intracellular free zinc concentration is strictly regulated, generally through two 




















Figure 5: Distribution and storage of zinc in the human body. 
Dietary zinc is absorbed in the small intestine and distributed to the peripheral tissues, including 
skeletal muscle (60%), bone (30%), skin and liver (5%), and other tissues (5%). 
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3.1 Zinc biochemistry and cellular functions 
 
Under physiological conditions, zinc exists as a divalent cation (Zn2+) and 
it is redox inert, meaning that it can neither oxidize nor reduce another 
substance [191]. Nevertheless, zinc is reactive as a Lewis acid in biological 
reactions, explaining its involvement in several physiological roles [192].  
Within proteins, zinc can be coordinated by nitrogen from histidine, sulfur 
from cysteine and oxygen from aspartate or glutamate. Zinc binding to protein 
ligands adopts typically a tetrahedral geometry and can have different 
coordination numbers. Therefore, proteins are able to modulate the properties 
of zinc affinity by using variable combinations of ligands, and consequently, are 
capable to regulate the function of the zinc binding site [193]. Due to these 
particular features, zinc can play critical roles as a structural, catalytic and 
signaling element.  
Proteins containing zinc finger motifs (ZNFs) constitute the most 
abundant class of structural zinc-binding proteins. Zinc contributes to the 
stability of these protein domains, characteristically comprised of four cysteine 
or two cysteines and two histidine residues. Given the wide variety of ZNFs, 
they are implicated in several cellular processes, such as nucleic acid 
replication, repair, transcription and translation [194].  
Beyond its structural roles, zinc is known to facilitate catalytic 
transformations. Due to its strong Lewis acid property, zinc is able to stabilize 
the negative charges and consequently activate substrates in enzymes [195]. 
The first evidence of the catalytic role of zinc was obtained in 1939, when the 
erythrocyte carbonic anhydrase was found to contain stoichiometric amounts of 
zinc essential for its enzymatic activity [196]. Later, the presence of zinc has 
been documented in many enzymes in all six classes defined in the Enzyme 
Commission system, namely oxidoreductase, transferase, hydrolase, lyase, 
isomerase and ligase enzyme classes [197].  
Additionally, biological regulation can be achieved by fluctuations of 
“free” zinc ion concentrations, which turns zinc into a signaling mediator in the 
transmission of information within cells and in the communication between cells 
[190].  
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 The extracellular release of zinc acts as a signaling mediator in 
endocrine, paracrine and autocrine systems, and in the nervous system it 
modulates synaptic transmission by binding to several transporters and receptor 
channels on postsynaptic neurons [198].  
In the cytosol, zinc influx can arise from extracellular sources, from 
intracellular organelles, such as the endoplasmic reticulum, and from redox-
sensitive cytosolic proteins, as metallothioneins [199]. Intracellular zinc 
signaling can be mediated through changes in gene expression and can require 
biosynthesis of proteins to control cytosolic zinc concentration. Additionally, zinc 
targets a diverse number of phosphatases and kinases, involved in cellular 
signaling [190].  
 
3.2 Interaction of cytoskeletal proteins with zinc 
 
Among the roles of zinc within the cell cytoplasm, this transition metal is 
also able to interact with cytoskeletal proteins, mediating their structural stability 
or inducing polymorphic assemblies putatively deleterious for the cell. 
 Zinc interacts with tubulin in vitro and in vivo. At low concentrations (1.6-
fold molar excess of zinc), zinc directly binds to tubulin and induces its 
assembly, in the absence of associated proteins [200]. At higher concentrations 
(20-fold molar excess of zinc) and longer periods of incubation, addition of zinc 
to polymerized tubulin in vitro results in the loss of microtubules and the 
formation of wide sheets [200]. Similar observations on the effect of zinc on 
tubulin assembly were found in vivo by implanting zinc wires into the brains of 
Lewis rats [201]. More recently, it was reported that zinc supplementation 
induced an increase of β-tubulin content in dendrites, indicating a putative 
involvement of this transition metal in microtubule stability within the dendritic 
cytoskeleton from hippocampal neurons [202].  
 Additionally, zinc is also able to interact with actin and alter the 
organization of its microfilament system. For instance, in cells of Madin-Darbin 
canine kidney, zinc exposure led to the loss of the stress fibers associated to 
the appearance of actin-rich plaques at the cell periphery. This was related to a 
reduction in cell adhesion and loss of junctional integrity, suggesting a 
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hypothetical negative effect of zinc in epithelial function, affecting the ability of 
the epithelium to act as a selective permeable barrier [203]. 
 Several studies have also evidenced zinc interactions with intermediate 
filaments. Zinc has been reported to induce neurofilament phosphorylation in a 
mouse neuroblastoma cell line, suggesting a possible link between zinc and the 
phosphorylated heavy and medium subunits of neurofilaments commonly found 
in the neurofibrillary tangles in Alzheimer’s disease [204].  
Interestingly, zinc may affect motility and invasiveness of malignant 
colonic cells SW480, by acting on several components of the cytoskeleton, such 
as E-cadherin, β-catenin, vimentin, α-tubulin and actin. Indeed, zinc depleted E-
cadherin and vimentin pools and promoted the remodeling and subsequent loss 
of tubulin and F-actin, in invasive colon cancer cells [205]. 
 Our group has previously demonstrated the interaction of zinc with 
vimentin, both in vitro and in cells. In vitro, vimentin-zinc interaction protects the 
protein from alkylation, and micromolar concentrations of zinc induce the 
formation of large assemblies of vimentin, as observed by staining with zinquin, 
a zinc-probe, followed by fluorescence microscopy [4]. In cells, vimentin 
function is influenced by zinc availability. In the adrenal carcinoma cell line 
SW13, zinc chelation and subsequent supplementation induced disassembly 
and reassembly of GFP-vimentin short filaments, respectively. Moreover, in a 
cellular model of genetic zinc deficiency, a lower proportion of polymerized 
vimentin, thinner appearance of filaments, and an increased susceptibility of the 
vimentin network to oxidative stress were observed, that were attenuated by 
zinc supplementation [4]. This evidence led us to hypothesize a reciprocal 
outcome of the vimentin-zinc interaction, that is, zinc may regulate vimentin, 
and vimentin could also play a crucial role in cellular zinc homeostasis [7]. This 
led us to further explore the structural and functional consequences of the 
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3.3 Zinc and redox biology 
 
 As mentioned above, zinc stably remains in the Zn(II) valence state and 
does not directly undergo redox reactions. Paradoxically, zinc ions have an 
important function in the regulation of redox metabolism [191]. Such role can be 
related to the ability of zinc to interact with the sulfur (thiolate) donor ligand of 
cysteine, giving origin to zinc thiolate coordination environments that can be 
redox-active [206]. Interestingly, zinc binding can be modulated by 
oxidoreduction, explaining how bound zinc can be released, distributed and 
regulated [207].  
In redox biology, zinc can support both pro-antioxidant and pro-oxidative 
processes. On one hand, this dual role arises from ability of the zinc to 
participate in the antioxidant system as a co-factor of various antioxidant 
enzymes. On the other hand, cellular oxidative stress can be caused by zinc 
deficiency or excess [208]. Consequently, it is important to be aware of zinc 
availability and concentration as a critical factor influencing its effects on the 






3.3.1 Pro-antioxidant effects of zinc 
 
The pro-antioxidant effects of zinc can be explained by three 
mechanisms, as detailed in figure 7: 1) induction of the antioxidant system, by 




Figure 6. Relationship between the cellular concentration of “free” zinc and its effects on 
the redox metabolism.  
Both deficiency and overload of zinc can contribute to induction of oxidative stress. The 
intermediate range of physiological concentrations of zinc supports “pro-antioxidant” processes. 
Adapted from [195]. 
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transcription factors involved in the antioxidant response; 2) protection of free 
sulfhydryl groups; and 3) competition with redox-active ions [191]. 
 Zinc is a structural component of the enzyme superoxide dismutase, 
which is present in the cytoplasm of cells and it is responsible for the conversion 
of the highly reactive superoxide radical to less reactive hydrogen peroxide and 
molecular oxygen, thus decreasing the toxicity of the reactive species [209], and 
act as cofactor of glutathione peroxidase [210].  
 Additionally, zinc modulates the antioxidant system by regulation of two 
important transcription factors, namely the nuclear factor Nrf2 and the 
responsive metal transcription factor 1 (MTF-1). In a zinc-dependent pathway, 
both transcription factors are part of the stress response to heavy metals, 
hypoxia and oxidative stress, which induce gene expression of several 
constituents involved in redox metabolism, as enzymes involved in glutathione 
biosynthesis, such as glutamate-cysteine ligase, and antioxidant enzymes, such 
as glutathione peroxidase, thioredoxin and thioredoxin reductase. Thus, zinc is 
able to modulate glutathione concentration and to neutralize free radicals [211, 
212].  
Zinc strongly induces metallothionein, which is a low-molecular weight 
cysteine-rich protein involved in zinc homeostasis and redox metabolism, 
through coordination of up to seven zinc atoms per molecule [213]. The 
cysteine thiolates of metallothionein react with oxidants and electrophiles with 
concomitant release of zinc. This effect may have a two-fold consequence in 
redox cellular state by working as an electrophile/oxidant scavenger or through 
antioxidant activity promoted by the release of physiological concentrations of 
zinc [213]. 
 Lastly, zinc can compete with iron and copper at the binding sites in the 
cell membrane, owing to the similarities in their coordination chemistry, and 
thereby suppress their ability to catalyze the production of radicals from lipid 
peroxides. For example, competition of zinc with iron and copper leads to 
inhibition of the NADPH oxidase enzyme, another source of superoxide radicals 
[210]. 
 In summary, physiological concentrations of zinc participate in the control 
of the production and elimination of reactive species and contribute to the 
proper functioning of the antioxidant defense system. 













3.3.2 Pro-oxidant effects of zinc 
 
Zinc elicits oxidative stress above and below its physiological 
concentrations, generally resulting in cytotoxic, proinflammatory and pro-
apoptotic outcomes [191].  
Overall, zinc deficiency limits the efficiency of the antioxidant defense 
system, induces a global change in gene expression and leads to membrane 
damage in isolated organelles, protein and DNA, due to loss of protection from 
lipid peroxidation and response to stress [184, 214, 215].  
Conversely, the perturbation of zinc homeostasis can lead to release of 
zinc above the physiological concentrations, which may have cytotoxic 



































Figure 7. “Pro-antioxidant” mechanisms of zinc action.  
Zinc supports the activity of antioxidant enzymes, such as superoxide dismutase (SOD) and 
glutathione peroxidase (GPx).  Zinc regulates the expression of transcription factors MTF-1 and 
Nrf-2, inducing the gene expression of several constituents involved in redox metabolism, such 
as glutamate-cysteine ligase, therefore controlling the cellular concentration of glutathione (GSH) 
Moreover, zinc induces metallothionein (MT), an electrophile scavenger, and protects the 
sulfhydryl groups (-SH) from electrophilic attack. Lastly, zinc competes with redox-active ions, as 
iron (Fe) and copper (Cu), and inhibits NADPH oxidase, preventing the production of superoxide 
radicals (O2
-
) and reactive species from lipid peroxides. Adapted from [210] 
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consequences [216]. The “free” zinc increases uncontrolled interactions with 
proteins that can cause protein misfolding and aggregation, and the inherent 
pathological outcomes [217]. In addition, supraphysiological zinc levels can 
activate an inflammatory response, leading to production of reactive species 
and concomitant alterations of glutathione concentrations. Moreover, cellular 
accumulation of zinc is accompanied by homeostatic changes of other ions, 
such as potassium and calcium, which can induce mitochondrial and lysosomal 
dysfunction, interfering with energy metabolism and with signal transduction 
pathways that determine cell fate [218-220]. 
 In summary, the cellular redox and zinc states are dynamic and strikingly 
connected, as zinc deficiency causes oxidative stress and oxidative stress 
affects cellular zinc metabolism. The interplay between redox and zinc biology 
has deep implications for physiology and for nearly all diseases associated with 
oxidative stress. 
 
3.4 Pathophysiological implications of zinc   
 
 Zinc essentiality was established in 1961 for humans, when a zinc 
deficient dietary uptake was associated with a clinical syndrome consisting of 
growth retardation, anemia, hypogonadism and mental lethargy and subsequent 
amelioration of the symptoms was achieved with zinc supplementation  [221] 
 Zinc is crucial in countless physiologic processes: zinc is essential in 
growth, brain development, immune function, tissue maintenance and wound 
healing [222].  
 Impairment of physical growth and development is one of the most 
studied clinical manifestations related to zinc deficiency. The underlying 
mechanisms are still not well understood, however its effect is significantly 
important during the periods of rapid growth such as embryonic development, 
infancy and puberty, during which, zinc requirements are the highest [223].  
 In the central nervous system, zinc plays essential roles in brain function 
either by regulating transcription factors and key enzymes involved in neuronal 
metabolism or by modulating the synaptic activity and neuronal plasticity. 
Therefore, chronic perturbations of brain zinc homeostasis have been related to 
the development of neurodegenerative diseases, such as Alzheimer’s disease, 
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Parkinson’s disease and amyotrophic lateral sclerosis, and implicated in 
neuronal damage associated to traumatic brain injury. Zinc deficiency has been 
often associated with impaired cognitive function, behavioral problems and 
learning disability [224]. 
 The immune system is highly proliferative, and therefore particularly 
vulnerable to zinc availability. Zinc affects cells involved in both innate and 
adaptive immunity, including monocytes, polymorphonuclear-, natural killer-, T- 
and B-cells. While acute zinc deficiency impairs the immune response, 
correlating with a higher risk of infections, chronic deficiency increases the 
production of pro-inflammatory cytokines and consequently, influences the 
outcome of several inflammatory diseases [225]. 
 Additionally, the prostate, mammary and pancreatic glands are secretory 
tissues that have unique zinc requirements. These tissues store zinc in 
secretory vesicles and control its secretion in order to guarantee the amount of 
zinc necessary for biological processes. Therefore, abnormal zinc metabolism 
in these organs is associated with disorders such as diabetes, infertility and 
cancer [222, 226]. Moreover, a putative association between the altered 
expression of zinc transporters and cancer progression and metastatic 
phenotypes has been suggested, thus they have emerged as possible new 
targets for cancer therapy [187]. 
 
3.5 Causes of zinc deficiency  
  
Zinc homeostasis is primarily regulated via the gastrointestinal system, 
by carrier-mediated absorption of exogenous zinc in the small intestine and by 
gastrointestinal secretion and excretion of endogenous zinc [227]. 
Nevertheless, zinc deficiency can be caused by different conditions, which 
include inadequate dietary intake, malabsorption syndromes and inflammatory 
diseases of the bowel, resulting in poor absorption and increased losses of zinc 
[222]. The prevalence of insufficient dietary zinc uptake is very high in 
developing countries, as well as in the elderly, even in industrialized countries 
[222]. 
Additionally, genetic zinc deficiency, which rarely occurs, is found during 
the infant stage and early childhood. In particular, genetic studies have 
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identified mutations in genes encoding zinc transporters that lead to zinc 
deficiency disorders, namely acrodermatitis enteropathica (AE) and transient 
neonatal zinc deficiency (TNZD) [228]. 
AE is an autosomal recessive disorder caused by mutations of the ZIP4 
gene, resulting in an impaired absorption of zinc primarily in the small intestine, 
which leads to lower levels of zinc in plasma. In addition, as several cells in the 
body express ZIP4, impaired zinc availability can occur at the cellular level in 
various tissues. Given the diverse physiologic functions of zinc, AE presents 
multiple signs and symptoms. The classic clinical manifestations of AE are 
characterized by the appearance of skin lesions around the body orifices and on 
the extremities, alopecia and diarrhea, and other gastrointestinal dysfunctions. 
In advanced stages of the disease, patients may also experience growth delay, 
impaired wound healing, mental lethargy, anemia and hypogonadism [229]. 
Besides, zinc deficiency alters immunity, contributing to a higher predisposition 
to fungal and bacterial infection, which can further trigger severe systemic 
scenarios [230].  
AE is fatal if zinc is not supplied, therefore zinc replacement therapy 
should be implemented and serum/plasma zinc levels should be periodically 
monitored. Theoretically, in the absence of a functional zinc transporter in the 
enterocytes, zinc supplementation will promote increased paracellular zinc 
absorption. Normally, clinical improvement is observed very rapidly, within days 
to weeks after starting the zinc therapy [229, 231].  
Due to the characteristics of this zinc deficiency disease, cells from AE 
patients, which display decreased zinc uptake and content [232], can be used 
as a pathophysiological model to explore the importance of zinc availability in 
cell responses to (lip)oxidative stress. The fact that vimentin is expressed in 
different cell types in which a zinc-vimentin interaction could be 
pathophysiologically important, such as immune, neuronal and endothelial cells, 
makes the study of the interplay between zinc availability and the function of 













































Vimentin is an intermediate filament protein typically expressed in 
mesenchymal cells, where it plays an important role in cell structure, division 
and response to injury and inflammation. Moreover, vimentin is a key sensor for 
oxidative or nitrosative stress, and is the target for lipoxidation by several 
electrophilic lipids.  
Importantly, vimentin organization and function can be modulated by 
context factors, as the presence of certain divalent cations. Among them, zinc 
may interact with proteins, either by inducing specific conformations, supporting 
catalytic activity or stabilizing oligomeric associations. Earlier investigation 
performed by our group, unveiled a robust interaction between vimentin and 
zinc, both in vitro and in the cell environment. 
Nevertheless, the mechanisms underlying the effect of lipoxidation on the 
organization of vimentin as well as the structural and functional consequences 
of the vimentin-zinc interplay and its impact on the response of vimentin to 
(lip)oxidative stress have not been totally elucidated.  
Therefore, the following objectives were proposed: 
 
 
 To set up reproducible refolding procedures yielding functionally competent 
vimentin preparations, suitable for the study of the effect of micromolar 
concentrations of electrophilic compounds and divalent cations. 
 To explore the effect of the modification of vimentin by several lipoxidants in 
vitro, and its impact on assembly behavior and on the morphology of 
preformed filaments. 
 To identify and characterize the mechanisms underlying the disruption of the 
vimentin network by electrophilic compounds in cells. 
 To address the role of zinc on the assembly and organization of vimentin in 
vitro. 
 To study the interplay between vimentin and zinc availability and its impact 
on the response of vimentin to (lip)oxidation in cells. 
 
 












































1. Materials  
 
Amicon ultrafiltration devices (10K cut-off) were from Millipore. PD-
SpinTrap G-25 columns were from GE Healthcare. Slide-A-Lyzer MINI Dialysis 
devices (20K cut-off) were from Thermo. 96-well plates were from Falcon. 
Carbon support grids, MESH CF 400 CU UL, used for electron microscopy were 
from Aname. High precision cells made of Quartz SUPRASIL, 1 mm and 10 mm 
path length, used for circular dichroism (CD) and for turbidity experiments, 
respectively, were purchased from Hellma. 
 
1.1 General reagents 
 
1.1.1 Electrophoresis and Western Blotting reagents 
 
Electrophoresis purity grade acrylamide, N,N’-methylenebisacrylamide, 
ammonium persulfate, N,N,N’,N’-tetramethylethylenediamine, sodium dodecyl 
sulfate (SDS) and glycine were purchased from Bio-Rad. 
Tris(hydroxymethyl)aminomethane was from Merck. Sypro-Ruby used for total 
protein staining was obtained from Bio-Rad. Polyvinylidene fluoride Immobilon-
P membranes were from Millipore. The enhanced chemiluminescence detection 
system was from Amersham Biosciences.  
 
1.1.2 Cell culture reagents 
 
Cell culture medium DMEM, DMEM without glucose, OPTIMEM used for 
cell transient transfections, as well as trypsin-EDTA were from Gibco Life 
Technologies. Fetal bovine serum was from Sigma or Biowest. Penicillin, 
streptomycin and geneticin G-418 antibiotics were from Invitrogen. Sterile 
plastic material for cell culture was acquired from Falcon (Corning).  35-mm 
glass bottom dishes (p35) for imaging of live cells were from MatTek Corp. 
 
 




1.1.3 Other reagents  
 
Recombinant hamster vimentin was from Cytoskeleton, Inc. Buffers, high 
purity salts and other reagents used for preparing solutions were mainly from 
Sigma and Merck. Milli-Q distilled water was obtained through a Millipore 
system. Lipofectamine 2000 was from Life Technologies. The bicinchoninic acid 
(BCA) Protein Assay Kit for measuring protein concentration in cell lysates was 
from Pierce. The polar extract of E. coli phospholipids was from Avanti Polar 
Lipids. Electrophilic lipids 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2) and its 
biotinylated analog, and 4-hydroxynonenal (HNE), were from Cayman 
Chemical. Hydroxynonenal-dimethyl acetate, sodium azide, dibromobimane 
(DBB), dimethylsulfoxide (DMSO), diamide and zinc chloride (ZnCl2) were from 
Sigma. Biotin polyethyleneoxide iodoacetamide (Iac-B) was from Sigma or from 
Santa Cruz Biotechnology. Carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone (FCCP) and disuccinimidyl tartrate (DST) 
were from Santa Cruz Biotechnology. 1,6-bismaleimidohexane  (BMH) and  
tris(2-maleimidoethyl)amine (TMEA) were purchased from Thermo Scientific. 
The reducing agent 1,4-Dithiothreitol (DTT) was obtained from Invitrogen Life 
Technologies. The luminescent ATP detection assay used to measure steady-
state ATP concentrations was from Abcam.  
 
1.2 Antibodies and reagents for protein labelling 
 
Alexa Fluor 488 carboxylic acid succinimidyl ester dye used for protein 
labelling, as well as Phalloidin-Alexa 568 used for F-actin staining were from 
Molecular Probes, Invitrogen. Anti-vimentin antibodies used were mouse 
monoclonal V9 clone (sc-6260) and its Alexa 488 and agarose conjugates from 
Santa Cruz Biotechnology. Anti-actin and diamidino-2-phenylindole (DAPI) were 
from Sigma. Anti-HNE adducts antibody was from Calbiochem. Secondary 
antibodies, namely anti-mouse and anti-rabbit immunoglobulins conjugated to 
horseradish peroxidase (HRP) were from DAKO. Streptavidin-HRP was from 
GE Healthcare Life Sciences.  
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1.3 Previously generated plasmids 
 
The GFP-vimentin wt and C328S constructs used for performing FRAP 
assays were previously generated and described in publications from the 
Pérez-Sala laboratory [34]. Briefly, full-length human cDNA vimentin (Origene) 
was cloned into the EcoRI, SmaI sites of pEGFP-C1 vector (Clontech) to obtain 
GFP-vimentin wt. Cysteine 328 was mutated to serine using the Quickchange 
XL site-directed mutagenesis kit from Stratagene and primers, forward 5’-
GGTGCAGTCCCTCACCTCTGAAGTGGATGCCC-3’ and reverse, 5’-GGGCAT 
CCACTTCAGAG GTGAGGGACTGCACC-3’ to obtain GFP-vimentin-C328S.  
For cell experiments, we have used SW13/cl.2 cells stably transfected 
with RFP//vimentin wt or RFP//vimentin C328S. These constructs were also 
generated before by Pérez-Sala’s group [4]. From the above described 
plasmids, vimentin wt and C328S were subcloned into the EcoRI and BamHI 
sites of pIRES2-AcGFP1 and pIRES2 DsRed-Express2 bicistronic plasmids, 
obtained from Clontech, to yield constructs that express the fluorescent protein 
and untagged vimentin as separate proteins. This strategy allows monitoring 




2.1 Protein preparation and in vitro reconstitution 
 
Recombinant human vimentin wt and C328S were purchased from 
Biomedal. This company performed a custom expression and purification 
procedure, based on solubilization from bacterial inclusion bodies by combined 
anion and cation-exchange chromatography, as described by Herrmann and 
colleagues [233]. After a two-step purification procedure, vimentin was obtained 
in 8 M urea, 5 mM Tris-HCl, pH 7.6, 1 mM EDTA, 10 mM β-mercaptoethanol, 
0.4 mM PMSF. Protein concentration was estimated from its A280 nm, using an 
extinction coefficient of 22450 M-1cm-1.  
Aliquots of the protein were kept at - 80ºC. In experimental descriptions, 
amino acid numbering for vimentin includes the initial methionine. 




2.1.1 Protein dialysis 
 
Dialysis of vimentin followed the standard refolding protocol [233]. Briefly, 
the human recombinant protein at 1 mg/ml in 5 mM Tris-HCl, pH 7.6, containing 
8 M urea, 1 mM EDTA, 10 mM β-mercaptoethanol, 0.4 mM 
phenylmethylsulfonyl fluoride and approximately 150 mM KCl, was subjected to 
step-wise dialysis against 5 mM Pipes-Na pH 7.0, 1 mM DTT, containing 6 M 
urea, then 4 M urea, 2 M urea and no urea at r.t., for 1 h each, and finally, to 
two additional steps against 5 mM Pipes-Na, pH 7.0, 0.25 mM DTT, the last one 
for 16 h at 16ºC. 
Bovine serum albumin (BSA) at 1 mg/ml in 5 mM Pipes-Na, pH 7.0 
containing 1 mM EDTA was dialyzed against 5 mM Pipes-Na, 1 mM DTT, pH 
7.0, with four buffer changes, for 1 h each, and, subsequently, into 5 mM Pipes-
Na, 0.25 mM DTT, pH 7.0, with two changes.  
 
2.1.2 Spin-column gel filtration and ultrafiltration 
 
Gel filtration was performed using PD SpinTrap G-25 1 ml columns 
equilibrated with 5 mM Pipes-Na, 0.1 mM DTT, pH 7.0, before loading 140 l 
samples of vimentin or BSA and eluting by centrifugation at 800 x g, according 
to the instructions of the manufacturer.  
For ultrafiltration, BSA or vimentin samples (250 l) containing 1 mM 
EDTA were diluted 10-fold with EDTA-free buffer, applied to Millipore Amicon 
Ultra filter units (10 K pore size) and centrifuged at 3000 x g for 15 min at 16ºC, 
which concentrated the samples down to their original volume. Then, samples 
were diluted again 10-fold with buffer without EDTA and the procedure was 
repeated. 
 
2.2 Colorimetric estimation of EDTA concentration 
 
The concentration of EDTA in the protein solutions was estimated 
through a colorimetric assay by monitoring its competition with 4-(2-pyridylazo)-
resorcinol (PAR) for zinc binding. The binding of zinc to PAR forms a colored 
complex with absorbance at 492 nm. The effective dissociation constant (Kd) of 
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the Zn(PAR)2 complex is 2.1 x 10
-12 M2 , at pH 7.0 [234, 235] . Since EDTA 
complexes zinc with higher affinity (Kd of 2.3 x 10
-14 M at pH 7.4, [236]), its 
presence decreases the formation of Zn(PAR)2 complex, thus decreasing the 
absorbance at 492 nm. A calibration curve was obtained by mixing samples 
containing 100 µM PAR and 10 µM ZnCl2 with known concentrations of EDTA 
and measuring the absorbance at 492 nm, using a Varioskan Flash (Thermo) 
microplate reader. The amount of EDTA in the protein preparations was 
determined from their absorbance at 492 nm after incubation with 100 µM PAR 
and 10 µM ZnCl2, and extrapolation using the calibration curve. Sample 
volumes of 1 to 10 l were used in a typical total assay volume of 100 l. 
Measurements were performed 5 min after mixing the reagents. 
 
2.3 NMR analysis 
 
NMR studies were performed with the help of The Nuclear Magnetic 
Resonance and Molecular Recognition group led by Professor F. Javier 
Cañada, mainly by Eva Martínez-Senra.  
NMR spectra were acquired in a 500 MHz Bruker AVANCE NMR 
spectrometer equipped with a SEF 19F-1H probe or a 600 MHz Bruker 
AVANCE NMR spectrometer equipped with a cryogenic triple resonance TXI 
probe. For samples dissolved in deuterated buffer (20 mM deuterated Tris, 
Cambridge Isotope), spectra were acquired with a simple 90º pulse sequence 
(zg Bruker pulse sequence) and with 32 K data points and 2 second recovery 
delay and 10 ppm of spectral width centered at 4.7 ppm (chemical shift of 
residual deuterated water signal). For samples dissolved in non-deuterated 
buffers, a 10% (v/v) final concentration of deuterated water was added for 
locking the deuterium signal and the standard Bruker pulse sequence “zgesgp”, 
using excitation sculpting gradients for water signal suppression, was used. The 
spectra were acquired at 25ºC with 32 K points, 2 second recovery delay and 
14 ppm of spectral width centered at 4.7 ppm (chemical shift of water). The 
spectra were acquired using from 8 to 2048 scans depending on the sample 
concentration; no line broadening was applied in the processing. Bruker 
TOPSPIN software was used for acquisition and processing of the spectra.  For 
testing the pH dependence of the chemical shift signals of EDTA, samples of 1 




to 3 mM EDTA, with and without cation (Ca2+, Zn2+, Mg2+ or La3+), in 20 mM 
deuterated Tris were prepared at different pH (between 5 and 9) by acidification 
with deuterated hydrochloric acid. The actual pH was measured after the 
addition of the corresponding dichloride salt of each cation. EDTA and ZnCl2 
solutions were prepared in deuterated water. 
 
2.4 Vimentin polymerization assay 
 
Vimentin wt at 3.8 µM in 5 mM Pipes-Na, pH 7.0, was incubated with  
150 mM NaCl, for 15 min at 37ºC or with the indicated concentrations of ZnCl2 
or MgCl2 for 1 h at room temperature (r.t.). All samples were submitted to 
ultracentrifugation at 55000 rpm for 30 min at 4ºC. Aliquots of supernatants, 
containing soluble vimentin, and of the pellets with polymerized vimentin 
resuspended in Laemmli buffer, were analysed by SDS-PAGE, followed by total 
protein staining with Sypro Ruby and ultraviolet (UV) light detection. 
 
2.5 In vitro modification of vimentin by oxidants and electrophiles  
 
Modification of vimentin was assessed by gel-based assays. Briefly, 
vimentin at 3.8 M in 5 mM Pipes-Na, pH 7.0, was incubated for 60 min at r.t. in 
the presence of the indicated compounds. DTT final concentration was kept 
below 0.2 mM. Incorporation of biotinylated prostaglandins was analyzed by 
SDS-PAGE followed by blot and biotin detection with HRP-streptavidin. HNE 
adduct formation was estimated by immunochemistry after SDS-PAGE and WB 
with an anti-HNE adducts antibody. The effects of diamide and of DMSO were 
assessed by electrophoresis under non-reducing conditions followed by protein 
staining with Sypro Ruby or by western blot (WB) with anti-vimentin antibody. 
 
2.6 In vitro crosslinking assays of vimentin 
 
Modification of vimentin by different crosslinkers was assessed by gel-
based techniques. Vimentin at concentrations between 3 and 5 µM in 5 mM 
Pipes-Na, pH 7.0, 0.2 mM DTT, was incubated during 60 min, at r. t., in the 
presence of the indicated compounds. To evaluate the protective effect of the 
Material and methods 
63 
 
different salts on vimentin crosslinking, the recombinant protein was 
preincubated with increasing concentrations of ZnCl2, MgCl2 or NaCl, as 
indicated in the figures, and then submitted to crosslinking with the different 
reagents. Equal volumes of the samples were run on 7.5% SDS-polyacrylamide 
electrophoresis gels and fixed with a solution of 40% (v/v) methanol/ 10% (v/v) 
acetic acid in H2O, during 60 min. The gels were incubated with Sypro Ruby 
stain overnight with gentle agitation, protected from light. After washing with a 
solution of 10% (v/v) methanol, 6% (v/v) acetic acid in H2O, the gels were 
visualized under UV light on a Gel-Doc XR Imaging System (Bio-Rad). 
 
2.7 Electrophoresis and Western blotting 
 
Incubation mixtures were denatured at 95ºC for 5 min in Laemmli sample 
buffer (80 mM Tris-HCl, pH 6.8; 2% (w/v) SDS, 10% (v/v) glycerol, 5% (v/v) β-
mercaptoethanol and 0.15% (w/v) bromophenol blue) and were separated on 
7.5 or 10% SDS-polyacrylamide electrophoresis gels and transferred to 
Immobilon-P membranes using a Bio-Rad Blot Semi-dry Transfer system and a 
Whatman filter-based method. Blots were blocked with 2% (w/v) non-fat dried 
milk and incubated with primary antibodies, typically at 1:500 dilution, and with 
HRP-conjugated secondary antibodies, at 1:2000 dilution, as described in [3, 4]. 
In all cases, the signal was obtained with the enhanced chemiluminiscence 
system (ECL), upon exposure of the blots to Agfa Curix film. Blots were 
quantified using Scion Image software (Scion Corporation MD, Frederick MD, 
USA). 
 
2.8 Electron microscopy 
 
For EM inspection of soluble oligomeric species, vimentin was prepared 
at 0.2 mg/ml in 5 mM Pipes-Na, pH 7.0, in the presence of DTT. Soluble 
vimentin samples were fixed by addition of 0.1% (v/v) glutaraldehyde, final 
concentration.  
For EM observation of filaments, vimentin polymerization was induced by 
incubation with 150 mM NaCl, at 37°C. Time-dependent assembly of vimentin 




was followed by fixing the mixtures at 5, 10, 60 and 120 min after addition of the 
polymerizing buffer.  
Assessment of the effect of electrophilic compounds or divalent cations 
on vimentin assembly or preformed filaments was done by inducing vimentin 
polymerization by incubation with 150 mM NaCl for 1 h at 37ºC before or after 
treatment with electrophilic compounds or divalent cations for 1 h at 37ºC or r.t., 
as indicated. Assays were repeated at least three times and all incubation 
mixtures were processed in duplicate.  
Drops of incubation mixtures were applied onto carbon support grids 
(MESH CF 400 CU UL, Aname), which were subsequently washed with water 
and stained with 2 % (w/v) uranyl acetate (Merck). Grids were inspected on a 
JEOL transmission electron microscope JEM-1230, equipped with a digital 
camera CMOS TVIPS TemCam-F416. EM images were processed with FIJI 
software for the measurement of width and length of vimentin oligomeric 
species and filaments. Filament width was determined using the “plot profile” 
plugin of straightened filaments. On average, 50 vimentin species were 
measured per experimental condition. 
 
2.9 Circular dichroism 
 
Far-UV CD spectra of vimentin wt at 5 µM in 5 mM Pipes-Na, pH 7.0,    
0.2 mM DTT, were recorded in a JASCO J-810 spectropolarimeter equipped 
with a Peltier type cell holder (Jasco Corp.) in 0.1 cm path length cells. 
Ellipticities corrected for buffer contribution were converted to mean residue 
ellipticities using a mean molecular mass per residue of 113. 
 
2.10 Turbidity experiments 
 
Turbidity of solutions containing 5 µM vimentin wt or C328S in the 
presence of the indicated compounds was determined by measuring the 
absorbance at 350 nm, at r.t, using an Agilent Cary 60 UV-Vis 
spectrophotometer. Incubation mixtures (70 µl) were placed in Hellma 
absorption cuvettes and increasing amounts of ZnCl2, MgCl2 or NaCl were 
sequentially added to the mixture to achieve the indicated final concentrations, 
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and the absorbance was immediately measured. In the graphics, absorbance 
values corresponding to control (vimentin without ZnCl2) were subtracted and 
were corrected accordingly to vimentin concentration and volume of the 
mixtures. For time-lapse monitoring, turbidity of vimentin was measured every 2 
min, for a total of 26 min in the analysis of the reversibility of the effect of ZnCl2, 
and for 16 min in the analysis of the effect of incubation with  ZnCl2 before or 
after addition of NaCl.  
 
2.11 Protein labeling and fluorescence anisotropy 
  
Vimentin wt and C328S were covalently labeled in the amino groups with 
a three-fold molar excess of Alexa Fluor 488 carboxylic acid succinimidyl ester 
dye [237]. After labelling, mixtures were loaded onto PD Minitrap G-25 columns 
in order to eliminate the free dye. The degree of labeling of vimentin, ranging 
between 0.2 and 0.9 moles of fluorophore per mole of protein, was estimated 
from the molar absorption coefficients of 22450 M-1cm-1 and of 71000 M-1cm-1, 
at 280 nm, for vimentin and for the dye, respectively. Aliquots of vimentin were 
stored at - 80°C, until assayed.  
Unlabeled vimentin (1 µM) was mixed with a tracer amount of Alexa 488-
labeled vimentin (50 nM) and were dispersed in Corning 96-well black 
microplates with different concentrations of ZnCl2. Fluorescence anisotropy was 
monitored using a POLARstar Galaxy plate reader, at λexc = 485 nm and λem = 
520 nm, at 26oC. 
 
2.12 Effect of zinc on the morphology of vimentin assemblies on 
different supports 
 
For visualization on glass slides, a 5 μl aliquot of vimentin at 5 μM in 5 
mM Pipes-Na (pH 7.0), 0.2 mM DTT, was placed on a glass slide, and 5 μl of 
vehicle, 200 μM, 500 μM or 2.5 mM ZnCl2 (final concentrations) were added to 
the solution and gently mixed with the pipette tip. Next, a coverslip was placed 
on top of the mixtures and samples were visualized on a Leica SP2 confocal 
microscope using the differential interference contrast mode for image 
acquisition. For zinc detection, Zinquin, a fluorescent probe to detect both free 




and protein-bound zinc, was added to the mixtures at 1 mM (final 
concentration). Zinquin fluorescence was detected by excitation with an 
ultraviolet laser at 351 and 364 nm, and emission between 450 and 520 nm was 
acquired. 
For monitoring vimentin assemblies formed in solution, 80 μl aliquots of 
vimentin at 5 μM were incubated with different concentrations of ZnCl2, in a flat-
bottom microplate. The solutions were observed under a Zeiss optical inverted 
microscope coupled to an Axiocam ERc 5s camera, after 20, 40 and 60 min of 
incubation.  
For observation of vimentin in microdroplets stabilized by Escherichia coli 
polar extract, phospholipids were dissolved in spectroscopic grade chloroform 
and kept at −20°C. Before use, a lipid film made by evaporating the chloroform 
under a nitrogen stream was resuspended in mineral oil to the final 
concentration by two cycles of vigorous vortexing plus 15 min sonication in a 
water bath. The solution containing a mixture of unlabeled vimentin wt (4 µM) 
and vimentin wt labeled with Alexa 488 (1 µM), in the absence or in the 
presence of 200 μM ZnCl2, was vigorously mixed with E. coli lipids. The 
emulsions containing E. coli stabilized microdroplets surrounding the protein 
solution were applied on a glass slide and observed on a Leica SP2 confocal 
microscope.  
 
2.13 Computational studies  
 
The computational studies were performed by Joan Guzmán-Caldentey 
at the group of Computational Chemical Biology led by Dr. Sonsoles Martín-
Santamaría. 
 
2.13.1 Building of the vimentin models 
 
PyMol software was used to build the 3D models from the vimentin X-ray 
structures available at the Protein Data Bank (PDB IDs 3KLT and 1GK4). PDBs 
3KLT and 1GK4 structures share seven amino acids of its sequence, where 
C328 is located. One monomer of each PDB structure was kept and 
superimposed to the dimer from the other PDB by the overlapping region. Thus, 
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two vimentin dimer models comprising the region between D264 and G406, 
differing in the geometry, were constructed: 1GK4 superimposed to 3KLT model 
(model A) and 3KLT superimposed to 1GK4 model (model B). These starting 
vimentin dimers were subsequently used to build other models. All the studied 
models were submitted to molecular dynamics (MD) simulations. 
 
2.13.2 Protein-protein docking 
 
The two models of vimentin dimer from the Molecular Dynamics (MD) 
simulations were submitted to servers HADDOCK and ZDOCK to perform 
protein-protein docking. Several tetramers were obtained (as dimers of dimers), 
studied and submitted to MD simulations. 
 
2.13.3 Molecular Dynamics simulations 
 
MD simulations were carried out using Amber14. Eight steps of 
preparation were performed before running MDs. The first one consisted of 
1000 steps of steepest descent algorithm followed by 7000 steps of conjugate 
gradient algorithm; a 100 kcal·mol−1·A−2 harmonic potential constraint was 
applied on the proteins and the ligand. In the four subsequent steps, the 
harmonic potential was gradually lowered respectively to 10, 5, and 2.5 
kcal·mol−1·A−2 for 600 steps of conjugate gradient algorithm each time, and then 
the whole system was minimized uniformly. In the following step the system 
was heated from 0 to 100 K using the Langevin thermostat in the canonical 
ensemble while applying a 20 kcal· mol−1·A−2 harmonic potential restraint on the 
proteins and the ligand. The next step heated up the system from 100 to 300 K 
in the isothermal−isobaric ensemble under the same restraint condition as 
before. In the last step the same parameters were used to simulate the system 
for 100 ps but no harmonic restraint was applied. At this point the system was 
ready for the production run, which was performed using the Langevin 
thermostat under NPT ensemble, at a 2 fs time step. All production runs were 
performed for 100 or 150 ns. Zinc atoms were added to the system using Leap. 
 




2.14 Cell culture 
 
The following cell lines were used throughout this work and cultured as 
follows: 
SW13/cl.2 human adrenal carcinoma vimentin-deficient cells were the 
generous gift of Dr. A. Sarriá (University of Zaragoza, Spain) [238]. SW13/cl.2 
cells stably transfected with RFP//vimentin wt or RFP//vimentin C328S 
(RFP//vimentin wt and C328S cells, respectively) have been previously reported 
[4]. Cells were cultured in DMEM supplemented with 10% (v/v) fetal bovine 
serum and antibiotics (100 U/ml penicillin plus 100 g/ml streptomycin). For 
maintenance of stably transfected cells, G-418 at 500 g/ml final concentration 
was added to the culture medium. 
Primary human fibroblasts from a control subject (AG10803) and from a 
patient with acrodermatitis enteropathica (AE) (ONIM entry 201100, cell line 
GM02814A) were obtained from the National Institute of General Medical 
Sciences (NIGMS) Human Genetic Cell Repository at the Coriell Institute for 
Medical Research (Candem, NJ), and were manipulated according to the 
instructions of the supplier. Cells were cultured in DMEM supplemented with 
10% (v/v) fetal bovine serum and antibiotics (100 U/ml penicillin plus 100 g/ml 
streptomycin). 
 
2.15 Cell treatments 
 
For immunofluorescence, SW13/cl.2 cells stably transfected with 
RFP//vimentin wt or RFP//vimentin C328S, grown on glass coverslips, were 
treated with vehicle or diamide, at 1 mM final concentration, for 5 or 15 min, as 
indicated, in the absence of serum. For glucose depletion, cells were washed 
with DMEM without glucose and cultured in this medium. In protection assays, 
cells were preincubated with DBB at 100 M for 15 min, with 20 mM sodium 
azide for 15 min, 10 M FCCP for 20 min, or 30 M or 200 M ZnCl2 for 1 h, 
prior to the addition of 1 mM diamide.  
Primary control fibroblasts (AG10803 cells) and primary fibroblasts from 
an AE patient (GM02814A cells), grown on glass coverslips, were preincubated 
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with H2O or with 30 µM ZnCl2 for 30 min, after which they were treated with 
vehicle (DMSO) or 10 µM HNE, for 2 h 30 min, in the absence of serum. At the 
end of the treatments, cells were washed with cold PBS, fixed and processed 




Cells were fixed with 4% (w/v) paraformaldehyde, permeabilized with 
0.1% (v/v) Triton X-100, blocked with 1% (w/v) BSA in PBS and incubated with 
anti-vimentin-Alexa 488 at 1:200 dilution. After washing, cells were incubated 
with Phalloidin-Alexa 568 (Molecular Probes) for filamentous actin (F-actin) 
staining. All the procedure was carried out at r.t. Coverslips were mounted on 
glass slides with Fluorsave (Calbiochem). Images shown were acquired on 
Leica SP2, SP5 or AF6000 LX microscopes. Image analysis was performed 
with software from Leica (LasX) or from FIJI.  
 
2.17 Transient transfection 
 
Transient cell transfection was carried out at 80% cell confluence, using 
Lipofectamine 2000, following the instructions of the manufacturer. Briefly, 1 μg 
of total DNA, comprising RFP//vimentin wt (0.8 g) plus GFP-vimentin wt (0.2 
g), and 3 μl of Lipofectamine, dissolved in OPTIMEM, were added to p35 
dishes containing 1 ml of DMEM. Cells were incubated with this mixture for 5 h, 
after which, they were allowed to recover for 48 h in complete medium before 
performing FRAP assays. 
 
2.18 FRAP assays 
 
For fluorescence recovery after photobleaching (FRAP) assays, 
SW13/cl.2 cells cultured on p35 glass bottom dishes, transiently transfected 
with RFP//vimentin wt plus GFP-vimentin wt, as detailed above, were placed on 
a thermostatized chamber for observation on a Leica SP5 microscope, 
essentially as described previously [4] . Briefly, a pre-bleach image was taken, 




after which, an area of 18 x 1.5 m was bleached by three pulses of 488 nm 
laser power. Post-bleach single section images were acquired every 3 s for 5 
min. Fluorescence recovery was registered and plotted in recovery graphs. A 
minimum of twenty FRAP assays were carried out per experimental condition. 
 
2.19 Vimentin solubility experiments  
 
The proportion of soluble and insoluble vimentin in cells was determined 
using a previously established protocol [239]. RFP//vimentin wt cells were 
treated with the indicated agents. At the end of the treatment, cells were lysed 
in 20 mM Tris-HCl, pH 7.4, 600 mM NaCl, 0.5 % (v/v) Triton X-100, 0.1 mM 
sodium orthovanadate and protease inhibitors (2 μg/ml each of leupeptin, 
aprotinin and trypsin inhibitor, and 1.3 mM Pefablock). Lysates were centrifuged 
at 12000 x g for 10 min at 4ºC. Aliquots from pellet (30 µl, insoluble vimentin) 
and supernatant (15 µl, soluble vimentin) fractions were separated by SDS-
PAGE and vimentin content was assessed by western blot. 
 
2.20 ATP measurements 
 
The luminescent ATP detection assay (Abcam) was used to measure 
steady-state ATP concentrations. RFP//vimentin wt cells were seeded onto 96 
well glass bottom plates (150 x 104 cells/well) and grown for 48 hours. Cells 
were treated with inhibitors of oxidative phosphorylation (20 mM NaN3 for 15 
min or 10 µM FCCP for 20 min), in the absence of glucose. ATP concentrations 
were determined in triplicate by luminescence measurement using a Varioskan 
Flash (Thermo) microplate reader according to the manufacturer’s instructions. 
 
2.21 Proteomic studies 
 
Primary human fibroblasts from a control subject (AG10803 cells) and 
primary fibroblasts from an acrodermatitis enteropathica (AE) patient 
(GM02814A cells), grown on p100 dishes, were preincubated with H2O or with 
30 µM ZnCl2 for 30 min, after which they were treated with vehicle (DMSO) or 
10 µM HNE, for 1 h, in the absence of serum. At the end of treatments cells 
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were washed with cold PBS. Next, 1 ml PBS was added to each p100 dish and 
cells were scraped and transferred to an eppendorff tube. This procedure was 
repeated twice and cells were centrifuged at 1000 x g, 5 min at 4 °C. The 
supernatant was discarded and the pellets were kept at – 80 °C until assayed. 
The proteomic analysis of control and zinc-deficient fibroblasts was 
performed in the University of Leipzig, as part of my secondment, in 
collaboration with the group of Dr. Maria Fedorova. 
 
2.21.1 Protein extraction  
 
Cell pellets were resuspended in lysis buffer (7 M urea, 2 M thiourea, 1 % 
(w/v) Na-deoxycholate in 50 mM Tris-HCl, pH 7.5). Samples were sonicated on 
ice using a Vibra-Cell tip sonicator (20 kHz, 1 min with on/off pulses of 5 s each, 
40% amplitude; Sonics & Materials, Inc., Newtown, CT, USA) and centrifuged 
(20 min, 10,000 × g, 4 °C). Supernatants were collected and protein 
concentrations were determined by the Bradford assay, as described in the 
literature [240]. 
 
2.21.2 FASP digestion  
 
Samples were processed by filter aided sample preparation (FASP) 
procedure using 30 K Microcon filtration devices (Millipore). Briefly, 50 μl 
aliquots of the total protein extracts were incubated with 100 mM DTT, during 1 
h at 37ºC. The samples were loaded into the filtration device and centrifuged at 
14000 x g for 30 min. The concentrates were diluted in the devices with 0.2 ml 
of urea solution (8 M urea, 0.1 M Tris-HCl, pH 8.5) and centrifuged again. After 
centrifugation, the concentrates were mixed with 0.1 ml of 50 mM 
iodoacetamide in urea solution and incubated in darkness at r.t. for 20 min, 
followed by centrifugation for 10 min. Then, the concentrate was sequentially 
diluted with 0.1 ml of urea solution and 0.1 ml of 0.05 M NH4HCO3 and 
concentrated again. The resulting concentrate of the total protein extract was 
incubated overnight at 37ºC with 1.2 μg of trypsin. Following digestion, peptides 
were collected in the filtrate by centrifugation for 10 min at 14000 x g at r.t and 




diluted with 0.05 M NH4HCO3. Peptides from total protein extracts were diluted 
1:2.5 in 3 % (v/v) aqueous acetonitrile. 
 
2.21.3 LC-MS/MS  
 
A nano-Acquity UPLC (Waters GmbH) was coupled online to a Linear 
Trap Quadrupole Orbitrap XL ETD mass spectrometer equipped with a nano-
electrospray ionization source (Thermo Fischer Scientific). The precursor ion 
survey scans were acquired at an orbitrap (resolution of 60,000 at m/z 400) for 
an m/z range from 400 to 2000. CID-tandem mass spectra (isolation width 2, 
activation Q 0.25, normalized collision energy 35%, activation time 30 ms) were 
recorded in the linear ion trap by data-dependent acquisition for the top six most 
abundant ions in each survey scan, with dynamic exclusion for 60 s, using 
Xcalibur software (version 2.0.7). 
 
2.21.4 Database search  
 
The acquired tandem mass spectra were searched against the Uniprot 
Human reviewed database using Sequest search engine (Proteome Discoverer 
1.4 and 2.2, Thermo Scientific), allowing up to two missed cleavages and a 
mass tolerance of 10 ppm for precursor ions and 0.8 Da for product ions. 
Oxidation of methionine and carbamidomethylation of cysteine were used as 
variable modifications. Only protein identifications with a protein score ≥ 10 and 
a minimum of 3 peptides per protein with peptides ranked on position 1 and 
charge-dependent scores (Xcorr ≥ 2.0, 2.25, 2.5, and 2.75 for charge states 2, 
3, 4, and 5) were considered. 
 
2.21.5 Label-free relative quantification 
  
Label-free relative quantification was performed using Progenesis QI for 
proteomics (Nonlinear Dynamics), using LC-MS data from three biological 
replicates analyzed in three technical replicates. Only peptides showing 
regulation with p-value < 0.05, by the one-way analysis of variance (ANOVA), 
were considered for further analysis. As control and zinc-deficient fibroblasts 
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were obtained from individuals with different age, namely 22 years and 6 
months-old, respectively, the protein levels were compared individually within 
each cell model and no comparisons were made between models. 
 
2.22 Statistical analysis 
 
All experiments were performed at least three times. Unless indicated, 
results are presented as average values ± standard error of mean (SEM). 
Statistical analyses were carried out using GraphPad Prism 5. For comparisons 
of different sets of values the Student’s t-test was used. Differences were 
considered significant for p<0.05. For comparison of multiple data sets ANOVA 
followed by Tukey's post-test was used. Whenever a statistically significant 
difference was found, it is indicated on the graphs. Although these types of 
statistical analyses are not commonly applied to biophysical techniques, we 















































1. Refolding and validation of vimentin functionality 
 
 Vimentin is a key sensor for oxidative or nitrosative stress, and is the 
target for lipoxidation by several electrophilic lipids. Cysteine 328 represents a 
common site for electrophile addition and it can work as a modulator of vimentin 
assembly properties and behavior towards (lip)oxidative stress. Therefore, 
vimentin assembly, the effect of (lip)oxidation and the importance of C328 will 
be addressed in this study. 
Consequently, parallel experiments were executed with wild-type 
vimentin (vimentin wt) and a vimentin mutant with cysteine 328 substituted by a 
serine residue (vimentin C328S), which demanded careful and reproducible 
preparation techniques for both protein forms. Moreover, in order to explore the 
interaction with divalent cations, appropriate methods had to be set up to 
remove metal chelators, in order to ensure the accurate interpretation of the 
results. 
 
1.1 Detection of EDTA in protein samples by NMR 
 
In order to study the effect of micromolar concentrations of divalent 
cations on vimentin behavior, it was necessary to assess the presence of metal 
chelators, such as EDTA, used during purification of the protein. 
NMR methods have been employed to detect EDTA and quantitate 
metals in human blood [241, 242]. Similarly, we set up a procedure using 1H 
NMR to analyze the presence of EDTA, using zinc to generate a diagnostic 
complex, in vimentin samples, commercial lyophilized vimentin and dialyzed 
vimentin. Upper panel of figure 8 shows a 500 MHz 1D-1H NMR spectrum of a 
commercial sample of vimentin. Commercial vimentin is a lyophilized 
preparation and it needs to be reconstituted in water. Analysis of reconstituted 
vimentin 1H NMR spectrum revealed the presence of a substantial amount of 
EDTA, assigned as the chelate formed between EDTA and 150 µM ZnCl2, 
together with signals corresponding to sucrose, a stabilizer present in the 
sample, and to Pipes-Na buffer. Corroborating the presence of EDTA 




the reference proton spectrum of this complex, where the two coupled doublets 
at 3.25 and 3.32 ppm (2JHH = 17.3 Hz) correspond to the AB spin system of 
the methylene protons of the four acetyl groups, non-equivalent due to the 
structure of the metal chelate, and the singlet at 2.79 ppm corresponds to the 
four equivalent protons of the ethylenediamine moiety. As presented in the 
lower panel of figure 8, free EDTA gives two singlet peaks, the one at low field 
corresponding to the 8 methylene protons of acetyl moieties and the one at high 
field to the 4 protons of the ethylenediamide moiety. These free EDTA peaks 
are strongly dependent on the pH of the sample, whereas the peaks of the 
EDTA-zinc complex do not change [243]. Therefore, we have considered the 
characteristic pattern of the shifts of the signals given by the EDTA-zinc 
complexes as the most reliable and specific way of detection of this metal 















Figure 8. Detection of EDTA by NMR analysis.  
Upper panel: 500 MHz 1D-
1
H NMR spectrum of a commercial sample of vimentin (0.7 µM) with 
150 µM ZnCl2. Sucrose and Pipes-Na buffer proton signals are identified. The 
1
H-NMR spectrum 
also displays an additional singlet at 2.79 ppm and two coupled doublets at 3.25 and 3.32 ppm. 
Middle panel: reference proton spectrum of EDTA complexed with Zn
2+
, which is detailed in the 




1.2 Design of a colorimetric procedure to quantitate EDTA  
 
In order to confirm the presence of EDTA and quantitate its levels in 
protein samples after dialysis, a colorimetric assay as described in Methods 
was designed, taking advantage of the ability of EDTA to compete with 4-(2-
pyridylazo)-resorcinol (PAR) for zinc binding. This competition allows 
performing a titration to obtain the EDTA concentration in the dialysates (fig. 9) 
This method demonstrated that samples of vimentin or bovine serum 
albumin (BSA) initially containing 1 mM EDTA still retained ~ 450 µM EDTA 
after dialysis, corroborating the values determined by NMR. Not discarding the 
possible competition of PAR with other metal-binding biomolecules, this 
technique was revealed to be an easy and convenient method for EDTA 






1.3 Procedures to remove EDTA from protein preparations  
 
After optimizing and validating this EDTA detection method, we applied it 


































Figure 9. Colorimetric assay to quantitate EDTA in protein samples. 
(A) Calibration curve obtained by the absorbance values at 492 nm of mixtures containing EDTA, 
at the indicated concentrations, with 100 µM PAR and 10 µM ZnCl2. (B) Determination of EDTA 
remaining after dialysis of vimentin and BSA, using the calibration curve. The initial EDTA 





in figure 10A, we assessed the presence of EDTA in BSA and vimentin 
preparations after dialysis followed by gel filtration, ultrafiltration, or ultrafiltration 
plus dialysis. As shown in the bar graph, protein dialysis followed by spin-
column gel filtration was insufficient, since ~ 200 µM EDTA still remained in the 
preparations.  
Ultrafiltration allowed the repetitive dilution of the protein samples with 
EDTA-free buffers, followed by centrifugation which permitted controlling protein 
concentration. This method used alone was able to reduce EDTA concentration 
below 10 µM, as determined by the PAR competition assay, and below the 
detection limits of NMR (fig. 10B). Ultrafiltration followed by dialysis turned out 
to be even more efficient, allowing EDTA removal to concentrations below        
5 µM. These virtually undetectable EDTA levels remaining in vimentin 
preparations allowed the execution of the intended assays in the presence of 






































Figure 10. Efficiency of different methods to remove EDTA. 
(A) Colorimetric detection of EDTA present in protein samples after diverse purification 
procedures using the PAR competition assay. Results shown are mean ± standard deviation of 4 
(dialysis plus gel filtration), 2 to 7 (ultrafiltration), or 3 to 7 (ultrafiltration plus dialysis) assays.  
(B) NMR analysis. Upper panel: 600 MHz 1D-
1
H NMR spectrum of an ultrafiltrated vimentin 
sample (1.8 μM final concentration). Signals of buffer and additives used in the purification 
(glycerol, from the ultrafiltration filters) are observed. Middle panel: The same sample analyzed 
was monitored again after addition of 150 μM of ZnCl2. A quadruplet that appears at 3.92 ppm 
corresponds to trifluoroethanol added as reference. Lower panel: NMR analysis of the sample 
after addition of 20 μM EDTA. The signal pattern of the AB system at 3.32 and 3.25 ppm and the 
singlet at 2.79 ppm corresponding to the Zn
2+




1.4 In vitro reconstitution of vimentin 
 
 Both preparations of vimentin wt and C328S were obtained in 8 M urea, 
5 mM Tris-HCl, pH 7.6, 1 mM EDTA, 10 mM β-mercaptoethanol, 0.4 mM PMSF. 
In such conditions, vimentin is mostly present in the soluble and unfolded form. 
Therefore, we focused in designing an effective method to refold vimentin into a 
functional protein, which required eliminating EDTA and gradually removing 
urea. Taking into account that ultrafiltration followed by dialysis was found to be 
the most effective method to remove EDTA, we employed the procedure 








Figure 11. Procedures for in vitro refolding of vimentin. 
Urea-solubilized vimentin was diluted with EDTA-free buffer, applied to Millipore Amicon Ultra 
filter units (10 K pore size) and centrifuged at 3000 x g for 15 min at 16°C, for concentration to its 
original volume. Then, samples were diluted again 10-fold with EDTA-free buffer and the 
procedure was repeated. The retained volume of vimentin sample was transferred to Slide-A-
Lyzer MINI Dialysis devices (20 K cut-off) and submitted to six steps of dialysis gradually 
decreasing urea concentrations, as described in Methods. Finally, the resulting vimentin 
preparation was centrifuged at 120000 x g for 15 min at 4°C, and the supernatant containing 
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Gradual removal of urea
Centrifugation at 120 000 x g for 15 





1.5 In vitro validation of vimentin functionality 
 
Validation of the structure and function of the vimentin preparation 
resulting from the above procedures is a critical point before starting the 
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Vimentin wt and vimentin C328S were first assessed by gel-based 
techniques (fig. 12A). Total protein staining with Sypro-Ruby revealed a band 
with an electrophoretical mobility of approximately 53 kDa, suggesting that both 
forms of vimentin exist as monomers, under denaturing conditions.  In non-
reducing conditions, we appreciated the absence of other oligomeric species 
which pointed out that the presence of the reducing agent dithiothreitol (DTT), at 
a concentration at or below 0.2 mM, was sufficient to prevent the formation of 
the typical oxidative dimer resulting from the disulfide bond of the cysteine 
residues, described previously [8], thus preserving this residue in its reduced 
form when stored at -80°C.  
Circular dichroism (CD) spectroscopy of the far- and near-UV regions 
has been used in studies exploring the assembly mechanism and the structural 
integrity of type III intermediate filaments [244, 245]. Thus, we recorded the 
near-UV CD signals of soluble vimentin wt in 5 mM Pipes-Na, pH 7.0, 0.2 mM 
DTT, where it is expected to exist as a mixture of oligomeric species (fig. 12B) 
[48, 51]. The CD spectrum revealed one broad negative band, which is 
characteristically given  by the significant intertyrosine coupling between 
Figure 12. In vitro validation of vimentin functionality. 
(A) Vimentin wt and C328S analysis by SDS-PAGE under non-reducing conditions followed by 
total protein staining with Sypro Ruby. (B) Far-UV CD spectrum of vimentin wt in 5 mM Pipes-
Na, pH 7.0, approximately 0.2 mM DTT. (C) Polymerization assay performed by incubation of 
vimentin wt or C328S at 3.8 µM in the presence of 150 mM NaCl during 15 min at 37ºC, in 5 mM 
Pipes-Na, pH 7.0, 0.2 mM DTT. All samples were submitted to ultracentrifugation, after which, 
supernatant (S) and pellet (P) containing soluble and polymerized vimentin, respectively, were 
assessed by SDS-PAGE. The proportion of polymerized vimentin was determined by image 
scanning and is displayed below the plots. Results are representative of five assays. (D) 
Analysis of vimentin structures by electron microscopy (EM). Soluble vimentin WT or C328S 
were processed and visualized by EM at 50000-fold magnification. (E) EM inspection of vimentin 
filaments obtained by incubation with 150 mM NaCl for different times, as specified. Filament 
width (F) and length (G) were measured using FIJI software. It is important to clarify that 
measurement of filament length was limited by the EM field; although some filaments can reach 
longer lengths, the values registered in the graph correspond to the length observed in a single 
field. Results shown are mean ± SEM of 50 to 200 filaments per condition (F): *p<0.05 and 
**p<0.001 vs vimentin wt at 5 min, #p<0.05 vs vimentin C328S at 5 min, §p<0.05 as indicated); 
(G): *p<0.05 and **p<0.0001 vs vimentin wt at 5 min, #p<0.05 vs vimentin C328S at 5 min, 




tyrosines and phenylalanines that are predicted to be in the position “a” and “d” 
of the heptad repeat of the rod domain coiled-coil of vimentin [246]. This 
confirms that after refolding procedures, ultrafiltrated and dialyzed vimentin is 
mostly organized as a coiled-coil alpha-helical structure, which is in good 
agreement with what was previously described  [244, 247]. 
In low ionic strength buffer, vimentin exists as soluble oligomeric species 
and these complexes form bona fide IFs when the ionic strength is increased 
[48]. Vimentin filaments are readily pelletable by ultracentrifugation. As 
demonstrated in figure 12C, both vimentin wt and C328S polymerized upon 
addition of 150 mM NaCl, and more than 90 % of the total protein was 
recovered in the pellet under the polymerization conditions, while, in the 
hypotonic buffer, the proportion of polymerized protein was approximately 16 % 
of the total protein.  
Inspection of negatively stained vimentin structures by electron 
microscopy (EM) revealed that soluble vimentin appeared in a homogeneous 
pattern of small rod-like structures of 2-5 nm width and variable length, together 
with fibrils and occasionally, some protein aggregates (fig. 12D). The vimentin 
rod-like structures likely correspond to the first stable soluble oligomers found in 
vitro after reconstitution in a urea-free buffer, which are mostly vimentin 
tetramers, as previously described [51, 248].  
Time-dependent assembly of vimentin was followed at 5 min, 10 min, 60 
min and 120 min after addition of 150 mM NaCl by EM (fig. 12E). As described 
earlier, vimentin assembly occurs in three steps: within the first seconds, 
soluble vimentin tetramers laterally associate to form unit-length filaments 
(ULFs); between the first and fifth minute of assembly, ULFs longitudinally 
anneal to form loosely packed filaments which finally undergo a radial 
compaction process to form IFs of width around 12-13 nm [59]. Therefore, EM 
images illustrated in figure 12E depict vimentin structures corresponding to the 
longitudinal annealing phase and to the time dependent radial IF compaction 
process. 
At early polymerization time points (5 min), both vimentin wt and C328S 
formed filaments of nearly normal appearance, of approximately 14 nm of width 
and mean filament length of 500 nm and 700 nm, respectively. At later 




decrease while filament length increased, consistent with the elongation and 
radial compaction phases. At all time points monitored by EM, vimentin wt 
filaments showed a slightly wider diameter compared to vimentin C328S 
filaments, reaching 12.3 and 11.8 nm of diameter, respectively. Regarding the 
elongation process, vimentin C328S filaments were significantly longer than wt 
at 5 and 10 min, suggesting a faster assembly and highlighting a role of the 
residue at the 328 position in the assembly process. 
In summary, combination of these distinct techniques validated the 
ultrafiltration process followed by dialysis as an effective method to remove 
EDTA and to renature vimentin in a functional state able to form structures 
consistent with those reported in the literature. Additionally, our results revealed 
for the first time subtle differences between the polymerization behavior of 
vimentin wt and C328S that should be the object of future studies. 
 
2. Characterization of vimentin as target for lipoxidation 
and oxidation 
 
As mentioned before, vimentin is a target for modification by several 
oxidants and electrophiles, a phenomenon referred here as (lip)oxidation, which 
induces an intense remodeling of its cellular network. Nevertheless, information 
on the impact of (lip)oxidation on filament assembly and structure is scarce. 
Once reproducible refolding methods had been set up yielding functionally 
competent vimentin, the morphological variations and putative mechanisms of 
its modification by various lipoxidants in vitro and in cells could be addressed. 
 
2.1 In vitro modification of vimentin by oxidants and electrophiles 
 
  Vimentin modification by several electrophiles and oxidants (fig. 13A) 
was first assessed in vitro. The cysteine residue at position 328 is highly 
susceptible to oxidation and a common site for electrophile addition. Therefore, 
we have explored the role of this residue in the impact of vimentin (lip)oxidation 


















Figure 13 Lipoxidants induce in vitro modification of vimentin.  
(A) Structures of the electrophilic compounds (lipoxidants) used and their mechanisms of 
reaction with proteins. Diamide reacts with thiol groups of proteins through its diazenecarbonyl 
moiety, a two-step reaction between thiolate anion and the diazene double bond yielding a 
disulfide and a hydrazine. 4-Hydroxynonenal (HNE) modifies proteins through two mechanisms: 
via Michael addition to a nucleophile by the active alkene bond or through Schiff’s base formation 
by reaction of the aldehydic group with an amino group of the protein. The cyclopentenone 
prostaglandin 15-deoxy-Δ
12,14
-PGJ2 (15d-PGJ2) reacts with proteins by forming Michael adducts 
through its electrophilic carbon atoms, marked with asterisks. The structure of DMSO is 
represented. (B) Diamide promotes disulfide-crosslinked oligomers of vimentin. Purified vimentin 
wt or C328S (3.8 M), as indicated, was incubated in the presence of 1 or 5 mM diamide for 1 h 
at r.t. Incubation mixtures were subjected to SDS-PAGE under non-reducing or reducing 
conditions and vimentin oligomeric species were inspected either by Sypro-Ruby staining 
followed by UV detection or by western blot (WB). The proportion of oligomer versus monomer 
was determined by image scanning.  
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Diamide is an oxidant able to promote disulfide bond formation between 
thiol groups of cysteine residues (fig. 13A) [249]. Treatment of vimentin wt with 
diamide induced the formation of an oxidative dimer of an apparent molecular 
weight of 150 kDa, as revealed by SDS-PAGE under non-reducing conditions, 
followed by either western blot with anti-vimentin antibodies or total protein 
staining with Sypro-Ruby. As reported previously by Rogers and colleagues, 
this dimer also occurs upon cysteine crosslinking and it has a particularly low 
electrophoretical mobility due to the presence of an elevated percentage of α-
helix within the protein [8]. On the other hand, this oxidative dimer was not 
detected in vimentin C328S or under reducing conditions, indicating that it was 
due to disulfide crosslinking between the cysteines (fig. 13B). 
HNE is able to react either through Michael addition with various 
nucleophilic residues or by Schiff base formation with amino groups (fig. 13A). 
In this experiment, HNE adducted to vimentin was detected by western blot 
using an anti-HNE adducts antibody [250]. As shown in figure 13C, both 
vimentin wt and C328S were similarly modified by HNE in a concentration-
dependent manner, consistent with the fact that HNE is not a cysteine-specific 
lipoxidant.  
(C) Modification of vimentin by HNE. Purified vimentin wt or C328S was incubated with 
vehicle (DMSO, 5 % v/v) or HNE at 50 or 100 M for 1 h. Western blot with an anti-HNE 
adducts and vimentin antibodies was performed to estimate the levels of HNE adduction and 
vimentin, respectively. The signal from the anti-HNE antibody after subtraction of the 
background value (vehicle), was corrected by the vimentin level. (D) Modification of vimentin 
by biotinylated 15d-PGJ2. Vimentin wt or C328S was incubated in the presence of vehicle 
(DMSO, 5 % v/v) or the biotinylated analog of 15d-PGJ2 (15d-PGJ2-B) at 10 or 50 M for 1 h. 
Incorporation of 15d-PGJ2-B was assessed by detection of the biotin signal on blots with 
HRP-conjugated streptavidin. Vimentin levels were monitored by western blot. (E) Vimentin 
wt or C328S was incubated in the presence of the indicated concentrations of DMSO (v/v), for 
1 h and the formation of disulfide-bonded oligomeric species was monitored by SDS-PAGE 
under non-reducing conditions and western blot. The levels of oligomer were estimated in 
overexposed films by image scanning. The size of the molecular weight standards used (in 
kDa) is given at the left of the blots. All experiments were executed at least three times and 
average values of the determinations ± SEM are shown either in the graphs or below the 
blots. (*p<0.05 vs the indicated conditions in panel C or vs the same condition for vimentin wt 




The biotinylated derivative of the cyPG 15d-PGJ2 (15d-PGJ2-B) 
covalently binds vimentin, mainly through its cysteine residue (fig. 13A) [4]. 
Vimentin was treated with two different concentrations of 15d-PGJ2-B, the 
incorporation of which was evaluated by SDS-PAGE followed by detection with 
HRP-streptavidin (fig. 13D). Monitoring the biotin signal showed a progressive 
modification of vimentin wt with increasing concentrations of this electrophilic 
prostaglandin. Likewise, vimentin C328S was modified when incubated in 
presence of 15d-PGJ2-B, but to a lower extent. This might be due to the ability 
of these electrophilic prostaglandins to form adducts with residues other than 
cysteine, such as histidine, as reported previously for a structurally related Δ12-
PGJ2 [251].  
These electrophilic compounds, except diamide, were dissolved in 
dimethyl sulfoxide (DMSO), as vehicle. It is known that DMSO may interact with 
L-cysteine leading to the oxidative formation of an L-cystine [252]. Taking into 
account this report, we have also explored the effect of different concentrations 
of DMSO on vimentin oxidation (fig. 13E). Under non-reducing conditions, we 
observed the concentration-dependent appearance of a faint band at 
approximately 150 kDa. This oligomer was detected in vimentin wt, but it did not 
occur in vimentin C328S, which suggests that DMSO is able to induce oxidative 
cysteine crosslinking of vimentin. 
Altogether, these results identify vimentin as target for several 
electrophilic compounds, which may result in the formation of adducts or 
oxidative cysteine-crosslinked dimers. 
 
2.2 Effect of lipoxidation/oxidation on the assembly of vimentin in 
vitro 
 
Electrophilic modification of vimentin may have functional consequences, 
for instance on its ability to properly assemble into long and well-compacted 
filaments. This possibility was explored by EM observation of vimentin 
preincubated with the indicated reactive compounds followed by polymerization 
























Figure 14. (Lip)oxidation effect on in vitro vimentin assembly.  
Purified vimentin wt or C328S was preincubated with 1 mM Diamide, 5% (v/v) DMSO or 100 µM 
HNE for 60 minutes (A) and (D) or with increasing concentrations of 15d-PGJ2 (E), after which, 
polymerization was promoted by incubation with 150 mM NaCl (final concentration), for 5 min (A) 
and for 60 min (D). Aliquots of the incubation mixtures were processed as detailed in Methods 
and filaments were visualized by EM. Images shown are representative of at least three 
independent assays with similar results. (B) Filament width was measured as the average 
thickness of segments of at least 100 nm, as illustrated in the right panel in D, and compiled in 
the graphs for 5 min (B) and for 60 min of polymerization (F). In (C), the length of filaments 
measured within the EM image field is represented in the scattered plot. A p value < 0.001 was 
obtained for comparison between all experimental conditions by ANOVA followed by Tukey's 
post-test, except for vimentin C328S control vs DMSO, and vimentin wt control vs vimentin 
C328S HNE (non significant). In the figure, only the differences between some of the conditions 
are marked for clarity (§ p<0.001). The results presented in (F) are average values from at least 
60 individual filaments per experimental condition ± SEM (*p<0.05 vs control, # p<0.05 vs 
DMSO, ¥ p<0.05 vimentin wt vs vimentin C328S by unpaired Student’s t-test). Scale bars are 
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Under these conditions, 5 min after inducing polymerization, vimentin wt 
preincubated in hypotonic buffer formed filaments of normal appearance (fig. 
14A). These filaments presented an average width of 14.7 ± 0.3 nm and a mean 
length of approximately 600 ± 21 nm, as quantitated in the graphs displayed in 
figure 14B and 14C, suggesting that at this time point, they were not completely 
elongated and compacted. In sharp contrast, preincubation with the oxidant 
diamide severely disrupted vimentin wt assembly (fig. 14A), leading to the 
formation of polymorphic aggregates and short incipient filaments. 
DMSO was used as vehicle for lipid electrophiles. Since we have 
observed that DMSO is able to induce the formation of an oxidative dimer, we 
also explored its effect on vimentin assembly by EM (fig. 14A). At 5 min of 
polymerization in the presence of 5% DMSO (% v/v), vimentin wt was able to 
form filaments, although shorter and wider than control ones (average width 
~15.5 nm). On the other hand, preincubation of vimentin wt with 100 µM HNE 
revealed it to be more deleterious than its vehicle (DMSO), since the mean 
length of HNE-pretreated filaments suffered a decrease of 27% compared to the 
length of DMSO-pretreated ones (fig. 14A). Taken together, these observations 
suggest that electrophilic compounds affect filament elongation or end-to-end 
annealing at early times of polymerization.  
Remarkably, assembly of vimentin C328S was less susceptible to 
preincubation with electrophilic compounds (lower images in fig. 14A). In the 
control condition, vimentin C328S filaments displayed longer mean length and, 
in general, they presented a more compacted morphology, exhibiting an 
average width slightly thinner than vimentin wt filaments. Notably, the effect of 
diamide was absent in vimentin C328S, which polymerized into filaments with 
normal morphology. Moreover, the shortening effect of DMSO was nearly 
abolished in the vimentin mutant, which displayed a non-significant  6% length 
reduction. Finally, although HNE caused a 19% decrease in the average length 
of vimentin C328S filaments, this damaging effect was also attenuated in 
respect to wt. 
Next, we evaluated the effect of preincubation with the same reactive 
compounds on filament assembly, after 1 h of polymerization (fig. 14D). At this 
time point, vimentin wt and C328S pretreated with vehicle were fully 




length. Vimentin wt presented a mean width of 13.5 ± 0.3 nm, whereas vimentin 
C328S compacted reaching an average diameter of 12.6 ± 0.3 nm, as 
summarized in figure 14F.  
At the end-point of polymerization, diamide-pretreated vimentin wt was 
not able to assemble into normal filaments, forming even bigger aggregates 
together with irregular filamentous structures (fig. 14D). Notably, vimentin 
C328S continued to be unaffected by this oxidant and polymerized properly into 
long and well compacted filaments. 
In presence of DMSO, vimentin wt was able to fully elongate (fig. 14D). 
However, DMSO-pretreated filaments presented a more irregular morphology, 
with more variable width along the filament, and in general wider than control 
filaments (~ 15 nm). On the other hand, vimentin C328S preincubated with 
DMSO fully polymerized into apparently normal filaments. 
After 1h of polymerization, filaments formed by HNE-pretreated vimentin 
wt were shorter, both ends being frequently visible in the same field at the 
magnification used (fig. 14D). Additionally, they displayed intense bundling and 
appeared as more irregular and disengaged filamentous structures. In this 
condition, filament width was markedly increased, reaching an average 
diameter of 16.9 ± 0.9 nm. Similarly to the early points of polymerization, the 
consequences of HNE pretreatment were mitigated in vimentin C328S. 
Nevertheless, the width of HNE-pretreated vimentin C328S filaments showed a 
significant increase compared to DMSO-preincubated ones, although the mean 
filament diameter was not wider than 14 nm. 
The effect of different concentrations of the cyclopentenone 15d-PGJ2 on 
vimentin assembly was also visualized under EM (fig. 14E). Increasing 
concentrations of this electrophilic prostaglandin slightly increased vimentin wt 
diameter in respect to DMSO vehicle (fig. 14F). Moreover, vimentin wt filaments 
preincubated with concentrations above 25 µM of 15d-PGJ2 showed a rougher 
appearance and more frequent aggregates. According to the previous results 
with the other electrophiles, vimentin C328S formed more homogenous 
filaments. Nonetheless, at the highest concentration of 15d-PGJ2 employed (84 
µM), both vimentin wt and C328S failed to assemble as normal filaments. 
In summary, these results show that lipoxidants disrupt vimentin 




patterns depending on the structural properties of the various agents used. 
Moreover, the presence of the single cysteine residue of vimentin appears to be 
required for (lip)oxidation-induced alterations of assembly. 
 
2.3 Susceptibility of polymerized vimentin to disruption by 
electrophilic agents  
 
In cells, vimentin occurs in polymerized and non-polymerized states, 
which are continuously exchanging. Therefore, we next investigated whether 
electrophilic agents exerted differential effects in non-polymerized and 
polymerized vimentin (fig. 15). To this end, we examined the sample mixtures 
resulting from incubation of vimentin wt with the indicated compounds before 
and after inducing polymerization with 150 mM NaCl by EM (fig. 15A). 
Interestingly, the first observation derived from these studies was that if 
assembly was induced just after thawing, vimentin formed filaments significantly 
narrower compared to the ones that were polymerized after preincubation in a 
hypotonic buffer, as displayed in the graph of figure 15A. This may reflect that 
soluble vimentin wt is sensitive even to environmental conditions. Notably, 
preformed filaments treated with diamide did not present any obvious alteration 
in filament morphology, in sharp contrast with the effect of diamide on soluble 
vimentin, which drastically disrupts subsequent assembly. 
Even though treatment with DMSO of polymerized vimentin caused a 
significant increase of filament width up to 13.3 nm ± 0.3 nm, filaments were still 
markedly narrower than those formed by vimentin assembled after 
preincubation with DMSO. Likewise, preformed filaments treated with HNE 
presented attenuated alterations of filament morphology, and were visibly 
longer and significantly more compacted than those assembled after HNE 
pretreatement. Similarly, preformed filaments were less susceptible to variations 
of filament morphology induced by treatment with 15d-PGJ2. Summarizing, EM 
observation revealed that vimentin wt preformed filaments were more resistant 
to the electrophilic treatment and presented, in general, a more homogenous 
appearance compared to the morphological alterations observed in filaments 

















In order to ascertain whether the attenuation of the effect of (lip)oxidation 
on preformed filament morphology was due to a lower extent of modification of 
polymerized vimentin, we have employed gel-based assays (fig. 15B). In these 
experiments, vimentin wt was initially preincubated in the absence or presence 
of 150 mM NaCl, followed by treatment with the indicated electrophilic 
compounds. As shown in the graphs, polymerized and non-polymerized 
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Control
Figure 15. Impact of (lip)oxidation on filament formation and on preformed vimentin 
filaments.  
(A) Inspection of filament morphology by EM. Purified vimentin wt was treated with the indicated 
oxidants or electrophilic lipids before (upper images) or after NaCl-induced polymerization (lower 
images). Scale bars, 200 nm. The histogram in the right panel shows filament width quantitated 
as in figure 14. Results represent average values ± SEM of 3 to 5 experiments totaling 50 
filaments. (*p<0.05 vs control of polymerization followed by electrophile treatment; #p<0.05 vs 
control of electrophile treatment followed by polymerization; §<0.05 vs the same treatment before 
polymerization by unpaired Student’s t-test). ND, not determined. (B) Vimentin was incubated for 
1 h at r.t. in the absence (- NaCl) or presence of NaCl (+ NaCl), after which, it was incubated with 
the indicated oxidants or electrophilic lipids for an additional hour and the extent of modification 
was assessed as in figure 13. Results shown in graphs are average values ± SEM of three 




vimentin treated with diamide or DMSO, formed a similar amount of oxidative 
dimers. In the same way, the extent of adducts formed by HNE or 15d-PGJ2-B 
and vimentin was similar or even larger at higher concentrations of the 
electrophilic agents, after prior polymerization with NaCl. 
These results suggest that, even though the modification of non-
polymerized and polymerized vimentin seems to occur to a similar extent, 
(lip)oxidation of vimentin is more detrimental for filament formation if it takes 
place prior to assembly. Nevertheless, we cannot exclude the possibility that the 
subunits modified in every situation are different; for instance, in polymerized 
vimentin, modification of accessible and peripheral subunits could have milder 
consequences on filament stability. Given the fact that, in cells, vimentin 
undergoes remodeling, we were interested in exploring this polymerization-
dependent effect of (lip)oxidation in the cellular environment. 
 
2.4 Impact of the oxidant diamide on vimentin organization in cells 
 
In order to study the role of vimentin dynamics and the cysteine residue 
in the response of vimentin towards (lip)oxidative stress, we have used the 
adrenal carcinoma cell line SW13/cl.2 (SW13), devoid of cytosolic IFs. This cell 
model allows transfection with different vimentin constructs, such as vimentin wt 
or C328S, which can be studied without the interference of endogenous 
vimentin [4]. 
SW13 cells were stably transfected with bicistronic expression plasmids 
coding for untagged vimentin wt or C328S and DsRed-Express2 protein (RFP) 
as separate products (RFP//vimentin wt or C328S). Cells expressing either 
construct were subjected to treatment with diamide and its effect on the 
vimentin network was visualized by immunofluorescence (fig. 16A). In the 
control condition, both vimentin wt and C328S formed an extended network of 
filaments, spreading from the juxtanuclear region to the cell periphery.  
Diamide is a chemical oxidizing agent, which was reported to decrease 
the concentration of glutathione in cells, indicating that this electrophilic agent is 
able to induce oxidative stress [253]. Treatment with 1 mM diamide for 15 min 
provoked an extensive remodeling of the vimentin network, which appeared as 




the graph of figure 16A. Strikingly, diamide-induced network reorganization was 












In order to explore if the deleterious effect of diamide was associated to 
changes in vimentin solubility, we estimated the proportion of soluble vimentin 
by means of a high-salt/Triton X-100-based fractionation protocol, as detailed in 
[239]. As illustrated in figure 16B, diamide treatment slightly decreased the 
Figure 16. Vimentin network reorganization induced by diamide in cells.  
(A) SW13/cl.2 cells stably transfected with RFP//vimentin wt or C328S were treated with vehicle 
(H2O) or with 1 mM diamide for 15 min, after which, cells were fixed and the vimentin network 
was visualized by immunofluorescence. Scale bars, 20 m. The graph depicts the proportion of 
cells with totally fragmented vimentin filaments in control or diamide treated cells (right panel) as 
average values ± SEM of three experiments totaling at least 150 cells (**p<0.01 vs wt-control; 
#p<0.05 vs wt-diamide by Student’s t-test). (B) The solubility of vimentin wt upon treatment with 
diamide was monitored by cell fractionation and western blot of supernatant (S) and pellet (P) 
fractions with anti-vimentin antibody. As a control, blots were probed with anti-actin antibody. The 
proportion of soluble vimentin wt was estimated by image scanning and average values obtained 




































































































proportion of soluble vimentin. This effect could be due to an increase in either 
vimentin aggregation or cysteine crosslinking induced by this oxidant. Notably, 
no vimentin degradation was observed after diamide treatment, indicating that 
the marked reorganization was not due to loss of integrity of the protein. Actin 
was used as control of diamide specificity, and it remained mostly soluble in all 
conditions.  
Taken together, these results show that the cysteine residue is required 
for vimentin network reorganization induced by diamide treatment. Additionally, 
vimentin disassembly or degradation do not seem to be associated with these 
morphological alterations. 
 
2.5 Modulation of vimentin dynamics in SW13/cl.2 cells 
 
The results presented above highlighted two critical points: preformed 
filaments are more resistant to (lip)oxidative treatments and diamide-induced 
remodeling was not caused by an increase of vimentin solubility. Therefore, we 
hypothesized that vimentin network disruption provoked by diamide would 
require active vimentin exchange of subunits, in a way that reincorporation of 
modified vimentin would cause anomalous filaments. Therefore, we first 
monitored vimentin filament dynamics in SW13/cl.2 cells, transiently transfected 
with a combination of untagged vimentin wt (80%) and GFP-vimentin wt (20%), 
by fluorescence recovery after photobleaching (FRAP) assays (fig. 17A). In the 
control situation, fluorescence reappearance was observed within the first 
seconds, as determined in the lower panel of figure 17A, indicating that this cell 
model has a high rate of subunit exchanging and consequently, very active 
vimentin dynamics. Nevertheless, this technique was not able to elucidate the 
nature or the oligomerization state of the fluorescent vimentin incorporated into 
the bleached filaments.   
Further experiments were done to assess strategies to preclude vimentin 
dynamics. Dibromobiname (DBB) is a bifunctional reagent which irreversibly 
crosslinks vicinal thiol groups and has been proposed to stabilize the vimentin 
filamentous network [4]. Quantitative analysis of fluorescence recovery revealed 
that DBB efficiently blocks vimentin dynamics, since the recovery of 















Depletion of ATP was previously described to inhibit subunit exchange 
on vimentin filament precursors [64]. Thus, cells were treated with the 
ionophore carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone (FCCP), 
which prevents ATP production by dissipating the mitochondrial proton gradient 
[254]. This treatment was performed in absence of glucose to prevent ATP 





















































































Figure 17. Modulation of vimentin dynamics in SW13/cl.2 cells.  
(A) Assessment of vimentin dynamics by FRAP. SW13/cl.2 cells were transiently transfected with 
RFP//vimentin wt plus GFP-vimentin wt for live cell monitoring as detailed in Methods. FRAP 
assays were performed in cells treated with vehicle (control), 100 M DBB or 10 M FCCP in 
glucose-free medium for 10 to 30 min. Representative images acquired prior to (pre-bleach), 
immediately after (0 s) and 150 s after bleaching are shown. The bleached area is delimited by a 
dotted yellow rectangle. Scale bars, 10 μm. The graph shows measurements of the fluorescence 
intensity of the bleached area taken every 3 s. Results are average values of at least 20 
determinations ± SEM. Differences between values from control and treated cells were 
statistically significant at all time points by Student’s t-test. (B) Vimentin solubility under the 
conditions of the assays was determined as above. The graph depicts average values from 3 to 




determinations showed a clear reduction of the fluorescence recovery rate after 
treating cells with this inhibitor of oxidative phosphorylation, indicating a sharp 
inhibition of vimentin dynamics. 
Potential alterations of vimentin solubility by these strategies were 
assessed as described in figure 16B and results are shown in figure 17B. 
Western blot analysis demonstrated that DBB treatment lowered the vimentin 
soluble pool by approximately 50%, consistent with the increase in cysteine 
crosslinking, which could lead to insoluble aggregates. In turn, the amount of 
soluble vimentin did not suffer changes when cells were treated with FCCP in 
the absence of glucose. In all situations, treatments had no effect on actin 
solubility (fig. 17B, lower blot). 
 
2.6 Protective effect of minimizing vimentin dynamics on diamide-
induced network disruption  
 
After confirming the ability of cysteine crosslinking and depletion of ATP 
to minimize vimentin filament dynamics, we tested the protective potential of 
these strategies against disruption of vimentin filaments by diamide (fig. 18). 
Diamide induced a strong reorganization of vimentin network into dots in 
approximately 80% of cells after a 5 min treatment and in more than 90% of the 
cells after 15 min (fig 18A). The percentage of cells with totally fragmented 
vimentin is detailed in figure 18B.  Pretreatment of cells with 100 µM of DBB for 
15 minutes, fully protected the vimentin network from remodeling by subsequent 
diamide treatment for 15 min. However, vimentin showed a tendency to 
accumulate close to nucleus and F-actin was not protected from oxidative 
damage, appearing as a reticular pattern instead of as a homogeneous 
network. Likewise, FCCP also triggered vimentin juxtanuclear condensation, an 
effect that was also perceived on F-actin. This effect, which was beforehand 
reported to be independent from inhibition of oxidative phosphorylation by Maro 
and colleagues [255], precluded long-term treatment with this inhibitor, for which 
its protective potential effect was assessed by adding diamide for 5 min. Under 
these conditions, FCCP in glucose-free medium virtually abolished diamide-
induced vimentin network disruption. We also observed a significant protection 




(NaN3), which reduces ATP production by inhibition of cytochrome C oxidase 















Regarding the strategies used to block vimentin dynamics, cysteine 
crosslinking by DBB was revealed to be the most efficient one, preventing 
vimentin fragmentation even after longer treatments with diamide. In turn, the 
protective properties of ATP depletion induced by FCCP or sodium azide were 
gradually lower during longer treatments. Besides, these compounds were toxic 
Figure 18. Protective effect of minimizing vimentin dynamics against diamide-induced 
network fragmentation.  
(A) SW13/cl.2 cells stably transfected with RFP//vimentin wt were pretreated with 100 µM DBB in 
serum-free medium or with 20 mM NaN3 or 10 µM FCCP for 15 or 20 min, respectively, in the 
absence of glucose, as indicated, before addition of vehicle (upper two rows) or 1 mM diamide 
(lower two rows) for 5 min in the case of FCCP or NaN3-pretreated cells, or for 15 min in control 
and DBB pre-treated cells. Cells were fixed and vimentin distribution (green) was assessed by 
immunofluorescence and representative images of “fragmented” vimentin network are shown. F-
actin distribution (red) was monitored by phalloidin staining. Overlay of vimentin and actin signals 
are presented in the insets. (B) Graph depicting the proportion of cells showing a completely 
fragmented vimentin network. In every experiment, at least 300 cells were monitored per 
experimental condition. Results are average values ± SEM of three experiments. (**p<0.0001 vs 
diamide 5 min, # p<0.05 vs diamide 15 min). (C) Steady-state ATP levels under the different 
experimental conditions were determined as detailed in Methods. Results are presented as 
mean values of three experiments performed in triplicate ± SEM (*p<0.05 vs control, § p<0.05 vs 
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at higher concentrations, compromising their effect against diamide-induced 
reorganization of vimentin. 
Steady-state levels of intracellular ATP under the conditions of these 
assays were determined and depicted in the graph in figure 18C. The inhibitors 
of oxidative phosphorylation, FCCP and NaN3 in glucose free-medium, 
diminished effectively the concentrations of ATP by 75% and 83%, respectively.  
In summary, these results show that the vimentin network is actively 
dynamic in SW13.cl2 cells. Nevertheless, vimentin subunit exchange can be 
prevented either by cysteine crosslinking or ATP depletion. Moreover, vimentin 
filament dynamics appears to be required for diamide-induced remodeling, as 
implied by the protective effect of strategies blocking vimentin subunit 
exchange, which suggests that vimentin network disruption occurs when 
modified vimentin “subunits” attempt to integrate into filaments.  
 
 
3. Vimentin-zinc interplay and its relevance in 
pathophysiology 
 
Previous chapters have highlighted the role of vimentin as a sensor of 
(lip)oxidation and the importance of C328 in these processes. Interestingly, 
vimentin (lip)oxidation can also be modulated by context factors, including the 
levels of antioxidant defenses and of certain divalent cations. Among them, zinc 
may interact with proteins, either by inducing specific conformations, supporting 
catalytic activity or stabilizing oligomeric associations [191]. Earlier investigation 
performed by our group, unveiled a robust interaction between vimentin and 
zinc, both in vitro and in the cell environment [4]. However, the structural 
features of vimentin-zinc interaction have not been elucidated. Thus, we 
designed a combination of experimental strategies to understand its role in the 
structural organization of vimentin in vitro and within the cellular context, 







3.1 Effect of divalent cations on vimentin polymerization in vitro  
 
The ability of zinc to induce vimentin polymerization was evaluated by 
incubation of vimentin wt or C328S with increasing concentrations of ZnCl2, 
followed by ultracentrifugation and gel electrophoresis of supernatant (S) and 
pellet (P) fractions, corresponding to soluble and polymerized vimentin, 
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Figure 19. Polymerization assays of vimentin wt and C328S with divalent cations.  
(A) Polymerization assays were performed by incubation of vimentin wt and C328S at 3.8 µM, 
in 5 mM Pipes-Na, pH 7.0, with increasing concentrations of ZnCl2 during 1 h at r.t. All samples 
were subjected to ultracentrifugation, after which, supernatant (S) and pellet (P) fractions were 
analysed by SDS-PAGE. Total protein was stained with Sypro-Ruby and visualized by UV 
detection. The proportion of polymerized vimentin was determined by image scanning and 
displayed in the graphs. Results shown are mean ± SEM of three independent experiments, 
**p<0.0005; *p<0.05 vs 0 µM ZnCl2 by Student’s t-test.  (B) Vimentin wt and C328S 
polymerization with increasing concentrations of MgCl2. Samples were subjected to the same 





In low ionic strength buffer, such as 5 mM Pipes-Na, pH 7.0, 75-80% of 
both forms of vimentin, wild-type and C328S, occurred as soluble species. Low 
concentrations of zinc, up to 50 µM, did not alter the proportion of soluble 
vimentin, but concentrations at or above 250 µM induced polymerization of 
practically 100% of vimentin (fig.19A). Vimentin has also been reported to 
interact with magnesium ions [62], which, as zinc are redox inactive. However, 
incubation with MgCl2 in the same concentration range did not elicit vimentin 
polymerization, as shown in figure 19B. Thus, at 500 µM MgCl2, vimentin wt and 
C328S still appeared mostly in the soluble fraction. These results could suggest 
that micromolar concentrations of zinc induce structural rearrangements of 
vimentin that alter its solubility, which do not occur in presence of equivalent 
amounts of other divalent cations. 
 
3.2 Turbidity and fluorescence anisotropy of zinc-induced vimentin 
polymerization 
 
In order to explore the nature of the vimentin polymers formed by 
incubation with zinc, we applied additional biophysical techniques. Turbidity or 
light scattering, and fluorescence anisotropy measurements allowed monitoring 
vimentin oligomerization when incubated with different concentrations of zinc 
(fig. 20). We observed an increase in the turbidity of the solutions of vimentin wt 
with increasing concentrations of the divalent cation (fig. 20A). A significant 
increase in turbidity could be detected with 150 µM ZnCl2. These results 
indicate the formation of bigger structures in the presence of zinc. Vimentin 
C328S displays a similar behavior, which suggests that the formation of zinc-
induced structures can occur in vimentin bearing either a cysteine or a serine 
residue at position 328. In this method, zinc concentrations above 300 µM and 
turbidometric measurements longer than 20 min, were not taken into account, 
since we detected a decrease on the absorbance that might be compatible with 





















Figure 20. Monitoring vimentin polymerization by turbidity and fluorescence anisotropy 
experiments.  
(A) Turbidity analysis of vimentin wt and C328S as a function of increasing concentrations of 
ZnCl2. Solutions of vimentin wt and C328S (70 µl) were placed in Hellma absorption cuvettes. 
Increasing amounts of ZnCl2 were sequentially added to the protein solution to achieve the 
indicated final concentrations. Absorbance values were immediately measured at 350 nm. At 
least three independent experiments were performed and mean values ± SEM are represented 
in the graphs. *p<0.05 vs 0 µM ZnCl2 in vimentin wt; #p<0.05 vs 0 µM ZnCl2 in vimentin C328S, 
by Student’s t-test. (B) Steady-state fluorescence anisotropy of vimentin wt or C328S as a 
function of zinc concentration. Sample mixtures of unlabeled vimentin (1 µM) with vimentin 
labeled with Alexa 488 (50 nM) were incubated with different concentrations of ZnCl2. 
Fluorescence anisotropy was monitored at λexc = 485 nm and λem = 520 nm, at 26 
o
C. Results 
presented are mean ± SEM of two (vimentin C328S) or eight replicates (vimentin wt). (C) 
Analysis of the reversibility of the effect of zinc on vimentin wt using TPEN (left panel) or EDTA 
(right panel). Turbidity changes were followed over time upon addition of ZnCl2 and metal 
chelators, as detailed in the graph. Three independent experiments were performed for each 
condition. *p<0.05 vs t = 2 min; # p < 0.05 vs t = 10 min. (D) Turbidity measurements of vimentin 
wt incubated with increasing concentrations of MgCl2 (left panel, n=3) and NaCl (right panel, 
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Next, we used fluorescence anisotropy to complement our studies about 
the potential of zinc as a polymerizing agent.  A mixture of unlabeled vimentin 
wt or C328S with the corresponding vimentin labeled with Alexa 488, as a 
tracer, was incubated with increasing concentrations of zinc and fluorescence 
was measured (fig. 20B). We observed a concentration-dependent increase in 
anisotropy that is compatible with the formation of larger protein species, which 
corroborated the ability of zinc to induce vimentin polymerization at micromolar 
concentrations. As observed above in the turbidity measurements, there were 
no significant differences in zinc-induced aggregation between vimentin wt and 
C328S.  
In order to explore whether the effect of zinc on vimentin polymerization 
is reversible, we monitored turbidity upon subsequent addition of ZnCl2 and two 
metal chelators, ethylenediaminetetraacetic acid (EDTA) and N, N, N', N' 
Tetrakis (2-pyridylmethyl) ethylenediamine (TPEN) (fig. 20C). Both TPEN and 
EDTA form a 1:1 complex with zinc; however TPEN has higher affinity for zinc 
than EDTA (Kd of 6.4 x 10
-16 M and 6 x 10-14 M, for TPEN and EDTA, 
respectively [236]. Addition of 150 µM ZnCl2 to the vimentin solution rapidly 
induced an increase in light scattering, according to previous assays. 
Subsequent addition of an equivalent concentration of zinc chelators elicited a 
fast decrease in absorbance, more marked in the case of TPEN. This decrease 
suggested disassembly of the zinc-induced polymers of vimentin upon chelation 
by TPEN or EDTA. Lastly, replenishment of 150 µM ZnCl2, final concentration, 
restored the light scattering to the initial or even higher levels, in the case of the 
assay with EDTA. The observation that TPEN was more effective in reversing 
the effect of zinc is in good agreement with its higher chelating potential. 
Finally, turbidity measurements were performed to explore the effect of 
other salts, such as MgCl2 and NaCl, on vimentin polymerization (fig. 20D). We 
observed that concentrations of MgCl2  at or above 500 µM induced a significant 
increase of light scattering. Moreover, millimolar concentrations of MgCl2 were 
required to promote similar turbidity changes to the ones observed with ZnCl2. 
In turn, incubation of vimentin with increasing concentrations of NaCl, up to 170 
mM, did not result in a significant increase in turbidity.  
As a conclusion of these experiments, we could propose that micromolar 




high order oligomeric species of vimentin, as indicated by increased turbidity 
and fluorescence anisotropy. In sharp contrast, millimolar concentrations of 
MgCl2 were required to induce similar changes. Moreover, millimolar 
concentrations of NaCl, sufficient to elicit the formation of vimentin filaments, do 
not increase turbidity, probably because of the different size and/or shape of 
filaments compared to zinc-induced vimentin oligomers.  
 
3.3 Assessment of the morphology of zinc-induced vimentin 
structures on different supports  
 
The techniques used above yielded valuable information on zinc-induced 
vimentin polymerization. However, they did not provide structural information on 
the polymers formed. Thus, we used optical and fluorescence microscopy to 
explore the morphology of vimentin oligomers formed on different supports (fig. 
21). First, we applied mixtures of vimentin wt with different concentrations of 
ZnCl2 on glass slides. Direct visualization by optical microscopy revealed the 
presence of long and thick filaments or filament bundles together with irregular 
aggregates, which displayed a larger size with increasing zinc concentrations 
(fig. 21A). Additionally, zinc-induced polymers were intensely stained by 
Zinquin, a fluorescent probe used to detect both free and protein-bound zinc 
[257], suggesting a robust binding of zinc to vimentin.  
We next incubated a solution of vimentin in a flat-bottom microplate, in 
the absence and presence of ZnCl2 as detailed in figure 21B. Vimentin 
assemblies formed in suspension were observed under an optical microscope 
at different time points (0, 20, 40 and 60 min). In the absence of zinc, 
occasional aggregates of vimentin were detected, appearing as disperse dots 
without any distinguishable structure. Incubation with 200 and 500 µM ZnCl2 led 
to the formation of an array of garland-like structures that homogeneously 
distributed in the solution. This particular “beading” network of vimentin in 




































































































































































Vimentin was also encapsulated inside aqueous droplets stabilized in an 
oil phase by a lipid layer, to obtain picoliter-sized compartments. A mixture of 
unlabeled vimentin wt with vimentin wt labeled with Alexa 488 (4:1) was 
encapsulated inside the droplets with or without zinc. These microdoplets were 
observed under fluorescence microscopy and representative images are 
displayed in figure 21C. Without zinc, vimentin was homogenously dispersed 
inside the vesicle, as shown by the plot of the fluorescence intensity, which 
remained virtually constant inside the indicated area of the vesicle (fig. 21D). On 
the other hand, micromolar concentrations of zinc induced vimentin aggregates, 
as demonstrated by the variations in fluorescence intensity inside the vesicle 
(fig. 21D). Moreover, the structure of these zinc-induced vimentin aggregates 
recalled the “beading” distribution observed in suspension (fig. 21C). In 
summary, zinc was able to induce vimentin oligomerization, leading to 










Figure 21. Effect of zinc on vimentin morphology on different supports. 
(A) Vimentin at 5 μM in 5 mM Pipes-Na (pH 7.0) , 0.1 mM DTT, was placed on a glass slide, and 
mixed with vehicle, 200 μM, 500 μM or 2.5 mM ZnCl2 (final concentrations) before visualization 
by differential interference contrast. In the right panel, ZnCl2-induced vimentin filaments were 
labeled with Zinquin and visualized by fluorescence microscopy . Scale bar, 20 µm. (B) Aliquots 
of vimentin at 5 μM were incubated with different concentrations of ZnCl2, in a flat-bottom 
microplate. The solutions were observed under the optical microscope after 20, 40 and 60 min of 
incubation. The experiments were performed in triplicate and representative results are shown. 
Scale bar, 25 µm. (C) Overall projections of representative confocal images of microdroplets 
containing a mixture of unlabeled  and Alexa 488-labeled vimentin wt (4 and 1 µM, respectively), 
in the absence and presence of 200 μM ZnCl2. Scale bar, 20 µm. (D) Fluorescence intensity was 




3.4 Electron microscopy of zinc-induced vimentin structures  
 
We next inspected the vimentin wt and C328S species formed in the 
presence of different concentrations of zinc, under EM after negative staining 










As described in the first chapter, vimentin in hypotonic buffer appeared 
mainly as small rod-like structures of 2-5 nm width and variable lengths, on 
average no longer than 40-50 nm. The dimensions of these oligomeric species 
were found to be very challenging to determine, due to the low contrast 




































































Figure 22. Morphology of zinc-induced vimentin structures monitored by electron 
microscopy.  
Negatively stained  vimentin wt or  C328S  species obtained  after 1 h incubation  with vehicle, 
10 μM or 100 μM ZnCl2 (final concentrations), at r.t, in 5 mM Pipes-Na, pH 7.0, 0.1 mM DTT. 
Graphs summarize the average values of width (left panel) and length (right panel) of zinc-
induced vimentin assemblies. The width was measured using FIJI software as the average 
thickness of segments of at least 20 nm in length, as illustrated in the right panel. Results shown 
are mean values ± SEM of 50 “structures” per condition. §p<0.05 vimentin wt vs C328S, as 
indicated; *p<0.05 vs vimentin wt -10 µM ZnCl2; # p<0.05 vs vimentin C328S-10 µM ZnCl2 by 




vimentin formed assemblies with easily distinguishable features. The width of 
the rod-shaped particles markedly increased in the presence of 10 µM ZnCl2, 
reaching 9.70 ± 0.03 nm and 9.43 ± 0.03 nm, in vimentin wt and C328S, 
respectively. Moreover, 100 µM ZnCl2 further increased the diameter of 
vimentin structures, as depicted in the graphs. The length of the structures did 
not suffer a noticeable variation with increasing zinc concentrations and 
remained at 50 nm. Taken together, these observations suggest that zinc may 
promote lateral association of vimentin oligomers. This effect could be similar to 
that reported for millimolar concentrations of magnesium ions, which are 
described to accumulate in the outer regions of vimentin filaments and are able 
to crosslink different vimentin subunits, leading to appearance of thicker 
filaments [5, 258]. 
 
3.5 Impact of zinc on NaCl-induced vimentin assembly and on 
preformed filaments 
 
The results shown indicate that zinc, at micromolar concentrations, can 
induce some kind of association between vimentin oligomers, under hypotonic 
conditions. Nevertheless, under physiological conditions, vimentin assembly 
takes place in the presence of 150 mM NaCl. Therefore, we were interested in 
exploring the effect of zinc on NaCl-induced vimentin assembly and on 
preformed filaments (fig. 23).  
Thus, we first performed turbidity assays to assess the size of vimentin 
assemblies in presence of zinc, before and after polymerization with NaCl (fig. 
23A). Soluble vimentin was first incubated with 150 µM ZnCl2, which increased 
turbidity as previously described (fig. 20A). Subsequent addition of 150 mM 
NaCl induced an abrupt increment in light scattering. Interestingly, in the inverse 
approach, NaCl-induced polymerization of vimentin only increased absorbance 
slightly, and subsequent addition of zinc further increased the absorbance, 
although to lower values compared to adding zinc before NaCl. This outcome 
may suggest that in both situations higher order associations occur; however 
the features of those complexes could vary depending on whether zinc is added 
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To explore this possibility, the morphology of assemblies formed in both 
situations was explored by electron microscopy. Figure 23B displays 
representative images of vimentin wt or C328S incubated with 10 and 100 µM 
ZnCl2 before assembly with 150 mM NaCl. As described previously, both 
vimentin wt and C328S form long filaments of approximately 12 nm of width, 
when incubated with assembly buffer, which is composed of 5 mM Pipes-Na, 
pH 7.0 and 150 mM NaCl. When 10 µM ZnCl2 was added to soluble vimentin wt 
for 1 h at r.t. before polymerization, vimentin formed aggregates that tended to 
align but could not form filaments. After preincubation with 100 µM ZnCl2, 
vimentin wt failed to assemble upon subsequent addition of NaCl, and formed 
larger irregular structures. A similar effect of zinc was observed in vimentin 
C328S, which did not assemble into filaments in either condition. Thus, the 
interaction of vimentin with zinc appears to preclude subsequent polymerization 
into “normal” filaments induced by physiological concentration of salt. Moreover, 
this effect of zinc on vimentin polymerization seems to be independent from the 
presence of cysteine in the position 328. 
In contrast, when vimentin wt was fully polymerized, incubation in the 
presence of 10 and 100 µM ZnCl2 caused both an increase in filament diameter 
and filament coalescence into bundles (fig. 23C). Determination of width 
revealed that 10 and 100 µM ZnCl2 were able to significantly increase the 
average filament diameter by 12% and 15%, respectively. Filament bundling 
Figure 23. Impact of zinc on vimentin assembly and on preformed filaments.  
(A) Turbidity measurements of vimentin wt were taken every 2 min during 16 min, at r.t, to 
monitor the effect of the order of addition of ZnCl2 and NaCl, as indicated, on the oligomerization 
of the protein (B) EM observation of the effect of zinc on vimentin wt or C328S assemblies 
before polymerization with NaCl. Vimentin samples  were incubated  with vehicle, 10  or 100 µM 
ZnCl2 for 1 h, at r.t, after which, they were incubated in the presence of 150 mM NaCl for an 
additional hour, at 37°C. (C) EM inspection of the effect of zinc on vimentin wt or C328S filament 
morphology after polymerization with NaCl. Vimentin wt or C328S was first polymerized with 
NaCl for 1 h at 37°C, and then, incubated with the indicated zinc concentrations. The right panel 
displays filament width as mean values ± SEM of 50 filaments per condition (**p<0.01 vs wt-
control; §p<0.05 vimentin wt vs C328S by Student’s t-test). (D) EM observation of the 
morphological changes of vimentin preformed filaments induced by increasing concentrations of 
ZnCl2. Filament width measurements are presented in the graph as average values ± SEM of 50 
filaments per condition. **p<0.005 vs control by Student’s t-test. Images shown are 




was scarce at lower concentrations of zinc, but at 100 µM ZnCl2, we observed a 
tighter union into intertwined filaments. In sharp contrast, vimentin C328S 
formed filaments with the typical morphology in presence of zinc, with no 
significant width alterations (fig. 23C). Nevertheless, at higher concentrations 
they also merged to form linear bundles, which seemed to be less intertwined 
and coiled than the ones observed in vimentin wt. These experiments 
corroborate that zinc is able to promote lateral association of vimentin filaments, 
and somehow it rearranges filament structure into a conformation that produces 
wider filaments, which is dependent on the presence of the cysteine residue. 
Evaluation of concentration-dependence of zinc impact was performed 
as shown in figure 23D. The above described bundling effect was cumulative 
with increasing concentrations of zinc. Regarding vimentin filament diameter, it 
suffered an important increase at the lowest concentration of zinc assayed and 
it was roughly maintained around 14 nm at higher concentrations. In summary, 
zinc is able to promote vimentin association into aggregates or bundles, 
depending on the polymerization state of the protein. 
 
3.6 Characterization of vimentin–zinc interaction by computational 
and crosslinking studies  
 
The vimentin sequence possesses a high proportion of negative charges 
and potential sites for interaction with divalent cations [5]. In addition, the results 
presented increased our interest to investigate the possible binding spots for 
zinc in vimentin and the role of C328 in this interaction.  
In collaboration with the group of  Computational Chemical Biology led by 
Dr. Sonsoles Martin-Santamaria, a 3D structure of a putative vimentin dimer 
was modeled, comprising amino acids from D264 to G406, which corresponds 
to coil 2 of the rod-domain where the cysteine is located at position 328 (fig. 
24A). Next, this dimer was used to explore the potential binding sites for zinc 
within this region (fig. 24A). Molecular dynamics (MD) simulations indicated that 
there exist 23 possible hot spots for zinc atoms within this modeled dimer of 
vimentin, in regions with predominant negative density charge. Moreover, stable 
interactions were observed between zinc atoms and residues D331 and E329, 




conditions, the thiol group of C328 can exist either in its protonated or thiolate 
form. Interestingly, MD simulations showed that C328 in its thiolate form can 
directly participate in the coordination with zinc. Consequently, such outcome 
led us to infer that C328-zinc interaction could hypothetically protect this residue 












Figure 24. Characterization of the vimentin–zinc interaction by computational and 
chemical modification studies.  
(A) Final structure of a putative dimer of the vimentin region comprising from D264 to G406, after 
100 ns of MD simulation. Zinc atoms are shown in the proximity of vimentin C328, in its thiolate 
form. (B) Protective role of zinc against vimentin modification. Purified vimentin wt at 4.3 µM was 
preincubated with the indicated concentrations of ZnCl2 for 1 h at r.t., after which, it was treated 
with vehicle, 10 µM of biotinylated iodoacetamide (Iac-B) or 1 µM biotinylated 15d-PGJ2 (15d-
PGJ2-B), for an additional hour at 37°C. Incubation mixtures were subjected to SDS-PAGE and 
the incorporation of the indicated compounds was assessed by detection of the biotin signal on 
blots with HRP-conjugated streptavidin. Vimentin levels were monitored by western blot. Dotted 
lines indicate where lanes from the same gel have been cropped. The proportion of the biotin 
signal with respect to vimentin was summarized in the graph as means values ± SEM of four 
independent assays. * p <0.05 vs Iac-B or 15d-PGJ2-B at 0 µM ZnCl2; *** p < 0.0005 Iac-B or 
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Thus,  in order to explore a putative protective role of zinc against 
cysteine modification of vimentin, we preincubated vimentin with increasing 
concentrations of ZnCl2 followed by treatment with the biotinylated analogs of 
iodoacetamide or 15d-PGJ2 (fig. 24B). The indicated biotinylated derivatives of 
electrophilic compounds covalently bound to vimentin, as previously described 
[3, 4]. Remarkably, analysis by SDS-PAGE and blotting for biotin detection 
showed that preincubation with 50 and 500 µM ZnCl2 significantly decreased 
the incorporation of Iac-B by 50% and 75%, respectively. Likewise, 500 µM 
ZnCl2 prevented the modification of vimentin wt by 15d-PGJ2-B by 
approximately 90%.  
Taken together, these results revealed important hot spots for zinc 
binding, emphasizing the potential coordination of zinc with the thiolate form of 
cysteine as a key interaction to prevent purified vimentin modification by 
cysteine-reactive agents. 
 
3.7 Protective role of zinc against cysteine-crosslinking of vimentin 
 
Previous studies have demonstrated that the single cysteine residue of 
vimentin participates in the formation of an oxidative dimer, resulting from a 
disulfide bond induced either by the oxidant diamide or by H2O2 [3, 8]. In 
addition, according to the model obtained, binding of zinc could not only protect 
vimentin from alkylation but also from crosslinking through disulfide bonds or by 
cysteine reagents. Therefore, we explored the chemical and oxidative 
crosslinking of vimentin and its potential protection by zinc (fig. 25).  
 The bifunctional cysteine crosslinker dibromobimane (DBB) irreversibly 
crosslinks vicinal cysteine groups within a distance of 3-6 Å [259], through a 
reaction mechanism depicted in figure 25A [260]. Analysis by SDS-PAGE 
showed that the cysteine-crosslinked product, resulting from treatment of 
vimentin with DBB, appears as one main band at ~150 kDa. This DBB-induced 
oligomer is similar to the ones formed through oxidative crosslinking induced by 
H2O2 or diamide (fig. 25B). Moreover, the formation of this crosslinked-dimer 
required the presence of the cysteine residue, as corroborated by the absence 
of the oligomer band in vimentin C328S (fig. 25C). Of note, cysteine residues 




would only occur if the cysteines from different dimers fall within close distance 
in tetramers or in filaments.  
In order to explore the ability of zinc to prevent oxidative or chemical 
cysteine crosslinking, we preincubated vimentin with increasing concentrations 
of this divalent cation before treatment with either the oxidant diamide (fig. 25D) 
or the cysteine crosslinker DBB (fig. 25E). Preincubation with micromolar 
concentrations of ZnCl2 tended to preclude the formation of the oxidative dimer 
induced by diamide. Notably, 500 µM ZnCl2 significantly decreased the 
appearance of the diamide-induced dimer by 65% (fig. 25D). Regarding DBB-
crosslinking of vimentin, these experiments revealed that preincubation with      
5 µM ZnCl2 diminished the levels of cysteine-crosslinked dimer by 
approximately 42%. Moreover, concentrations at or above 20 µM ZnCl2 
significantly prevented vimentin crosslinking by DBB (fig. 25E). 
The organization of vimentin tetramers within filaments is not completely 
understood. As shown in figure 25F, vimentin polymerization prior to 
crosslinking resulted in increased levels of oligomeric species, together with the 
appearance of extra bands with different electrophoretical mobilities. This result 
may imply that in filaments, vimentin rearranges into tetramer configurations 
where cysteines are closer or more prone to crosslink, than in soluble vimentin. 
Importantly, micromolar concentrations of zinc were capable of decreasing the 
formation of oligomers, both in soluble and assembled vimentin (fig. 25F). In 
contrast, millimolar concentrations of another divalent cation, namely 
magnesium, failed to prevent DBB-induced crosslinking (fig. 25G). In summary, 
vimentin is susceptible to both oxidative and chemical crosslinking, which 
results in the formation of a cysteine-crosslinked product. Remarkably, zinc is 
able to prevent vimentin crosslinking by different agents, an effect that is not 
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Figure 25. Protective role of zinc against cysteine-crosslinking.  
(A) Dibromobimane (DBB) structure and its crosslinking mechanism of thiol-containing proteins. 
DBB reaction occurs by nucleophilic substitution (SN2), where the bromide ion is displaced by the 
thiolate anion of a cysteine residue. DBB contains two electronegative bromine atoms which 
allow the reaction with two thiol groups of the same or different proteins, forming a 4.8 Å-long 
crosslink between them. (B) Cysteine-crosslinking of vimentin induced by several agents. 
Vimentin wt at 4.7 µM was incubated with vehicle, 1 mM diamide, 24 µM DBB or 1 mM H2O2 for 
1 h at r.t. Incubation mixtures were subjected to SDS-PAGE under non-reducing conditions and 
vimentin levels were assessed by western blot. The amount of oligomer is displayed below the 
plot as average values ± SEM of three independent experiments. (C) Vimentin wt or C328S at 
4.5 µM were incubated with 50 µM DBB for 1 h at r.t, and subjected to SDS-PAGE. Vimentin 
oligomeric species were visualized by Sypro-Ruby staining followed by UV detection. The 
formation of the cysteine-crosslinked oligomer was assessed by image scanning and values are 
presented below the plot. (D,E) Impairment of diamide or DBB-induced crosslinking of vimentin 
by preincubation with ZnCl2. Vimentin wt at 4.3 µM was preincubated with vehicle or with 
increasing concentrations of ZnCl2, as shown, during 1 h at r.t, and then, incubated for an 
additional hour with 1 mM diamide (D) or 24 µM DBB (E). In (D), samples were analyzed by non-













3.8 The selective effect of zinc against crosslinking of vimentin 
 
Further studies into the protective role of zinc against cysteine 
crosslinking were performed using other bifunctional cysteine crosslinkers with 
spacer arms of different lengths, as detailed in the table of figure 26A. Both 
tris(2-bismaleimidohexane)amine (TMEA) or bismaleimidohexane (BMH), which 
span 10.3 Å and 13.0 Å, respectively, gave rise to the appearance of vimentin 
crosslinking products compatible with vimentin dimers (fig. 26B). It should be 
noted that, although TMEA is a three-arm crosslinker, it apparently only gives 
rise to vimentin dimers. As shown before, we observed that zinc significantly 
reduced DBB-crosslinking. However, the presence of zinc was less efficient to 
preclude the crosslinking reaction by BMH or TMEA. Densitometric scanning of 
gels estimated that preincubation of vimentin with 500 µM ZnCl2 diminished the 
TMEA-induced oligomer by 56%, while no significant decrease was observed 
for the BMH-induced oligomeric band (fig. 26B).  
Earlier studies used the amino-crosslinker disuccinimidyl tartrate (DST) 
to propose several potential conformations of vimentin dimers in the tetramers 
[50]. Using the properties of this amino-crosslinker, we explored whether zinc 
could affect crosslinking through residues other than cysteine (fig. 26C). As 
observed in denaturing SDS-PAGE, DST induced the formation of two main 
bands, at ~140 kDa and ~150 kDa. 
In (E), vimentin oligomers were detected by Sypro-Ruby staining followed by UV detection. 
The proportion of vimentin oligomer vs monomer was determined and average values ± SEM 
from three assays are depicted in the graphs. *p<0.05 vs diamide or DBB in the absence of 
ZnCl2;**p<0.001 vs DBB in the absence of ZnCl2, by unpaired Student’s t-test. (F) DBB 
crosslinking of soluble and polymerized vimentin in the presence and absence ZnCl2. 
Vimentin at 3.8 µM was first incubated with vehicle or 150 mM NaCl during 10 min at 37°C, 
after which, it was incubated for 1 h at r.t with 500 µM ZnCl2, followed by an additional hour 
incubation with 24 µM DBB. Mixtures were processed as above and representative results 
are presented. (G) Vimentin crosslinking by DBB after preincubation with ZnCl2 or MgCl2. 
Vimentin wt at 4.3 µM was first incubated with vehicle, 500 µM ZnCl2 or 500 µM MgCl2 for 1 
h, at r.t, after which, it was incubated with 45 µM DBB. At least three independent assays 
were performed and mean values ± SEM are shown. *p<0.05 vs DBB in the absence of salts, 
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Figure 26. Selectivity of the protective effect of zinc on vimentin crosslinking.  
(A) Structures and spacer arms of three cysteine-crosslinkers: dibromobimane (DBB), tris(2-
maleimidoethyl)amine (TMEA) and bismaleimidohexane (BMH). (B) Vimentin wt at 4.3 µM was 
preincubated with vehicle (H2O) or with 500 µM ZnCl2 for 1 h at r.t, after which, it was incubated 
with vehicle (DMSO) or with 24 µM of the indicated cysteine-crosslinker. Incubation mixtures 
were subjected to SDS-PAGE, stained with Sypro-Ruby and detected under UV light. Oligomer 
formation was evaluated by image scanning and mean values ± SEM from three assays are 
represented in the graphs. *p<0.05, with respect to the reaction with the same crosslinker in the 
absence of ZnCl2 by paired Student’s t-test. (C) Zinc effect on amino-crosslinking of vimentin. 
Vimentin wt at 5.8 µM was incubated with vehicle (H2O), 150 mM NaCl, or 500 µM ZnCl2, as 
indicated. Then, incubation mixtures were treated with 400 µM disuccinimidyl tartrate (DST) for 1 
h at 37°C. Samples were processed similarly as described above. The proportion of oligomeric 
species (bracket) vs monomer of three assays were determined and depicted in the graph. No 




The previous reports assigned this particular electrophoretical mobility to 
a vimentin dimer. Smeared bands also appeared at higher molecular weights, 
suggesting the formation of tetramers or even higher oligomeric species, under 
our conditions. Previous polymerization with NaCl did not alter the pattern or 
intensity of the oligomeric species, whereas, preincubation with zinc slightly 
decreased, although non-significantly, DST-crosslinking, both in soluble and 
polymerized vimentin. 
Taken together, our results indicate that preincubation with zinc 
selectively protects vimentin from cysteine crosslinking, and more specifically, 
from crosslinking by agents inducing a relatively short-distance linkage, from   
2-3 Å, in the case of the disulfide bond, to 10 Å in the case of TMEA. 
 
3.9 Influence of zinc on the response of vimentin to oxidative 
conditions in cells  
 
In the cell environment, “free” zinc concentrations vary from picomolar to 
nanomolar in the cytoplasm, to millimolar levels in certain organelles such as 
lysosomes [188]. Moreover, zinc may serve regulatory and structural roles and 
support the activity of antioxidant enzymes. Based on the evidence obtained so 
far, an experimental approach to verify the protective role of zinc against the 
oxidative damage of the vimentin network in cells was set up (fig. 27). 
Vimentin deficient SW13/cl.2 adrenal carcinoma cells, stably transfected 
with vimentin wt, were used first as a cell model for this experiment. In this type 
of cells, vimentin appears as an extended filamentous network, as visualized by 
immunofluorescence and described in Section 2 (fig. 27A). Incubation with 
ZnCl2 induced vimentin reorganization into thicker filaments, appearing more 
condensed in the central region of the cell. Vimentin filament retraction was 
determined by measuring the area occupied by vimentin within the cell with 
respect to the area covered by F-actin, as represented in the upper graph of 
figure 27B. Although visually there appeared to be a difference in the vimentin 



















As an oxidant agent for these assays, we chose diamide due to the short 
incubation time necessary for its effect and the clarity of the morphological 
changes induced, as shown before in Section 2: between 90% and 100% of the 
cells showed total reorganization of vimentin filaments into dots, after a 5 or 15 
min incubation. Determination of the percentage of cells that presented 
punctuated vimentin, without any apparent filament, is depicted in the lower 
graph of figure 27B. Preincubation for 1 hour with 30 µM ZnCl2 offered a partial 
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Figure 27. Influence of zinc on vimentin remodeling upon oxidative damage by diamide.  
(A) SW13/cl.2 cells stably transfected with RFP//vimentin wt were preincubated with vehicle 
(H2O), 30 µM ZnCl2 or 200 µM ZnCl2 for 1 h. Then, cells were treated with 1 mM diamide for 5 or 
15 min, as indicated. Cells were fixed and vimentin distribution (green) was evaluated by 
immunofluorescence. Phalloidin staining was used to monitor F-actin distribution (red). Insets 
display the overlay of vimentin and actin signals. Scale bars, 20 µm. (B) The upper graph shows 
the effect of zinc on the extension of the vimentin IF network, as the area occupied by vimentin 
vs that occupied by F-actin. The lower graph corresponds to the assessment of the protection 
exerted by zinc against the disruption of the vimentin IF network provoked by diamide. 
Accordingly, the proportion of cells with totally fragmented vimentin filaments was determined in 
the different conditions. Results are mean values ± SEM of three independent experiments. 
Regarding the upper graph, no significant differences were found by paired Student’s t-test. In 
the lower graph, *p<0.05 vs diamide 5 min; **p<0.01 vs diamide 5 min; § p< 0.0001 vs diamide 




was insufficient to prevent vimentin reorganization into dots after longer 
treatments with the oxidant. Notably, increasing the concentration of ZnCl2 to 
200 µM protected vimentin against diamide-induced reorganization more 
efficiently, thus, the percentage of cells with totally fragmented vimentin was 
significantly reduced to 5% and 20%, after 5 and 15 min diamide treatments, 
respectively.  
Taken together, these results show that zinc induces a mild 
reorganization of the vimentin network in cells, but exerts a significant protective 
effect against the drastic disruption of vimentin filaments elicited by the oxidant 
diamide. 
 
3.10 Importance of zinc availability in a pathophysiological model 
 
Further studies were done to substantiate the vimentin-zinc interaction 
and its role in a pathophysiologically relevant model (fig. 28). For this, we used 
primary human fibroblasts from a control subject (AG10803 cells), and primary 
fibroblasts from an acrodermatitis enteropathica (AE) patient (GM02814A cells), 
which have a deficiency in zinc uptake and content [232]. Using this model, a 
protective effect of zinc supplementation on diamide-induced filament 
fragmentation has been previously reported [4]. Therefore, we have explored a 
potential protective role of zinc on HNE-induced cell damage. As detailed in the 
scheme represented in figure 28A, both cell types were preincubated with H2O 
or with 30 µM ZnCl2 for 30 min, after which, they were treated with vehicle 
(DMSO) or 10 µM HNE, for 1 h or 2 h 30 min.  
As described previously by our group [4], control fibroblasts displayed a 
robust filamentous network of vimentin, where filaments were found uniformly 
and longitudinally distributed along the cell (fig. 28B, left panels). In turn, zinc-
deficient fibroblasts appeared with a more elongated shape, in which vimentin 















Figure 28. Importance of zinc availability in a pathophysiological model. 
 (A) Scheme outlining the experimental procedure. Primary human fibroblasts (AG10803 cells) 
as control, and primary fibroblasts from an acrodermatitis enteropathica (AE) patient (GM02814A 
cells) were preincubated with H2O or with 30 µM ZnCl2 for 30 min, after which, they were treated 
with vehicle (DMSO) or 10 µM HNE, for 2 h 30 min. (B) Representative fluorescence microscopy 
images of four independent experiments with similar results are displayed. Vimentin (green) and 
actin (red) were visualized by immunofluorescence and Phalloidin-Alexa 568 staining, 
respectively. Insets show the overlay of vimentin and actin signals. Scale bars, 20 µm. (C) 
Measurements of vimentin area vs actin area from four independent assays, in each of which, an 
average of 15 cells per condition were measured. Results are mean values ± SEM. *p<0.05 vs 













Vehicle (H2O) 30 µM ZnCl2
Vehicle (DMSO) 10 µM HNE Vehicle (DMSO) 10 µM HNE
Zinc-deficient fibroblasts
Vehicle (H2O) 30 µM ZnCl2
Vehicle (DMSO) 10 µM HNE Vehicle (DMSO) 10 µM HNE
Control fibroblasts Zinc-deficient fibroblasts




























































































































In both cell types, HNE treatment induced vimentin reorganization into 
thicker filaments in the perinuclear area. To support this evidence, the area 
occupied by vimentin within the cell was determined (fig. 28C). In the control 
situations, vimentin immunostaining occupied 50-60% of the cell area in both 
normal and zinc-deficient fibroblasts. Supplementation with 30 µM ZnCl2 did not 
induce significant changes in the extension of the vimentin filamentous network. 
Filaments appear to be thicker, which is in good agreement with zinc ability to 
favor lateral association of vimentin, as previously reported in [4] and with the 
induction of vimentin bundling by zinc, observed by EM (fig. 23). In turn, HNE 
induced filament condensation and significantly reduced the area occupied by 
vimentin by 30% and 25%, in control and zinc-deficient fibroblasts, respectively 
(fig. 28C). Cell supplementation with zinc prior to HNE treatment appeared to 
attenuate HNE-induced retraction of vimentin filaments, although changes were 












































































































































Figure 29. Effect of zinc availability and HNE on control and zinc-deficient fibroblasts.  
(A) Effect of zinc and HNE on the cell size estimated by measuring the area covered by F-actin. 
The results are mean values ± SEM of four independent assays in each of which, an average of 
15 cells per condition were measured. *p<0.05; **p<0.0005, §p< 0.01 as indicated, by paired 
Student’s t-test. (B) Assessment of the protection exerted by zinc against the disruption of the 
actin network provoked by HNE. The proportion of cells displaying stress fibers was determined 
in the different conditions. Results are mean values ± SEM of four independent experiments with 
an average of 20 determinations each. *p<0.05; **p<0.005, as indicated, #p<0.05, ##p<0.005, 




Moreover, treatment with HNE and/or zinc not only affected vimentin 
organization but also other cellular features, namely the cell size (fig. 28). 
Therefore, we determined the cell size by measuring the area occupied by F-
actin and the results are summarized in figure 29. 
As described above, control and zinc-deficient fibroblasts are 
morphologically different and they displayed considerably distinct sizes, with the 
control fibroblasts 3.7-fold larger than the AE fibroblasts. 
In control fibroblasts, zinc supplementation caused a moderate, although 
non-significant, decrease of the cell size; whereas in zinc-deficient fibroblasts, 
zinc did not induce a noticeable change in the cell area (fig. 29A). Remarkably, 
HNE reduced the cell area by 56% and 28%, in control and zinc-deficient 
fibroblasts, respectively. Interestingly, the effect of HNE on the cell area was 
attenuated when both cell types were previously supplemented with zinc.  
Additionally, HNE treatment drastically disrupted the actin cytoskeleton 
(fig. 28). Under control and zinc supplementation conditions, actin 
predominantly formed stress fibers, which were longitudinally distributed along 
the cell cytoplasm, and actin was well defined at the edges of the cell. However, 
in HNE-treated fibroblasts, actin suffered an intense remodeling into a diffuse 
and dotted pattern in the cytoplasm, and into an irregular and scalloped edge at 
the cell periphery. Determination of the proportion of cells displaying stress 
fibers showed disruption of these structures by HNE treatment in more than 
50% and 75% of the cells, in control and zinc-deficient fibroblasts, respectively 
(fig. 29B). Remarkably, zinc supplementation exerted a clear protection on the 
actin cytoskeleton, since only 27-37% of the cells suffered stress fiber disruption 
upon subsequent treatment with HNE. Therefore, besides the partial protection 
of the vimentin network observed, zinc also played a protective role on actin, 
preserving the stress fibers upon lipoxidative attack. Together with previous 
evidence, these results suggest the importance of zinc availability on the 
structure of the vimentin network under pathophysiological conditions. Likewise, 
they unveil a more general protective role of zinc against the cytoskeletal 







3.11 Proteomic study of the effects of zinc and 4-hydroxynonenal in 
control and zinc-deficient fibroblasts 
 
 In order to obtain a more comprehensive view of the cellular effects of 
zinc availability and HNE treatment, we performed analysis of the cellular 
proteome using a bottom-up proteomic approach. The effects of HNE in 
fibroblasts with or without zinc supplementation were studied proteome-wide by 
relative label-free quantification (tables 5 and 6).  
 
Considering the four experimental treatments, assigned as control, zinc, 
HNE, and zinc plus HNE, only 6 proteins were up or downregulated in the 
fibroblasts from the healthy subject with respect to the control condition 
(ANOVA p < 0.05) (table 5). Zinc finger protein 613 was remarkably up-
regulated in cells supplemented with zinc (10.5-fold), treated with HNE (9.4-
fold), and preincubated with zinc and treated with HNE (4.5-fold). Other proteins 
able to bind zinc were weakly up-regulated, such as synaptic vesicle membrane 
protein VAT-1 homolog and transcription intermediary factor 1-beta. Moreover, 
variations in abundance were observed in other cytoskeletal proteins, including 
Table 5. Functional annotation of proteins differentially regulated in control fibroblasts 
treated with vehicle, zinc, HNE and zinc plus HNE (ANOVA p < 0.05). Fold changes in 
protein levels are shown relative to a control sample. Fold changes lower or equal to 










Zinc finger protein 613 Q6PF04 Transcriptional regulation; 10.5 9.4 4.5
Synaptic vesicle membrane protein VAT-1 
homolog
Q99536
Oxidoreductase activity; 1.3 1.2 1.1
Transcription intermediary factor 1-beta







ATP metabolic process; 0.8 0.7 0.7
Actin regulation






Actin-related protein 2/3 complex subunit 4
P59998
Actin binding;






actin-related protein 2/3 complex subunit 4 and myosin light chain kinase, under 
some of the conditions. 
In turn, in zinc-deficient fibroblasts, a higher number of proteins were 
significantly up- or downregulated across the different experimental conditions, 
summing a total of 55 proteins differentially regulated compared to the control 
(ANOVA p < 0.05). Analysis using DAVID functional annotation tool [261, 262] 
did not demonstrate a significant enrichment of any KEGG pathway. 
Nevertheless, up- and downregulated proteins were attributed to three different 
groups, based on their biological functions provided by UniProtKB, as 
summarized in table 6. Thus, proteins were grouped as being involved in cell 
adhesion/junction, SRP-dependent cotranslational protein targeting to 
membrane/ ribosomal proteins and in protein transport.  
Supplementation with zinc promoted a slight downregulation of 16 
proteins, out of the 29 proteins gathered in table 6, through the different 
biological function groups. Interestingly, HNE treatment and the combination of 
zinc plus HNE slightly stimulated the expression of proteins involved in cell 
adhesion and junction. This is the case of annexin, catenin alpha-1, catenin 
delta-1 and fermitin, which have been reported to bind cadherin or modulate 
actin cytoskeleton dynamics [263, 264]. Nevertheless, the potential role of these 
proteins in the cytoskeletal alterations observed under confocal microscopy 
needs further study (fig. 28). Notably, levels of several ribosomal proteins that 
might be involved in signal recognition particle SRP-dependent cotranslational 
protein targeting to membrane were increased by HNE, suggesting a 
stimulation of protein biogenesis in response to lipoxidation. These analyses will 
be complemented using additional bioinformatics tools as wells as validation 
strategies in future studies. 
Overall, evaluation of differentially regulated proteins between all 
experimental conditions suggest a higher susceptibility of fibroblasts with lower 
zinc content to HNE treatment and zinc supplementation. Although statistically 
significant, the magnitude of many of the changes observed is small. Therefore, 
interpretation of these proteomic data should be done cautiously, bearing in 
mind the possibility of false positives in large datasets and the limitations of 









Table 6. Functional annotation of proteins differentially regulated in zinc-deficient 
fibroblasts treated with vehicle, zinc, HNE and zinc plus HNE (ANOVA p < 0.05). Fold 
changes in protein levels are shown relative to a control sample. Fold changes lower 














Cell-cell adhesion/ junction/stress fiber
Annexin A2 P07355 Cytoskeletal protein  and cadherin binding 0.8 1.1 1.1
Calponin-2 Q99439 Actin,   cadherin and calmodulin binding 0.7 1.0 1.0
Calreticulin P27797 Chaperone, zinc ion binding 1.1 0.9 0.8
Catenin alpha-1 P35221 Actin-f, beta-catenin and cadherin binding 1.1 1.3 1.5
Catenin delta-1 O60716 Cadherin and protein kinase binding 1.1 1.1 1.2
Paxillin 
P49023
Beta-catenin and integrin binding, metal 
ion binding
0.8 0.8 1.1
Integrin-linked protein kinase 
Q13418
ATP binding, integrin binding, protein 
kinase binding
0.8 1.0 1.1
Fermitin family homolog 2 Q96AC1 Actin-f binding; 1.0 1.3 1.4





containing protein 1 
Q7KZF4
Cadherin binding, endonuclease activity
1.1 1.2 1.2
Chloride intracellular channel protein 1 O00299 Cadherin binding, chloride channel activity 0.7 1.0 0.9
6-phosphofructokinase type C 
Q01813
6-phosphofructokinase activity, ATP and 
cadherin binding
0.9 1.2 1.4
GTP-binding nuclear protein Ran P62826 Cadherin and chromatin binding 0.8 1.1 1.0
SRP-dependent cotranslational protein targeting to membrane/ Ribosomal proteins
60S ribosomal protein L7 
P18124
DNA and mRNA binding, protein 
homodimerization
1.0 1.4 1.7
40S ribosomal protein S18 
P62269
RNA binding, structural constituent of 
ribosome
1.1 1.7 1.7
60S ribosomal protein L10a 
P62906
RNA binding, structural constituent of 
ribosome
0.8 1.3 1.3
Signal recognition particle receptor 
subunit alpha 
P08240
GTPase activity, GTP and RNA binding, 
signal recognition particle binding
0.8 1.8 1.9
40S ribosomal protein S3 
P23396
Class I DNA endonuclease activity; 
damaged DNA binding
0.9 1.3 1.5
40S ribosomal protein S5 
P46782
mRNA binding, structural constituent of 
ribosome
0.6 1.1 1.3
40S ribosomal protein S25 P62851 RNA binding 0.9 1.4 1.4
40S ribosomal protein S4
P62701
RNA binding, structural constituent of 
ribosome
0.8 0.9 1.2
60S ribosomal protein L3 
P39023
5S rRNA binding structural constituent of 
ribosome
1.1 0.9 1.1
60S ribosomal protein L12 P30050 Large ribosomal subunit, rRNA binding 0.6 1.1 1.2
40S ribosomal protein S15a
P62244




Importin subunit beta-1 Q14974 Hsp90 protein binding, zinc ion binding 1.0 1.2 1.2
Nuclear transport factor 2 
P61970
Protein transporter activity, constituent of 
nuclear pore
0.4 0.6 0.6
Mitochondrial import receptor subunit 
TOM22 homolog 
Q9NS69
Protein transmembrane transporter activity
1.1 0.7 0.6













Remarkably, no significant changes were found in vimentin expression. 
As a follow up of these results, further studies will be performed in vimentin 
immunoprecipitated from fibroblasts, to get insight into the possible post-
translational modifications induced by HNE treatment in the absence and 
presence of zinc. This work will provide more information to substantiate the 
vimentin-zinc interaction and unveil the mechanisms underlying vimentin 
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Vimentin is a highly dynamic protein that forms an extended network of 
filaments in cells, regulating a wide spectrum of cellular functions. Moreover, 
vimentin acts as mediator of cell responses to mechanical forces and/or 
biochemical stress [1]. The highly conserved cysteine residue, C328, arises not 
only as a fundamental key for the organization and function of vimentin, but also 
as an important regulator of its behavior in response to (lip)oxidative stress [4]. 
 Although extensive work has been performed to explore vimentin 
features both in vitro and in cells, vimentin structure and the mechanisms 
underlying its assembly are not completely understood. Moreover, the 
remodeling under stress conditions as well as the influence of cellular context 
factors, such as the presence of divalent cations need further study. In this 
thesis, we have elaborated an integrative approach in order to explore the 
oligomerization of vimentin under different conditions and to characterize this 
protein as a target for lipoxidation, paying special attention to the cysteine 
residue as a hinge influencing vimentin response to different stimuli.  
 
1. Refolding and validation of vimentin functionality 
 
 Vimentin morphology as well as its assembly properties are sensitive to 
different factors as the ionic strength, the presence of metals or the reaction 
with electrophilic compounds [4, 6].  
In vitro assays were the first approach used to study vimentin 
oligomerization and modification by different electrophilic agents. To this end, 
we have used recombinant vimentin wild-type and vimentin mutated at the 
cysteine residue that was substituted by a serine residue. Purification of 
recombinant vimentin needs to be performed under denaturing conditions using 
high concentrations of urea [233]. In addition, metal chelators, such as EDTA, 
are generally used for inhibition of proteases during protein purification, to 
eliminate endotoxin or to prevent oxidation by metals in protein preparations 
[265-267].  
Since the aim was to study the effect of micromolar concentrations of 
divalent cations on vimentin structure and function, a method to correctly refold 




other possible additives that could interfere with the interpretation of the results, 
was needed.  
 
1.1 NMR and colorimetric assays demonstrate that EDTA can be 
carried on unnoticed during protein dialysis 
 
Here, simple methods to interrogate the presence of EDTA, namely, 
NMR experiments and a complementary colorimetric assay to estimate the 
amount of EDTA present in the protein preparations (fig. 8-10) have been 
provided. Both detection methods use the ability of EDTA to chelate zinc, 
forming a 1:1 complex of extremely high affinity with a dissociation constant of 
2.3 x 10-14 M at pH 7.4 [236]. In 1H NMR experiments, the characteristic pattern 
of the shifts of the signals given by the EDTA-zinc complexes is considered the 
most reliable and specific way of detection of this metal chelator in protein 
samples (fig. 8). Such conclusion is supported by the fact that the peaks 
resulting from EDTA-zinc complex do not change through a wide pH range 
(from 5.9 to 8.2) [243], in sharp contrast with the free EDTA peaks which are 
strongly dependent on the pH of the sample.  
Additionally, EDTA binds zinc ions much more tightly than the other 
common divalent metals such as magnesium and calcium ions, which have 
dissociation constants of approximately 10-9 M and 10-11 M, respectively [268]. 
Therefore, EDTA selectively chelates zinc present in a protein solution, even in 
the presence of high concentrations of the other divalent cations, which 
increases the sensitivity and reproducibility of the detection method. 
Similarly, the colorimetric assay set up in this work also takes advantage 
of the high affinity of EDTA for zinc (fig. 9). In this technique, EDTA competes 
with the chromogenic compound 4-(2-pyridylazo)-resorcinol (PAR) for zinc 
binding, in such a way that the decrease in the absorbance at 492 nm, 
characteristic for the PAR-zinc complex, can be used to estimate the amount of 
EDTA present in the sample. 
Both detection methods revealed to be easy and convenient ways to 
monitor the presence of EDTA in the vimentin preparation. Moreover, the 
colorimetric method does not require sophisticated equipment and can be 




presence of other metal-binding compounds or proteins in the sample that may 
also compete with the chelators for zinc binding; therefore a combination of 
different methods to detect EDTA is advisable.    
 
1.2 Ultrafiltration followed by dialysis allows the efficient removal of 
EDTA and the functional refolding of vimentin 
 
The application of the mentioned techniques to different protein 
preparations, initially containing 1 mM EDTA, demonstrated that EDTA can be 
carried on unnoticed during protein dialysis (fig. 30). The lack of effectiveness of 
dialysis could be explained by the capacity of EDTA to form supramolecular 
aggregates in solution and its ability to associate with proteins, which prevent its 
elimination through the dialysis devices with pore-sizes over a hundred times 
larger [269]. In addition, the efficacy of dialysis may vary with buffer 
composition. Indeed, our group tested the influence of the ionic strength in the 
performance of the dialysis procedure, and the results confirmed previous 
observations [270] showing that EDTA removal by dialysis is more effective 
when physiological concentrations of NaCl are added to the dialysis buffers 
[243].  
The concentration of EDTA remaining after dialysis (~ 450 µM) probably 
does not affect the results of studies employing millimolar concentrations of 
divalent cations [271]. Nevertheless, additional care should be taken when 
performing assays with micromolar concentrations of metals. Moreover, the 
presence of EDTA can change several protein parameters, such as thermal 
denaturation [272], or promote pH alterations after addition of divalent cations 
[273]. Therefore, the concentration of EDTA present in the protein preparations 
should be carefully monitored and the complete removal of EDTA should be 
assessed by the methods described herein or by other techniques, like HPLC or 
spectrometric procedures [274, 275]. 
Although there are previous reports on the inefficiency of several 
procedures to remove EDTA [270, 272], the information is scarce and not 
readily found in bibliographic searches. Therefore, our observations call 
attention to the fact that EDTA is not thoroughly removed by dialysis 




protein preparations, which may contain considerable amounts of EDTA not 
listed in the buffer composition. 
Besides dialysis, other procedures routinely used to separate 
macromolecules from small compounds were tested for reducing EDTA 
concentration, namely, spin column gel filtration and ultrafiltration (fig. 30). Size 
exclusion chromatography using spin desalting columns was less effective 
compared with ultrafiltration; however the use of longer columns with higher 










After testing several methods, we concluded that ultracentrifugation could 
be a good choice for efficient removal of EDTA, suitable for small sample 
volumes. Moreover, since vimentin requires dialysis to gradually remove urea 
as a part of the refolding protocol, we also tested the combination of both 
procedures and the results indicate that this approach efficiently eliminates 
EDTA from vimentin preparations (fig. 30). These results led us to establish the 
Figure 30. Efficiency of several procedures to remove EDTA.  
Colorimetric determination of EDTA present in protein samples, initially containing 1 mM EDTA 
(100%), using the PAR competition assay, allowed the assessment of the efficacy of several 
purification procedures. Dialysis is the less effective method to eliminate EDTA from hypotonic 
protein solutions, as 50% of the EDTA remains in the dialyzed protein preparations; when 
followed by gel filtration, the EDTA amount is decreased down to ~20%. Ultrafiltration applied 
individually diminishes the EDTA concentration down to 3-10%; when combined with dialysis, the 
EDTA amount becomes virtually undetectable, therefore revealing to be the most efficient 
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ultrafiltration procedure prior to dialysis, detailed in the scheme of figure 11, as 
the most suitable method to reconstitute vimentin before performing the 
intended assays. 
Beyond assessing the presence of putative additives that might interfere 
with the results, it is imperative to confirm that the techniques described above 
allow the correct refolding of vimentin into a functional protein. Therefore, 
biochemical and biophysical techniques associated to electron microscopy were 
applied to ensure the correct and functional reconstitution of both vimentin wt 
and C328S (fig. 12). 
Analysis of ultrafiltrated and dialyzed preparations of vimentin by gel-
based assays shows that both forms maintain a high level of purity after the 
refolding procedures, without apparent signals of degradation and/or cysteine 
oxidation (fig. 12A). Importantly, the tertiary structure of vimentin is functionally 
rescued after the refolding procedure, being mostly organized as a coiled-coil 
alpha-helical structure, as analyzed by CD (fig. 12B), and consistent with what 
is reported in the literature [244].  
Further characterization of vimentin wt and C328S functionality involves 
the assessment of vimentin ability to polymerize when the ionic strength is 
raised up to physiological concentrations. Ultracentrifugation experiments show 
that both vimentin wt and C328S are able to polymerize into insoluble oligomers 
after addition of the polymerizing buffer, containing 150 mM NaCl (fig. 12C). 
Previous studies using analytical ultracentrifugation gave a detailed 
characterization of the vimentin species formed in hypotonic buffers [48, 51].  In 
fact, these studies also showed that the assembly process starts during 
renaturation of monomers by dialysis from 8 M urea into low ionic strength 
buffer, in which stable tetrameric assemblies are primarily formed. 
Many available protocols recommend single-step polymerization and 
centrifugation procedures to confirm vimentin functionality. Nevertheless, 
confirmation of the formation of bona fide IFs is desirable, given the possibility 
that vimentin polymerizes into non-filamentous structures, as observed here 
with zinc (fig. 23). Under our conditions, EM inspection of non-polymerized 
vimentin wt and C328S morphology shows a homogeneous pattern of small 
rod-like structures. Moreover, raising the ionic strength gives origin to filaments 




oligomeric species are assembled in a non-aggregated and functional fashion 
after ultrafiltration and dialysis (fig. 12D). 
 
1.3 The substitution of C328 by serine appears to promote a faster 
assembly of vimentin 
  
Our results indicate that both vimentin wt and C328S functionally 
undergo lateral assembly, elongation and compaction till filaments reach the 
typical width of nearly 12 nm and span, in some cases, several micrometers, at 
the end-point of polymerization.  
Interestingly, determination of filament width and length show that 
vimentin C328S filaments present a diameter slightly narrower than those 
formed by vimentin wt, through all the different polymerization time points. In 
addition, at the earlier polymerization time points, vimentin C328S filaments are 
significantly longer than vimentin wt filaments, a tendency that is observed even 
at the end-point of assembly. The differences observed indicate that the highly 
conserved cysteine residue plays an important role in vimentin assembly and it 
influences the morphology of filaments. Indeed, the presence of cysteine seems 
to be related to a slower filament elongation and to the appearance of looser 
filaments with respect to vimentin mutant C328S, in the first stages of assembly. 
Substitution of cysteine by serine, on the other hand, could lead to tighter 
packing, due to its smaller size of the side chain and/or occurrence of different 
electrostatic interactions [276]. 
In fact, vimentin filaments are polymorphic and can comprise a variable 
number of tetramers per section, depending on the assembly conditions, the 
integrity of the protein, and the presence of certain divalent cations [55, 277]. 
The most accepted model comprises eight tetramers per section; however a 
higher number of subunits per filament cross-section has also been reported 
[54], which may result in a wider diameter.  
Importantly, our results show that vimentin elongation and diameter are 
highly sensitive to oxidative modifications, a factor that had not been previously 
identified. In our conditions, preincubation of vimentin wt with electrophilic 
compounds prior to polymerization appears to delay filament elongation, an 




could be related, at least in part, to oxidative modifications of the cysteine 
residue, and therefore, could contribute to explain the formation of longer 
filaments when the cysteine is not present. In sum, our results, summarized in 
figure 31, reveal for the first time subtle differences between the polymerization 
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Figure 31. Influence of C328 on the first stages of vimentin polymerization.  
The presence of the cysteine residue could induce variable conformations of the assembly 
intermediates, resulting in shorter, wider and more heterogeneous filaments, in the first 5 or       
10 min of assembly. In turn, vimentin C328S assembles into more homogenous filaments, which 




2. Characterization of vimentin as target for lipoxidation 
and oxidation 
 
The unique biochemical and biophysical features of the vimentin 
structure together with the formation of an extensive and dynamic filamentous 
network confer vimentin an important role as a sensor of altered cell 
environment as well as a mediator of cell changes in response to mechanical 
and biochemical stress [1, 161, 278]. In fact, vimentin is a target for several 
oxidants and electrophilic lipids that, in general, lead to a marked vimentin 
network remodeling [4, 34]. Here, we have addressed the mechanisms 
underlying the effect of (lip)oxidative modifications of vimentin, both in vitro and 
in cells.  
 
2.1 Vimentin is susceptible of modification by structurally diverse 
electrophilic compounds 
 
Assessment of the in vitro modification of vimentin by different 
electrophilic species allowed the observation of distinct patterns depending on 
the reactivity of the modifying agents (fig. 13). Diamide induced the formation of 
a thiol-crosslinked product through disulfide bonding, therefore dependent on 
the presence of the single cysteine residue of vimentin, C328. A similar type of 
modification was detected upon incubation of vimentin wt with DMSO. DMSO is 
used as a solvent of both polar and hydrophobic compounds and it is frequently 
used as a vehicle for the storage and delivery of various molecules, both in vitro 
and in cell culture experiments [279, 280]. Although the effect of DMSO on 
oxidative modifications is rarely reported [281], our results indicate that even 
when used as vehicle, DMSO can induce a mild oxidation of vimentin.  
In turn, HNE has a broader reactivity and its incorporation is detected in 
both vimentin wt and C328S mutant. Studies in biological systems reported that 
HNE primarily targets cysteine C328 in vimentin [167], however, our 
observations indicate that HNE can form adducts with other vimentin residues, 
when C328 is not present. Indeed, although cysteine residue is the most 




has been reported to be less stable than histidine and lysine conjugates to HNE 
[282], which could explain the similar extent of HNE adduct formation in both 
vimentin wt and C328S. In contrast, the biotinylated analog of 15d-PGJ2 shows 
a higher selectivity for the cysteine residue. This agrees with previous results in 
the literature, showing that cyclopentenone prostaglandins have selectivity for 
cysteine residues, as occurs for instance in the transcription factor NF-κB or in 
the Ras proteins [147].  
Overall, these results indicate that the single cysteine residue of vimentin 
is particularly reactive, arising as an important hot spot for (lip)oxidative 
modifications. In fact, earlier experiments have reported that substitution of the 
cysteine residue by serine results in a vimentin mutant which is more resistant 
to the effect of treatment with electrophilic agents, in cells [4, 34, 164]. 
Moreover, the described observations are consistent with previous studies 
showing that cysteine C328 is a common target for several oxidative 
modifications besides lipoxidation, such as thiolation, glutathionylation and 
nitrosylation [283-285]. Indeed, proteomic studies have reported that the 
specific consensus sequence I/L-X-C-X2-D/E directs the selective S-
nitrosylation of cysteine in target proteins [285]. In vimentin, C328 is located 
within the L-T-C-E-V-D sequence that coincides with the required motif for S-
nitrosylation. In this location, the cysteine residue is surrounded by acidic 
residues, glutamic acid, E329, and aspartic acid, D331, and by a hydrophobic 
residue, L326, which could increment cysteine nucleophilicity, and therefore 
could increase its susceptibility to post-translational modifications.  
 
2.2 Morphological alterations of vimentin depend on the presence of 
C328 and on the properties of the lipoxidant agents 
 
Vimentin is therefore susceptible to modification by structurally diverse 
compounds. Interestingly, the functional consequences of (lip)oxidation are 
dependent on the chemical structure and reactivity of the electrophilic 
compounds, as indicated by the variability of the electrophile-induced effects on 
vimentin assembly and on filament morphology (fig. 14). In vitro, diamide 
induces abnormal vimentin aggregation which drastically disrupts subsequent 




tetramers are linked by disulfide bonds, their conformation does not allow 
normal assembly or elongation. In contrast, preincubation with DMSO affects 
filament length and induces a marked increase of filament width. This effect is 
notably attenuated in vimentin C328S, suggesting that it could be partially 
caused by the formation of disulfide-bonded dimer observed in DMSO-treated 
vimentin wt. In turn, treatment with HNE has a stronger effect on filament length 
and width, inducing the formation of shorter and wider filaments of vimentin wt, 
at early and late time points of polymerization, respectively. This could be 
related to its ability to modify several residues. 15d-PGJ2 induces various 
morphological alterations likely due to the disruption of assembly by the 
introduction of the bulky moiety of the prostaglandin.  
 It is worth noting that preincubation of vimentin wt in buffer before 
polymerization leads to the appearance of wider filaments compared to the 
ones assembled without delay. In addition to the herein reported evidence that 
vimentin C328S filaments are consistently thinner and longer, with respect to 
wild-type filaments, these observations suggest that oxidation occurring during 
preincubation, mainly affecting the cysteine residue, alters filament assembly 
through the putative cysteine-mediated mechanisms mentioned above. This 
possibility is further supported by the attenuation of the lipoxidant-induced 
morphological alterations in the vimentin C328S mutant. Therefore, the highly 
conserved cysteine residue is emerging not only as a hot spot for post-
translational modification in vimentin, but also as a switch influencing its 
assembly properties and its behavior in response to electrophilic or oxidative 
stress. 
 
2.3 The polymerization state of vimentin influences the functional 
outcome of the lipoxidative modification 
 
 The functional outcome caused by electrophilic modification is strikingly 
attenuated in preformed filaments of vimentin wt (fig. 15). However, gel-based 
assays confirm that the extent of (lip)oxidative modification is similar in both 
polymerized and non-polymerized vimentin, being in some cases higher in 




the modified residues could be different in preformed filaments, which do 
neither interfere with the filament structure nor induce filament disruption.  
Alternatively, previous incubation of soluble vimentin with (lip)oxidants 
could lead to the formation of bulky subunits, due to the adducted moiety, which 
would not be suitable for subsequent assembly. An additional possibility arises 
from potential conformational changes in the isolated subunits induced by the 
modification of C328, which putatively do not occur once incorporated in the 
filament. Inversely, C328 modification could impair the conformational 
rearrangements required for the formation of mature filaments.   
 As an overview, our in vitro results highlight vimentin as a target for 
several electrophilic agents. The structural and chemical properties of the 
lipoxidant agents markedly influence assembly, inducing morphological 
alterations such as aggregation, increased filament diameter, heterogeneity 
and/or bundling. Most importantly, the single cysteine residue arises as a critical 
modulator of vimentin behavior in response to (lip)oxidative stimuli and as a 
regulator of the intensity of the functional outcome. In addition, the impact of 
treatment with lipoxidants is strongly dependent on the polymerization state of 
vimentin, in such a way that modification of isolated subunits is more 
deleterious than that of preformed filaments. These observations are 

























Figure 32. Relevance of the polymerization state of vimentin and the role of its single 
cysteine residue in the impact of (lip)oxidation. 
In vitro, preincubation of soluble vimentin with electrophilic lipids and/or oxidants (lipoxidants) 
hampers subsequent filament formation induced by NaCl, leading to impaired elongation and/or 
aggregates, filaments of increased diameter or filament bundles, in a manner dependent on the 
presence of C328. In contrast, lipoxidation of preformed filaments does not severely alter 




2.4 In cells, diamide-induced disruption of the vimentin network 
requires active filament dynamics and the presence of C328 
 
 In cells, (lip)oxidation induces a noticeable reorganization of the vimentin 
network. In particular, cell treatment with the oxidant diamide intensely disrupts 
vimentin filaments, which is reliant on the presence of C328 (fig. 16). Although 
in vitro, diamide clearly induces the formation of a cysteine-crosslinked product, 
previous studies from our group did not detect this oxidative dimer in cells. In 
fact, diamide could induce the formation of mixed disulfides with other proteins 
or small molecules resulting in glutathionylation or cysteinylation [286, 287]. In 
addition, diamide is also able to decrease the concentration of glutathione [253], 
an essential thiol molecule for the regeneration of oxidized protein sulfhydryls, 
which in turn could increase vimentin susceptibility to lipoxidation. Lastly, 
diamide could indirectly promote the irreversible oxidation of the cysteine 
residue to sulfinic or sulfonic acids [288]. Such modifications may be involved in 
the disruption of vimentin network; nevertheless we cannot discard the 
possibility of diamide-induced oxidation of other cytoskeletal components or 
regulatory proteins that may indirectly affect the organization of the vimentin 
filamentous network [67, 289]. Therefore, the characterization of diamide-
induced vimentin modification in cells requires further study. 
 In cells, vimentin exists both as soluble and polymerized forms, which are 
continuously exchanging subunits, therefore constituting a highly dynamic 
network [63]. In fact, our FRAP experiments show that after photobleaching, 
vimentin filaments are able to rapidly reincorporate “new subunits” and 
therefore, undergo a fluorescence recovery within seconds/minutes (fig. 17). 
Interestingly, there are several strategies, involving ATP depletion or cysteine 
crosslinking, which are able to minimize vimentin dynamics. The motile 
properties of vimentin have been reported to require ATP [290], and under our 
conditions, treatment with inhibitors of ATP synthesis, indeed blunted 
fluorescence recovery. However, the mechanism by which these compounds 
block vimentin dynamics is not completely understood. Previous studies 
suggest that ATP could either mediate the dissociation of vimentin tetramers 
from filaments, by regulating IF disassembly through phosphorylation, or 











On the other hand, the cysteine crosslinker DBB could fix/stabilize the 
filament structure through direct or indirect mechanisms, preventing the 
exchange of vimentin subunits.  
Remarkably, blocking vimentin dynamics protects its network against 
diamide-induced remodeling, indicating that the electrophilic disruption requires 
the active exchange of vimentin subunits (fig. 18). As observed in vitro, 
preformed filaments are more resistant to disruption. This leads us to propose a 
model according to which, modification of vimentin would occur in polymerized 
and soluble forms, but the disruption of the network would take place when 
soluble modified vimentin would be recruited into the filaments. Nevertheless, 
we should take into account other potential mechanisms. In the case of DBB, 
crosslinking of cysteine residues could directly protect this residue from other 
modifications. On the other hand, the protective effect of mitochondrial 
uncouplers could be the result of the alteration of other mitochondrial functions. 





















































Figure 33. Importance of vimentin dynamics for the disruption of vimentin filaments 
induced by diamide.  
In cells with active vimentin dynamics, diamide induced fragmentation of vimentin wt, but not 
C328S filaments. Minimizing vimentin dynamics protects the morphology of the vimentin wt 
network from diamide-induced disruption. Taken together these observations suggest that 
incorporation of modified vimentin subunits into filaments would be the process leading to 




Lastly, both strategies used to minimize vimentin dynamics could act through 
indirect mechanisms that prevent vimentin disruption in response to diamide 
treatment.  
Taken together, these results indicate that the vimentin network can be 
intensely remodeled by treatment with electrophilic compounds, an effect that 
requires an active vimentin dynamics and it is modulated by the presence of the 
single cysteine residue (fig. 33).  
 
3. Vimentin-zinc interplay and its relevance in 
pathophysiology 
 
The organization and function of the vimentin network can be modulated 
by several factors. Besides post-translational modifications, such as 
phosphorylation and the herein described lipoxidation, the ionic strength and the 
presence of divalent cations also play an important role in the regulation of 
vimentin behavior [5, 6]. Zinc is the second most abundant trace element and is 
essential for a wide range of biological functions [191]. Previous work unveiled 
that in vitro, vimentin binds zinc and its function is clearly modulated by zinc 
availability, in cells [4, 7]. Therefore, here we have addressed the structural and 
functional consequences of the vimentin-zinc interplay and its impact on the 
response of vimentin to (lip)oxidative stress.  
 
3.1 Zinc reversibly induces the formation of large assemblies of 
both vimentin wt and C328S 
 
In vitro studies performed with the wt and C328S forms of the protein 
unveil a similar behavior of both in presence of micromolar concentrations of 
zinc (fig. 19A). Likewise, turbidity and fluorescence anisotropy measurements 
show an analogous effect of increasing concentrations of zinc on the formation 
of larger assemblies, in both forms of vimentin (fig. 20A). In fact, within proteins, 
zinc coordinates mainly with cysteine, histidine, aspartate and glutamate 
residues [193]. Even though it is a rare situation, accounting for less than 1 % of 




threonine or lysine, are also able to interact with zinc [291]. Therefore, zinc 
binding is not strictly dependent on the presence of the cysteine residue.  
Interestingly, zinc has been reported to promote protein aggregation 
through various mechanisms. In the case of the transcription factor p53, zinc is 
able to bridge individual subunits, through coordination of different residues at 
protein-interface sites, consequently leading to the formation of larger 
assemblies [292]. Moreover, in vitro addition of an excess of zinc to polymerized 
tubulin results in the loss of microtubules and  the formation of wide β-sheets 
[200]. Hypothetically, similar mechanisms could be involved in the formation of 
larger assemblies of vimentin in presence of this divalent cation. Therefore, the 
principle of zinc binding at protein-interface sites could be putatively involved in 
the formation of larger assemblies of vimentin. Alternatively, zinc could promote 
different vimentin subunit interactions favorable to the formation of β-sheets, 
instead of the typical α-helical organization, and consequently, induce vimentin 
associations more prone to oligomerization. Confirmation of these hypotheses 
would require further experimentation. However, zinc addition promoted the fast 
precipitation of vimentin on CD cuvettes, for which alternative strategies could 
be needed to address this point. Among them, thioflavin T, a probe used to 
explore the role of zinc binding in the formation of amyloid fibrils by Aβ11-28 
[293], could be proposed.  
Over the zinc proteome, proteins bind zinc with variable affinity. In the 
case of metallothioneins, these proteins bind zinc with an affinity constant 
ranging from nanomolar to picomolar order [294],  whereas for tubulin, the zinc 
binding affinity is over the micromolar to millimolar ranges [295]. Our in vitro 
results suggest that vimentin binds zinc with an affinity in the micromolar range, 
therefore, similar to tubulin.  
Remarkably, the action of zinc on vimentin polymerization/aggregation is 
fully reversed by the addition of metal chelators, EDTA or TPEN (fig. 20C and 
fig. 34). This is consistent with previous work reporting that zinc depletion 
induces reversible filament disassembly, in cells [4]. These observations are 
particularly relevant for the putative role of zinc in the regulation of vimentin 
dynamics, meaning that release of zinc into the cytoplasm as a response to 
extra- or intracellular stimuli, could contribute to rapid vimentin 




homeostatic concentrations of zinc [190]. Nevertheless, the possibility also 
exists that high concentrations of zinc could cause irreversible alterations of 







Notably, the effect of zinc on vimentin polymerization, detected by 
turbidity assays, is not mimicked by the same concentration range of other 
divalent cations, such as MgCl2, or monovalent salts, as NaCl. Although        
150 mM NaCl is herein described to assemble vimentin into long 12 nm-wide 
filaments, it does not significantly increase vimentin turbidity, suggesting that 
zinc-induced structures are considerably larger and/or morphologically different.  
On the other hand, millimolar concentrations of MgCl2 are required to induce 
changes similar to the ones observed with ZnCl2. Even though our experiments 
could not ascertain the binding constants of these divalent cations to vimentin, it 
could be inferred that vimentin binds zinc with higher affinity than magnesium. 















































Figure 34. Reversible effect of zinc on vimentin polymerization.  
Monitoring the turbidity changes shows that incubating vimentin with zinc induces the formation 
of larger assemblies, which are disassembled upon addition of an equivalent amount of a metal 
chelator, as suggested by the decrease of the solution turbidity. Subsequent addition of zinc 




through coordination with the oxygen atoms from their carboxyl or carbonyl 
groups [296], while zinc preferably coordinates with the sulfur atom of the 
cysteine residues [297]. These variations of metal coordination preferences 
within the protein could be related to the differences observed in the effect of 
the divalent cations on vimentin aggregation.  
 
3.2 The effect of zinc on the morphology of vimentin assemblies is 
variable depending on the support used 
 
The effect of zinc on the morphology of vimentin aggregates varies 
according to the support used for the incubation mixture, ranging from the 
appearance of a “beaded” network of protein, in solution, to the formation of 
robust cables, on glass slides (fig. 21). The morphological differences observed 
could putatively arise from changes in the conformation of the protein and/or in 
the overall charge of the molecule that occur on the distinct supports. 
Consequently, these variable factors could influence the nature of zinc 
interactions within the vimentin structure, which could lead to different subunit 
associations and consequently, could build morphologically distinct vimentin 
structures. Indeed, zinc coordination is dynamic, involving changes in geometry 
and/or coordination number and ionization of ligands [298]; therefore, zinc 
binding sites have plasticity and/or can adopt several structures, according to 
the features of the protein environment.  
Importantly, vimentin can exist both in intra and extracellular spaces [1], 
being subjected to different environmental conditions that may promote different 
rearrangements of the vimentin structure. In diseases such as age-related 
macular degeneration, vimentin can be found in extracellular deposits, where 
micromolar to millimolar zinc concentrations have been measured and could be 
involved in vimentin aggregation [299, 300]. Taken together, these observations 
suggest that the functional outcome of exposure of vimentin to zinc can vary 






3.3 The functional outcome of zinc interaction with vimentin 
depends on the polymerization state of the protein 
 
EM inspection of both vimentin wt and C328S structures formed in 
presence of zinc corroborate the results obtained in the turbidity and 
fluorescence anisotropy experiments, that this divalent cation is able to induce 
the formation of larger assemblies of vimentin (fig. 22). Determination of the 
dimensions of these vimentin structures indicates that width is the feature more 
affected by increasing concentrations of zinc, thus, it could be inferred that this 
divalent cation primarily induces lateral association of vimentin oligomers. 
Nevertheless, we cannot discard the possibility that zinc promotes vimentin 
elongation, at longer times of polymerization. 
Turbidity experiments gave the first evidence that the polymerization 
state of vimentin could influence the functional outcome of the interaction with 
zinc, indicating that the size and/or shape of the zinc-induced structures are 
different if vimentin is soluble or previously assembled (fig. 23A). EM inspection 
of the morphological changes revealed that preincubation with zinc prior to 
assembly induces atypical protein aggregation that fails to further assemble into 
filaments upon addition of 150 mM of NaCl, in both vimentin wt and C328S. 
These observations suggest that zinc binding rearranges the structure of the 
soluble subunits of vimentin into non-functional assemblies that are incompetent 
to form filaments. Moreover, this suggests that this effect is due to the 
interaction of zinc with residues other than cysteine, most likely, carboxylic 
residues, which account for 18 % of vimentin sequence. 
In contrast, zinc addition to preformed filaments of vimentin wt induces 
intense bundling and a marked increase of filament diameter. This effect could 
be due to filament reorganization into a looser configuration and/or to a higher 
level of polymorphism, as a result of lateral association of an unusual number of 
vimentin subunits, in presence of zinc. Notably, this effect does not occur in 
vimentin C328S filaments. Therefore, whereas zinc appears to alter the 
structure of both wt and C328S subunits, its effect on preformed filaments 
requires the presence of C328, which underlines the importance of this residue 





3.4 Zinc coordinates with the thiolate form of C328 and protects 
vimentin from modification by different cysteine-reactive compounds in 
vitro 
 
The relevance of the potential cysteine-zinc coordination is highlighted by 
the results obtained from the computational and crosslinking experiments (fig. 
24). Besides the 23 possible hot-spots for zinc binding found within the modeled 
dimer of vimentin, MD simulations indicated that cysteine residue, C328, in its 
thiolate form, participates in the coordination with zinc. In nature, an important 
proportion of the cysteine residues occur in its thiolate form, where the 
thiol/thiolate proportion is dependent on the pKa and accessibility of the 
cysteine residue within the protein environment [301]. Our group was able to 
experimentally determine the pKa of C328, by setting up a procedure based on 
the modification of cysteine residues by the fluorescent compound 
monobromobimane (Mónico et al., manuscript in preparation). Interestingly, 
soluble vimentin presents two different pKa values, of approximately 4.6 and 
7.4, possibly resulting from the existence of distinct oligomeric or conformational 
species in the protein preparation. Therefore, under physiological conditions, 
the cysteine residue will occur in both thiol and thiolate forms, and the 
interaction between the latter form and zinc may have important implications in 
the regulation of vimentin function within the cellular environment. This is 
strongly supported by the ability of zinc to prevent vimentin alkylation by 
cysteine-reactive agents (fig. 24B) and to preclude chemical and oxidative 
cysteine crosslinking in vitro (fig. 25). In particular, the protective role of zinc 
against vimentin modification by 15d-PGJ2 and diamide, lipoxidant agents 
which, as described here, strongly affect vimentin functionality, could be highly 
relevant.  
The disposition of the tetrameric units within the filaments is not 
completely understood. Nevertheless, it is currently accepted, that in dimers, 
cysteine residues are oriented outwards. In turn, dimers can adopt different 
alignments within tetramers, in which the distance between cysteines is variable 
[50, 51]. Indeed, cysteine crosslinking induced by DBB indicates that there are 
cysteines from distinct dimers that fall within close distance (3 to 6 Å), likely in 




Remarkably, zinc selectively prevents DBB-induced cysteine crosslinking 
(fig. 25 and fig. 26). One putative explanation arises from the sterical hindering 
caused by the zinc coordination with the cysteine. Alternatively, zinc could bind 
to other sites of vimentin, rearranging its structure in such a manner that 
cysteines could no longer be at a distance amenable for DBB crosslinking, but 
still be at a distance adequate for crosslinking with longer space-arm 
crosslinkers, as bismaleimidohexane (BMH). These hypothetical mechanisms 
are summarized in the scheme of figure 35.  
Even though the protective role of zinc towards cysteine modification in 
vitro is used here to support its interaction with the thiolate form of C328, it 
should be borne in mind that, some of these zinc-thiolate coordination 
environments, could be even more reactive and susceptible to modification, 
which is reliant on the affinity properties of the zinc binding sites within the 




























Figure 35. Hypothetical mechanisms for the protective role of zinc against cysteine 
modification of vimentin. 
Interaction between zinc and vimentin subunits prevents cysteine modification by diverse 
reactive agents, in vitro. This protection could be due to direct steric hindrance through zinc 
coordination with C328, in the case of alkylating agents and crosslinkers (left panel), or to 
conformational changes that result in longer distance between vimentin subunits and preclude 
cysteine crosslinking by shorter crosslinkers, as DBB, but do not affect the crosslinking by longer 




3.5 In cells, supplementation with zinc prevents diamide-induced 
disruption of the vimentin network 
 
The effects of zinc on vimentin in vitro have a clear counterpart in cells. 
In fact, zinc treatment, at concentrations in the physiological range, shows a 
tendency to promote vimentin network reorganization into thicker filaments, in 
adrenal carcinoma cells and in fibroblasts (fig. 27A and fig. 28B). These 
alterations could be due to the capacity of zinc to induce lateral association and 
filament bundling, as observed in vitro. 
Additionally, prior supplementation with zinc attenuates the network 
fragmentation induced by diamide, a protective role that is dependent on the 
concentration of zinc and on the time of exposure to the oxidant (fig. 27 and fig. 
36). Based on the in vitro observations, this protection could be explained by 
the direct effect of zinc on vimentin, through mechanisms associated to thiolate-
zinc coordination that precludes vimentin modification by diamide. However, 
within the cell environment, the interpretation is much more complex, since 
additional mechanisms could also be indirectly involved in the protective 
function of zinc. For instance, the “pro-antioxidant” effect of this divalent cation 
is well-recognized, by supporting the activity of several enzymes and regulating 
the concentration of important antioxidant molecules, such as glutathione, that 
are capable of scavenging reactive electrophilic compounds [210]. Therefore, 
zinc could decrease diamide availability through the antioxidant system, and 
thus mitigate its deleterious effect. Lastly, a decline in ATP production, via zinc 
inhibition of glyceraldehyde 3-phosphate dehydrogenase [302], could indirectly 
block vimentin dynamics, consequently preventing the oxidatively-modified 
isolated subunits to reincorporate into the filaments and subsequently disrupt 









3.6 Zinc attenuates the effect of lipoxidation induced by HNE, in a 
pathophysiological model 
 
The reported observations of zinc in the prevention of diamide-induced 
disruption of the vimentin network have extended our interest to explore this 
putative protective role in a relevant pathophysiological model. Genetic 
alteration of zinc availability has important consequences on vimentin 
functionality, as indicated by the observation of a basal alteration of the vimentin 
network, in acrodermatitis enteropathica (AE) fibroblasts, which after zinc 
addition rearranges to a morphology closer to the one observed in the control 
fibroblasts [4]. Therefore, we have used fibroblasts from AE patient, displaying 
low cellular zinc uptake and content, to address the interplay between zinc 
availability and vimentin function as well as its impact on the lipoxidation 
induced by HNE.  
Supplementation with zinc and treatment with HNE have clear effects not 
only on the vimentin network but also in the overall state of the cell, namely on 
the cell size and on the actin microfilament system, in both control and zinc-
deficient fibroblasts (fig. 28 and fig. 29).  
Interestingly, the extent of the effects of HNE varies depending on the 
cell model and the feature under study. For instance, the effects of HNE on the 
retraction of vimentin appear to be similar in control and zinc-deficient cells, 
whereas the effect on cell shrinking is stronger in control and the effects on 
actin appear to be more marked in zinc-deficient fibroblasts. Nevertheless, 
differences between both cell types should be interpreted cautiously for the 
reasons given in the following section.  
Remarkably, most of HNE-induced alterations are significantly attenuated 
by previous supplementation with zinc, both in control and zinc-deficient 
fibroblasts (fig. 28 and fig. 29). Therefore, these observations substantiate the 
protective role of this divalent cation against the cytoskeletal reorganization 























Figure 36. Importance of zinc availability in the response of vimentin to (lip)oxidative 
stress induced by diamide and HNE.  
Cell treatment with diamide induces fragmentation of vimentin network, whereas HNE provokes 
reorganization of the network into thicker filaments, appearing closer to the perinuclear area of 
the cell. In stress conditions, prior supplementation with zinc attenuates the effects of diamide  




















































3.7 Proteomic studies unveil effects of zinc and HNE on the 
abundance of proteins involved in cytoskeletal organization 
 
Quantitative proteomics was used in an attempt to obtain a more 
systematic view of the changes in cellular homeostasis induced by HNE and 
zinc (tables 5 and 6). In control fibroblasts, only 6 proteins suffered significant 
changes across the different experimental conditions. In contrast, 55 proteins 
were differentially regulated in zinc-deficient fibroblasts, indicating a higher 
susceptibility to HNE and zinc treatment. Nevertheless, as control and AE 
fibroblasts were derived from individual donors, we will not attempt to make a 
direct comparison of their response to the different experimental conditions, 
since they could be influenced by factors as donor age or genetic background. 
For this, our aim is to compare the distinct conditions within each cell model, 
separately. 
In control fibroblasts, functional analysis has demonstrated that the 
proteins which suffered the higher variation of its abundance are reported to 
bind zinc and to be involved in the reorganization of the cytoskeletal network. 
This is the case of the zinc-finger protein 613 (Q6PF04), a transcription factor 
belonging to the abundant family of zinc-finger proteins (ZNFs) [194]. 
Nevertheless, the function of this protein is still not well characterized.  Other 
important examples are the myosin light chain kinase and the actin-related 
protein 2/3 complex subunit 4, which modulates the movement of actin 
filaments and regulates actin polymerization, respectively [303, 304]. Therefore, 
these proteins are important for actin-driven processes, such as the formation of 
filopodia, lamellipodia and stress fibers and consequently, important for cell 
migration, adhesion and shape [305]. Remarkably, there is a complex interplay 
between actin and vimentin, both in resting and in dividing cells [67, 306]. 
Indeed, plectin-mediated interaction between contractile actomyosin arcs and 
vimentin filaments controls the localization and dynamics of these two 
cytoskeletal systems and it is therefore important for cell morphogenesis [307]. 
Thus, we could assume that changes in the actin system may have putative 
functional outcomes in the vimentin network, and the other way around.  
Regarding zinc-deficient fibroblasts, analysis of the biological function 




associated to cell junction formation or to cell adhesion, thus being closely 
involved in the reorganization of the cytoskeletal network that is required for 
these cellular processes, although the amplitude of the changes observed in 
most proteins was limited. In particular, annexin A2, calponin-2, paxillin and 
integrin-linked protein kinase are reported to bind actin, inducing conformational 
changes and regulating its dynamics [263, 308]. Besides being involved in cell-
adhesion processes, these proteins also play an important role in the 
transduction of extracellular signals into intracellular responses, and 
consequently they are significant mediators of the cell response to lipoxidative 
stress [309]. In particular, catenin alpha-1 and catenin delta-1 are moderately 
up-regulated in all conditions. These proteins are able to bind actin and to form 
a dynamic complex with cadherin, participating in the formation of adherens 
junctions, which are key contributors to tissue morphogenesis and homeostasis 
[264]. Nevertheless, the extent of the changes observed is in general small. 
Moreover, there do not seem to be changes elicited by HNE that are reverted in 
the zinc-supplemented cells. Indeed, in some cases, both zinc and HNE induce 
changes in protein abundance, that although small, go in the same direction. 
Interesting studies have described that certain oxidized phospholipids 
exhibit potent barrier-protective effects in lung endothelial cell barrier 
dysfunction, putatively through enhancement of peripheral actin cytoskeleton, 
cell-cell and cell-substrate contacts [310, 311]. Thus, HNE- and zinc-mediated 
regulation of different classes of cell adhesive structures may have a prominent 
role in the cell response to lipoxidative stress. Nevertheless, the functional 
consequences warrant further investigation in order to understand whether this 
interaction is beneficial or detrimental for cell homeostasis.  
Remarkably, HNE and zinc plus HNE treatments caused an increase of 
the levels of several ribosomal proteins involved in signal recognition particle 
SRP-dependent cotranslational protein targeting to membrane. These proteins 
constitute essential cellular machinery that mediates the proper localization of 
membrane and secretory proteins, ensuring the correct membrane protein 
biogenesis for cell structure and function, and contributing to the effectiveness 
of cellular adaptive responses to the stress caused by compromised protein 
biogenesis [312]. Moreover, the cotranslational protein translocation pathway 




eliminate unfolded/damaged non-functional proteins [313]. Therefore, these 
observations suggest that HNE-induced lipoxidation and/or supplementation 
with zinc could trigger important cellular adaptive pathways in order to restore 
cell homeostasis, either by activating cell machinery involved in protein 
biogenesis, therefore contributing to protein turnover and guaranteeing the 
optimal protein functioning, or by up-regulating pathways responsible for the 
efficient elimination of damaged proteins. 
Notably, no significant changes were observed in the levels of vimentin 
during the time frame of these treatments. Nevertheless, previous studies have 
reported an effect of zinc on vimentin levels in lung cancer cells [314] and in 
renal tubular epithelial cells [315]. Moreover, earlier proteomic studies, in 
several experimental models and in samples from patients, have identified 
HNE-adducts in vimentin, as well in other cytoskeletal proteins, such as tubulin 
and actin [167, 316]. Immunofluorescence studies, using anti-vimentin and anti-
HNE adduct antibodies, have shown colocalization of HNE at the edges of the 
vimentin network where the intermediate filaments are less organized and do no 
reach the cell periphery, in senescent fibroblasts [316]. Thus, hypothetically, the 
changes observed in the vimentin network could be the direct result of the 
modification by HNE and/or interaction with zinc, or could arise from indirect 
effects occurring in other proteins or structures that affect vimentin organization. 
Future studies will focus on the PTMs of vimentin induced by HNE and zinc as 
well as in the development of models to elucidate the mechanisms underlying 
their functional consequences. 
 In summary, our results unveil novel features of vimentin assembly in 
vitro and in cells, highlighting the modulatory effect of (lip)oxidation and zinc 
availability. Moreover, they open novel perspectives for the study of other IF 
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As the result of the work presented in this thesis, in which the effect of 
lipoxidation on vimentin organization as well as the functional and structural 
consequences of the vimentin-zinc interaction were addressed, we have 
reached the following conclusions:  
 
1. The chelator agent, EDTA, present in protein preparations, is often 
inefficiently removed by dialysis. 
2. NMR detection of the complex formed between EDTA and zinc and the 
colorimetric assay monitoring the competition between EDTA and the zinc-
binding compound PAR are adequate methods for an initial assessment of 
the presence of this chelator agent. 
3. Ultrafiltration followed by dialysis achieve an efficient removal of EDTA from 
purified vimentin preparations, allowing the functional refolding of the 
protein, in the absence of metal chelators. 
 
These results shed light on the importance of effective methods to 
detect and remove EDTA from protein preparations. 
 
4. Vimentin is susceptible to modification by structurally diverse electrophilic 
compounds. The functional consequences of the modification depend on the 
reactivity and chemical structure of the modifying agents. 
5. The single cysteine residue of vimentin, C328, is particularly reactive, arising 
as an important hot spot for (lip)oxidative modifications and as a hinge 
influencing the morphological changes in vimentin configuration in response 
to lipoxidation. 
6. The impact of treatment with lipoxidants on vimentin organization is strongly 
dependent on its polymerization state, in such a way that modification of 
isolated subunits is more deleterious than that of preformed filaments. 
7. In cells, the vimentin network can be intensely remodeled by treatment with 
electrophilic compounds. This effect requires an active dynamics/subunit 
exchange and is modulated by the presence of the single cysteine residue. 
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Taken together, these results unveil the role of the cysteine residue, 
C328, and filament dynamics in the functional outcome of vimentin 
lipoxidation  
 
8. Zinc reversibly induces vimentin assembly into larger structures, possibly by 
inducing lateral association of vimentin oligomers. This outcome is not 
mimicked by other salts, such as MgCl2 and NaCl. 
9. The functional consequence of the exposure of vimentin to zinc and the 
morphology of the assemblies formed depend on the support used and on 
the polymerization state of the protein.  
10. The cysteine residue, C328, is important for zinc-induced morphological 
alterations of vimentin preformed filaments. 
11. Zinc protects vimentin from in vitro modification by various electrophilic 
compounds and crosslinkers targeting the cysteine residue. 
12. In cells, prior supplementation with zinc attenuates the remodeling of the 
vimentin network induced by diamide and some of the morphological and 
cytoskeletal alterations provoked by HNE. 
 
These results indicate that zinc induces vimentin polymerization and 
protects it from modification by electrophilic compounds in vitro, 
putatively through interaction with its cysteine residue. Zinc also exerts 
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Como resultado del trabajo presentado en esta Tesis, en la que se ha 
estudiado el efecto de la lipoxidación sobre la organización de la vimentina, así 
como las consecuencias funcionales y estructurales de la interacción 
vimentina-zinc, se han alcanzado las siguientes conclusiones: 
 
1. El agente quelante, EDTA, presente en las preparaciones de proteínas, no 
se elimina de manera eficiente mediante diálisis. 
2. La detección mediante RMN del complejo formado entre EDTA y zinc y el 
ensayo colorimétrico basado en la competición entre EDTA y el compuesto 
PAR, capaz de unir zinc, son métodos adecuados para una evaluación 
inicial de la presencia de este agente quelante en las preparaciones de 
proteínas. 
3. La ultrafiltración seguida de diálisis logra una eliminación eficiente de EDTA 
de las preparaciones de vimentina, permitiendo el plegamiento funcional de 
la proteína, en ausencia de quelantes de metales. 
 
Estos resultados destacan la importancia de utilizar métodos efectivos 
para detectar y eliminar el EDTA de las preparaciones de proteínas. 
 
4. La vimentina es susceptible de modificación por compuestos electrófilos 
estructuralmente diversos. Las consecuencias funcionales de la 
modificación dependen de la reactividad y la estructura química de los 
agentes implicados.  
5. El único residuo de cisteína de la vimentina, C328, es particularmente 
reactivo, y se destaca como una diana importante de modificaciones 
(lip)oxidativas e que influyen en los cambios morfológicos en la 
conformación de los filamentos de vimentina en respuesta a la lipoxidación. 
6. El impacto del tratamiento con lipoxidantes en la organización de la 
vimentina depende en gran medida de su estado de polimerización, de tal 
manera que la modificación de las subunidades aisladas es más perjudicial 
que la de los filamentos preformados. 
7. En las células, la trama de filamentos de la vimentina puede sufrir una 
intensa remodelación en respuesta al tratamiento con compuestos 
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electrófilos. Este efecto requiere un intercambio activo de subunidades y 
está modulado por la presencia del único residuo de cisteína, C328. 
 
En conjunto, estos resultados revelan el papel del residuo de cisteína, 
C328, y la dinámica de los filamentos en las consecuencias funcionales 
de la lipoxidación de vimentina. 
 
8. El zinc induce el ensamblaje de vimentina en estructuras de mayor tamaño de 
forma reversible, posiblemente favoreciendo la asociación lateral de oligómeros 
de vimentina. Este resultado no se observa tras la incubación de vimentina con 
otras sales, como MgCl2 y NaCl. 
9. La consecuencia funcional de la exposición de vimentina al zinc y la morfología 
de los complejos formados dependen del soporte utilizado y del estado de 
polimerización de la proteína. 
10. El residuo de cisteína, C328, es importante para las alteraciones morfológicas 
de los filamentos preformados de vimentina inducidas por zinc.  
11. El zinc protege la vimentina de la modificación in vitro por diversos compuestos 
electrófilos y agentes de crosslinking dirigidos al residuo de cisteína. 
12. En las células, el suplemento previo con  zinc atenúa la remodelación de la 
trama de filamentos de vimentina inducida por diamida y algunas de las 
alteraciones provocadas por HNE en proteínas del citoesqueleto. 
 
Estos resultados indican que el zinc induce la polimerización de 
vimentina y la protege de la modificación por compuestos electrófilos in 
vitro, potencialmente a través de la interacción con su residuo de cisteína. 
El zinc también ejerce efectos protectores complejos sobre las 
alteraciones inducidas por (lip)oxidación en las células. 
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